{
  "type": "FeatureCollection",
  "features": [
    {
      "type": "Feature",
      "id": "12",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.793937,
            4.985354
          ],
          [
            -21.792589,
            4.863656
          ],
          [
            -21.766266,
            2.475355
          ],
          [
            -21.764933,
            2.354004
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "1",
        "dest": "2",
        "label": "Progesterone Receptor Signaling Mechanisms. -- The biology of progesterone receptor in the normal mammary gland and in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "13",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.794767,
            4.995078
          ],
          [
            -21.816208,
            5.129974
          ],
          [
            -22.272981,
            7.995233
          ],
          [
            -22.294384,
            8.129031
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "1",
        "dest": "3",
        "label": "Progesterone Receptor Signaling Mechanisms. -- Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "24",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.758641,
            2.344409
          ],
          [
            -21.427765,
            2.08912
          ],
          [
            -8.039669,
            -8.219507
          ],
          [
            -7.706325,
            -8.47417
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "4",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.032629,
            2.348988
          ],
          [
            -23.634189,
            2.34758
          ],
          [
            -31.936016,
            2.340277
          ],
          [
            -33.68227,
            2.338742
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "5",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Interplay between progesterone and prolactin in mammary development and implications for breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.769762,
            2.344333
          ],
          [
            -21.877241,
            2.236767
          ],
          [
            -23.723205,
            0.388435
          ],
          [
            -23.829473,
            0.281993
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "7",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- From the ranks of mammary progesterone mediators, RANKL takes the spotlight.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "210",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.7682,
            2.354181
          ],
          [
            -21.892756,
            2.539961
          ],
          [
            -25.476664,
            7.866614
          ],
          [
            -25.599125,
            8.047681
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "10",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone/RANKL is a major regulatory axis in the human breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "214",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.772618,
            2.353972
          ],
          [
            -22.151792,
            2.586874
          ],
          [
            -36.344316,
            11.240461
          ],
          [
            -36.725394,
            11.470163
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "14",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "231",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.770142,
            2.354004
          ],
          [
            -21.881719,
            2.455377
          ],
          [
            -23.731659,
            4.134885
          ],
          [
            -23.843564,
            4.236379
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "2",
        "dest": "31",
        "label": "The biology of progesterone receptor in the normal mammary gland and in breast cancer. -- Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "48",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.669826,
            -8.474257
          ],
          [
            -6.718144,
            -8.324512
          ],
          [
            16.441768,
            -4.665126
          ],
          [
            17.391287,
            -4.514584
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "8",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "419",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.706249,
            -8.483718
          ],
          [
            -7.990907,
            -8.698324
          ],
          [
            -17.901758,
            -16.073432
          ],
          [
            -18.187217,
            -16.282462
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "19",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "420",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.72184,
            -8.474289
          ],
          [
            -8.078012,
            -8.397419
          ],
          [
            -12.67433,
            -7.404081
          ],
          [
            -13.030638,
            -7.32698
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "20",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "422",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.725633,
            -8.48373
          ],
          [
            -7.938154,
            -8.522915
          ],
          [
            -9.405348,
            -8.793308
          ],
          [
            -9.617709,
            -8.832429
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "4",
        "dest": "22",
        "label": "Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. -- A role for site-specific phosphorylation of mouse progesterone receptor at serine 191 in vivo.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "56",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.327593,
            2.342179
          ],
          [
            -35.559957,
            2.356366
          ],
          [
            -39.955378,
            2.406974
          ],
          [
            -41.067056,
            2.419772
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "6",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- Progesterone regulation of stem and progenitor cells in normal and malignant breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "527",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.008561,
            2.343272
          ],
          [
            -34.129719,
            2.500063
          ],
          [
            -37.171724,
            6.427415
          ],
          [
            -37.293469,
            6.584096
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "27",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- The pivotal role of insulin-like growth factor I in normal mammary development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "533",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.017952,
            2.343208
          ],
          [
            -34.306289,
            2.447557
          ],
          [
            -39.256182,
            4.237382
          ],
          [
            -39.545973,
            4.342052
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "5",
        "dest": "33",
        "label": "Interplay between progesterone and prolactin in mammary development and implications for breast cancer. -- Hormonal regulation of the immune microenvironment in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1059",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.602728,
            8.057264
          ],
          [
            -25.613178,
            8.184434
          ],
          [
            -25.826483,
            10.770569
          ],
          [
            -25.836888,
            10.896246
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "10",
        "dest": "59",
        "label": "Progesterone/RANKL is a major regulatory axis in the human breast. -- Comment on \"Progesterone/RANKL is a major regulatory axis in the human breast\".",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1060",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.606628,
            8.057264
          ],
          [
            -25.758383,
            8.22821
          ],
          [
            -29.883144,
            12.841385
          ],
          [
            -30.036163,
            13.011088
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "10",
        "dest": "60",
        "label": "Progesterone/RANKL is a major regulatory axis in the human breast. -- RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1478",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.746835,
            11.479568
          ],
          [
            -37.055036,
            11.58574
          ],
          [
            -42.491368,
            13.451648
          ],
          [
            -42.799036,
            13.556833
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "78",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1479",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.739751,
            11.479717
          ],
          [
            -36.984871,
            11.66125
          ],
          [
            -44.037935,
            16.827195
          ],
          [
            -44.278935,
            17.001502
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "79",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "1482",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.969973,
            11.479519
          ],
          [
            -38.342835,
            11.506468
          ],
          [
            -45.267794,
            11.642353
          ],
          [
            -46.641211,
            11.669293
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "82",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1484",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.736392,
            11.47963
          ],
          [
            -36.845798,
            11.643121
          ],
          [
            -39.739955,
            15.929252
          ],
          [
            -39.850138,
            16.090799
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "14",
        "dest": "84",
        "label": "Progesterone receptor A stability is mediated by glycogen synthase kinase-3\u03b2 in the Brca1-deficient mammary gland. -- Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "31196",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.854166,
            4.246025
          ],
          [
            -23.973085,
            4.35454
          ],
          [
            -26.052318,
            6.249073
          ],
          [
            -26.169988,
            6.356112
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "31",
        "dest": "196",
        "label": "Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. -- Harmful effect of ER\u03b2 on BCRP-mediated drug resistance and cell proliferation in ER\u03b1/PR-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.422561,
            -4.505004
          ],
          [
            17.501828,
            -4.199137
          ],
          [
            21.327314,
            10.541035
          ],
          [
            21.407625,
            10.846428
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "9",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "811",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.418554,
            -4.514773
          ],
          [
            17.368962,
            -4.603688
          ],
          [
            16.667275,
            -5.86049
          ],
          [
            16.617995,
            -5.948649
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "11",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Paracrine-rescued lobulogenesis in chimeric outgrowths comprising progesterone-receptor-null mammary epithelium and redirected wild-type testicular cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "812",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.426895,
            -4.514691
          ],
          [
            17.717113,
            -4.767675
          ],
          [
            29.229844,
            -14.678699
          ],
          [
            29.516498,
            -14.921075
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "12",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "813",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.416528,
            -4.504985
          ],
          [
            17.313231,
            -4.400457
          ],
          [
            15.570785,
            -2.635277
          ],
          [
            15.467084,
            -2.530122
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "13",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "815",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.58638,
            -4.514558
          ],
          [
            18.146968,
            -4.530636
          ],
          [
            19.973952,
            -4.583025
          ],
          [
            20.534174,
            -4.599094
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "15",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "821",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.420588,
            -4.505016
          ],
          [
            17.403009,
            -4.388537
          ],
          [
            17.071813,
            -2.191505
          ],
          [
            17.054363,
            -2.075608
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "21",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "849",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.433224,
            -4.505054
          ],
          [
            17.746803,
            -4.379466
          ],
          [
            24.147491,
            -1.812257
          ],
          [
            24.459835,
            -1.686842
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "8",
        "dest": "49",
        "label": "Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. -- A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1923",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.327089,
            -16.291625
          ],
          [
            -19.192466,
            -16.321145
          ],
          [
            -23.996392,
            -16.484965
          ],
          [
            -24.861846,
            -16.514461
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "23",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1926",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.193584,
            -16.291747
          ],
          [
            -18.197027,
            -16.49401
          ],
          [
            -18.310797,
            -23.052784
          ],
          [
            -18.31424,
            -23.246885
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "26",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Progesterone receptor A-regulated gene expression in mammary organoid cultures.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "19104",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.194445,
            -16.291783
          ],
          [
            -18.220875,
            -16.42454
          ],
          [
            -18.796376,
            -19.29151
          ],
          [
            -18.822775,
            -19.421892
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "104",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "19105",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.198131,
            -16.29168
          ],
          [
            -18.443457,
            -16.536517
          ],
          [
            -28.370006,
            -26.141306
          ],
          [
            -28.61716,
            -26.371911
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "105",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "19107",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.202366,
            -16.291753
          ],
          [
            -18.430554,
            -16.412497
          ],
          [
            -22.99323,
            -18.810385
          ],
          [
            -23.220336,
            -18.928882
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "107",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19111",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.197392,
            -16.291717
          ],
          [
            -18.284512,
            -16.395946
          ],
          [
            -19.807788,
            -18.209061
          ],
          [
            -19.894001,
            -18.311129
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "111",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19114",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.220997,
            -16.291619
          ],
          [
            -18.543083,
            -16.344933
          ],
          [
            -21.592567,
            -16.84901
          ],
          [
            -21.914776,
            -16.902194
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "19",
        "dest": "114",
        "label": "Progesterone receptor directly inhibits \u03b2-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. -- Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "2048",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -13.386299,
            -7.317543
          ],
          [
            -14.468295,
            -7.302293
          ],
          [
            -17.871094,
            -7.254338
          ],
          [
            -18.952998,
            -7.239086
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "20",
        "dest": "48",
        "label": "Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse. -- Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "635",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.344661,
            2.427515
          ],
          [
            -41.716446,
            2.513459
          ],
          [
            -46.975713,
            3.728503
          ],
          [
            -47.347605,
            3.814366
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "6",
        "dest": "35",
        "label": "Progesterone regulation of stem and progenitor cells in normal and malignant breast. -- Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "640",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.337692,
            2.417927
          ],
          [
            -41.513881,
            2.356265
          ],
          [
            -43.329713,
            1.72063
          ],
          [
            -43.504859,
            1.659308
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "6",
        "dest": "40",
        "label": "Progesterone regulation of stem and progenitor cells in normal and malignant breast. -- Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "27158",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.291207,
            6.593692
          ],
          [
            -37.161167,
            6.696646
          ],
          [
            -34.967547,
            8.429807
          ],
          [
            -34.836989,
            8.532736
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "158",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27159",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.294779,
            6.593711
          ],
          [
            -37.228849,
            6.722357
          ],
          [
            -35.854525,
            9.395543
          ],
          [
            -35.788793,
            9.522921
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "159",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- On the possible role of mammary-derived growth hormone in human breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "27161",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.293263,
            6.584172
          ],
          [
            -37.224287,
            6.501446
          ],
          [
            -36.277167,
            5.364149
          ],
          [
            -36.206972,
            5.279761
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "27",
        "dest": "161",
        "label": "The pivotal role of insulin-like growth factor I in normal mammary development. -- Critical questions in mammary gland development, lactational biology and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "33202",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.726786,
            4.342103
          ],
          [
            -40.226958,
            4.327969
          ],
          [
            -41.70541,
            4.286185
          ],
          [
            -42.205308,
            4.272063
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "202",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33203",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.562563,
            4.351672
          ],
          [
            -39.636102,
            4.457928
          ],
          [
            -40.898582,
            6.279408
          ],
          [
            -40.972495,
            6.385862
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "203",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33204",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.58082,
            4.351609
          ],
          [
            -39.85796,
            4.412779
          ],
          [
            -42.713653,
            5.042752
          ],
          [
            -42.990481,
            5.103792
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "204",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Hormonal regulation of the cytokine microenvironment in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33205",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.566752,
            4.35164
          ],
          [
            -39.713381,
            4.445107
          ],
          [
            -41.952617,
            5.87079
          ],
          [
            -42.098979,
            5.963852
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "33",
        "dest": "205",
        "label": "Hormonal regulation of the immune microenvironment in the mammary gland. -- Stromal fibroblasts and the immune microenvironment: partners in mammary gland biology and pathology?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60337",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.040977,
            13.020703
          ],
          [
            -30.053042,
            13.14915
          ],
          [
            -30.304583,
            15.810556
          ],
          [
            -30.31661,
            15.937015
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "337",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60338",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.042798,
            13.020721
          ],
          [
            -30.106587,
            13.155497
          ],
          [
            -31.495543,
            16.070424
          ],
          [
            -31.559264,
            16.203191
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "338",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "60339",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -30.047512,
            13.020573
          ],
          [
            -30.203997,
            13.124524
          ],
          [
            -32.938699,
            14.933878
          ],
          [
            -33.096136,
            15.037593
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "60",
        "dest": "339",
        "label": "RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. -- Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78459",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.816128,
            13.566101
          ],
          [
            -42.896423,
            13.671715
          ],
          [
            -44.32526,
            15.543051
          ],
          [
            -44.406126,
            15.648474
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "459",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal physical activity up-regulates estrogen receptor beta, BRCA1 and p53 mRNA expression in the rat mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78460",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.841857,
            13.556833
          ],
          [
            -43.121572,
            13.51248
          ],
          [
            -45.319686,
            13.163623
          ],
          [
            -45.598685,
            13.119309
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "460",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal exposure to cow's milk reduces susceptibility to carcinogen-induced mammary tumorigenesis in rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78461",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.883429,
            13.566082
          ],
          [
            -43.340422,
            13.595844
          ],
          [
            -45.868895,
            13.760445
          ],
          [
            -46.326833,
            13.790243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "461",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78462",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.836883,
            13.566107
          ],
          [
            -43.161613,
            13.628096
          ],
          [
            -46.640564,
            14.291197
          ],
          [
            -46.966002,
            14.353127
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "462",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Prepubertal genistein exposure affects erbB2/Akt signal and reduces rat mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78463",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.821444,
            13.566101
          ],
          [
            -43.012067,
            13.666039
          ],
          [
            -46.227679,
            15.345199
          ],
          [
            -46.419063,
            15.444734
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "463",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Lack of ABCG2 shortens latency of BRCA1-deficient mammary tumors and this is not affected by genistein or resveratrol.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "78464",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.819906,
            13.566132
          ],
          [
            -42.974509,
            13.664872
          ],
          [
            -45.537912,
            15.295756
          ],
          [
            -45.692972,
            15.394015
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "78",
        "dest": "464",
        "label": "Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression. -- Segregated responses of mammary gland development and vaginal opening to prepubertal genistein exposure in Bscl2(-/-) female mice with lipodystrophy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79466",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.285767,
            17.01071
          ],
          [
            -44.299904,
            17.138165
          ],
          [
            -44.601022,
            19.831343
          ],
          [
            -44.615128,
            19.956457
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "466",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79467",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.326912,
            17.010613
          ],
          [
            -44.746813,
            17.056353
          ],
          [
            -48.208511,
            17.433011
          ],
          [
            -48.629516,
            17.478762
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "467",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "79468",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.290261,
            17.010686
          ],
          [
            -44.413925,
            17.124602
          ],
          [
            -46.789348,
            19.298866
          ],
          [
            -46.912213,
            19.410568
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "468",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79469",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.287953,
            17.010782
          ],
          [
            -44.3622,
            17.140322
          ],
          [
            -45.943721,
            19.877094
          ],
          [
            -46.017808,
            20.004209
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "469",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- BRCA1, hormone, and tissue-specific tumor suppression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79470",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.299409,
            17.010631
          ],
          [
            -44.547819,
            17.090668
          ],
          [
            -47.985883,
            18.194802
          ],
          [
            -48.234012,
            18.274224
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "470",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "79471",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -44.291959,
            17.010674
          ],
          [
            -44.457698,
            17.124342
          ],
          [
            -47.641206,
            19.293806
          ],
          [
            -47.805863,
            19.405267
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "79",
        "dest": "471",
        "label": "BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. -- TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82488",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.883346,
            11.678598
          ],
          [
            -47.011077,
            11.793551
          ],
          [
            -49.463352,
            13.990768
          ],
          [
            -49.592585,
            14.106006
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "488",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- HIF-1\u03b1 overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82489",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.97978,
            11.678592
          ],
          [
            -47.591004,
            11.706563
          ],
          [
            -50.773049,
            11.852125
          ],
          [
            -51.384135,
            11.880066
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "489",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "82490",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.884298,
            11.669237
          ],
          [
            -47.016447,
            11.567649
          ],
          [
            -49.245591,
            9.848681
          ],
          [
            -49.378259,
            9.746076
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "490",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "82491",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.893072,
            11.66925
          ],
          [
            -47.134209,
            11.59324
          ],
          [
            -50.22512,
            10.617195
          ],
          [
            -50.466233,
            10.540923
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "491",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Expression microarray identifies the unliganded glucocorticoid receptor as a regulator of gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82492",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.895022,
            11.678642
          ],
          [
            -47.179802,
            11.758069
          ],
          [
            -50.984054,
            12.816839
          ],
          [
            -51.267859,
            12.895652
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "492",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "82493",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.886826,
            11.678623
          ],
          [
            -47.077106,
            11.78147
          ],
          [
            -50.343673,
            13.540804
          ],
          [
            -50.534913,
            13.643419
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "493",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1 through GABP beta.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "82494",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -46.966832,
            11.669287
          ],
          [
            -47.494699,
            11.641573
          ],
          [
            -50.218562,
            11.498526
          ],
          [
            -50.746185,
            11.470808
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "82",
        "dest": "494",
        "label": "Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. -- Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84502",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.85368,
            16.100123
          ],
          [
            -39.862675,
            16.232171
          ],
          [
            -40.062963,
            19.14847
          ],
          [
            -40.071959,
            19.278274
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "502",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "84503",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.860748,
            16.100104
          ],
          [
            -40.001847,
            16.187509
          ],
          [
            -42.122042,
            17.496146
          ],
          [
            -42.264741,
            17.583897
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "503",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84504",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.851814,
            16.100147
          ],
          [
            -39.813395,
            16.214203
          ],
          [
            -39.075369,
            18.391721
          ],
          [
            -39.037194,
            18.503634
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "504",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Myc is required for \u03b2-catenin-mediated mammary stem cell amplification and tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "84505",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.85796,
            16.100135
          ],
          [
            -39.973643,
            16.216097
          ],
          [
            -42.239339,
            18.472918
          ],
          [
            -42.35653,
            18.588877
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "505",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "84506",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.855645,
            16.100129
          ],
          [
            -39.919701,
            16.229409
          ],
          [
            -41.314263,
            19.022175
          ],
          [
            -41.378235,
            19.149223
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "84",
        "dest": "506",
        "label": "Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. -- Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "947",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.407092,
            10.855972
          ],
          [
            21.291661,
            11.151913
          ],
          [
            15.721207,
            24.945291
          ],
          [
            15.60426,
            25.221939
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "47",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "950",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.419484,
            10.85604
          ],
          [
            21.612506,
            10.942449
          ],
          [
            24.384369,
            12.1805
          ],
          [
            24.576325,
            12.266032
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "50",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Epimorphin is a novel regulator of the progesterone receptor isoform-a.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "951",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.413223,
            10.856146
          ],
          [
            21.557742,
            11.018203
          ],
          [
            25.282818,
            15.160963
          ],
          [
            25.424641,
            15.317238
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "51",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "952",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.392338,
            10.856021
          ],
          [
            21.072506,
            10.947061
          ],
          [
            16.22665,
            12.322848
          ],
          [
            15.907572,
            12.413193
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "52",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "953",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.437657,
            10.855978
          ],
          [
            21.88091,
            10.92803
          ],
          [
            27.306144,
            11.80844
          ],
          [
            27.750441,
            11.880418
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "9",
        "dest": "53",
        "label": "The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. -- Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1241",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            29.633635,
            -14.930263
          ],
          [
            30.034753,
            -14.946737
          ],
          [
            31.399921,
            -15.002802
          ],
          [
            31.800833,
            -15.019265
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "41",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- High hopes for RANKL: will the mouse model live up to its promise?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "1242",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            29.528167,
            -14.93033
          ],
          [
            29.647399,
            -15.019412
          ],
          [
            31.439779,
            -16.354009
          ],
          [
            31.558676,
            -16.442222
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "42",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "1244",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            29.558047,
            -14.921088
          ],
          [
            29.922056,
            -14.874832
          ],
          [
            32.922915,
            -14.493119
          ],
          [
            33.287876,
            -14.446651
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "44",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1245",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            29.534733,
            -14.930306
          ],
          [
            29.757551,
            -15.010869
          ],
          [
            32.818666,
            -16.114513
          ],
          [
            33.042566,
            -16.195002
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "45",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- RANKL inhibition: a promising novel strategy for breast cancer treatment.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1246",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            29.525303,
            -14.930263
          ],
          [
            29.686952,
            -15.150774
          ],
          [
            35.626229,
            -23.0697
          ],
          [
            35.788593,
            -23.280537
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "46",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1269",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            29.542174,
            -14.92102
          ],
          [
            29.971458,
            -14.822193
          ],
          [
            37.090726,
            -13.176847
          ],
          [
            37.517908,
            -13.077753
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "69",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1270",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            29.5187,
            -14.930263
          ],
          [
            29.400778,
            -15.096987
          ],
          [
            26.105176,
            -19.699258
          ],
          [
            25.986135,
            -19.863241
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "12",
        "dest": "70",
        "label": "RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. -- Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1376",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.462643,
            -2.520484
          ],
          [
            15.4724,
            -2.400798
          ],
          [
            15.663427,
            -0.055401
          ],
          [
            15.673306,
            0.065951
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "13",
        "dest": "76",
        "label": "Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. -- Hormone action in the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1585",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.090314,
            -4.601716
          ],
          [
            21.852515,
            -4.59762
          ],
          [
            23.51296,
            -4.588696
          ],
          [
            24.10141,
            -4.585539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "15",
        "dest": "85",
        "label": "The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse. -- Wnt4 is not sufficient to induce lobuloalveolar mammary development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49235",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.477316,
            -1.677287
          ],
          [
            24.606571,
            -1.567486
          ],
          [
            26.906809,
            0.387183
          ],
          [
            27.036986,
            0.497815
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "235",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49278",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.477697,
            -1.687032
          ],
          [
            24.601361,
            -1.788018
          ],
          [
            26.5839,
            -3.405999
          ],
          [
            26.707686,
            -3.506949
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "278",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49279",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.48299,
            -1.677306
          ],
          [
            24.872759,
            -1.51265
          ],
          [
            35.183288,
            2.843487
          ],
          [
            35.575837,
            3.009174
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "279",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49280",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.474886,
            -1.677281
          ],
          [
            24.551563,
            -1.562968
          ],
          [
            25.967984,
            0.549224
          ],
          [
            26.045385,
            0.664651
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "280",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Conditional deletion of \u03b2-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49281",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.481604,
            -1.686893
          ],
          [
            24.678526,
            -1.781787
          ],
          [
            27.734111,
            -3.253409
          ],
          [
            27.93085,
            -3.348095
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "281",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49282",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.481657,
            -1.677268
          ],
          [
            24.676363,
            -1.583317
          ],
          [
            27.649718,
            -0.148183
          ],
          [
            27.844057,
            -0.05437
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "282",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "49283",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.516542,
            -1.677351
          ],
          [
            24.937752,
            -1.632824
          ],
          [
            28.190868,
            -1.288904
          ],
          [
            28.61319,
            -1.244256
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "283",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Corneal morphogenesis during development and diseases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "49284",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.494956,
            -1.686849
          ],
          [
            24.822649,
            -1.753604
          ],
          [
            28.500874,
            -2.502793
          ],
          [
            28.828887,
            -2.569583
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "284",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "49285",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.64016,
            -1.686842
          ],
          [
            25.269055,
            -1.704549
          ],
          [
            27.474999,
            -1.766653
          ],
          [
            28.103649,
            -1.784353
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "285",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- A bioluminescence reporter mouse that monitors expression of constitutively active \u03b2-catenin.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "49286",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.472235,
            -1.677294
          ],
          [
            24.485755,
            -1.565483
          ],
          [
            24.730875,
            0.462047
          ],
          [
            24.744509,
            0.574827
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "49",
        "dest": "286",
        "label": "A mouse transgenic approach to induce \u03b2-catenin signaling in a temporally controlled manner. -- In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-O\u0394N89\u03b2-catenin system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "23125",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.018171,
            -16.523565
          ],
          [
            -25.844748,
            -16.689091
          ],
          [
            -48.949081,
            -21.253455
          ],
          [
            -49.777998,
            -21.414803
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "23",
        "dest": "125",
        "label": "A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells. -- ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "26156",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.316891,
            -23.255807
          ],
          [
            -18.425862,
            -23.444005
          ],
          [
            -21.971025,
            -29.411514
          ],
          [
            -22.081787,
            -29.592836
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "26",
        "dest": "156",
        "label": "Progesterone receptor A-regulated gene expression in mammary organoid cultures. -- Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "26157",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.320318,
            -23.255895
          ],
          [
            -18.48528,
            -23.380083
          ],
          [
            -21.998932,
            -25.996926
          ],
          [
            -22.163544,
            -26.118159
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "26",
        "dest": "157",
        "label": "Progesterone receptor A-regulated gene expression in mammary organoid cultures. -- A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "104631",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.822189,
            -19.431026
          ],
          [
            -18.792057,
            -19.520228
          ],
          [
            -18.324492,
            -20.897845
          ],
          [
            -18.294391,
            -20.986122
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "631",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- The chromatin landscape of the casein gene locus.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "104632",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.824543,
            -19.43099
          ],
          [
            -18.844254,
            -19.537084
          ],
          [
            -19.208317,
            -21.483954
          ],
          [
            -19.228211,
            -21.589623
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "632",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- Lactogenic hormone stimulation and epigenetic control of L-amino acid oxidase expression in lactating mammary glands.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "104633",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -18.828427,
            -19.431121
          ],
          [
            -18.926629,
            -19.526955
          ],
          [
            -20.528189,
            -21.081773
          ],
          [
            -20.625066,
            -21.175318
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "104",
        "dest": "633",
        "label": "Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. -- A functional study of proximal goat \u03b2-casein promoter and intron 1 in immortalized goat mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "105106",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -28.63071,
            -26.380593
          ],
          [
            -28.86372,
            -26.493845
          ],
          [
            -33.620057,
            -28.780718
          ],
          [
            -33.852168,
            -28.891082
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "106",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "105110",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -28.622179,
            -26.380633
          ],
          [
            -28.630466,
            -26.492572
          ],
          [
            -28.796244,
            -28.707545
          ],
          [
            -28.804492,
            -28.816607
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "110",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Oct-1 functions as a transactivator in the hormonal induction of beta-casein gene expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "105634",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -28.624883,
            -26.380718
          ],
          [
            -28.803891,
            -26.642585
          ],
          [
            -36.863172,
            -37.75975
          ],
          [
            -37.040229,
            -37.988239
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "105",
        "dest": "634",
        "label": "Collaborative interaction of Oct-2 with Oct-1 in transactivation of lactogenic hormones-induced \u03b2-casein gene expression in mammary epithelial cells. -- Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "107639",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.232454,
            -18.938091
          ],
          [
            -23.316885,
            -19.05483
          ],
          [
            -24.971206,
            -21.325121
          ],
          [
            -25.055157,
            -21.439438
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "639",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107640",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.270286,
            -18.937971
          ],
          [
            -23.647998,
            -18.979353
          ],
          [
            -26.505191,
            -19.292065
          ],
          [
            -26.882994,
            -19.33337
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "640",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107641",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.237436,
            -18.938007
          ],
          [
            -23.420586,
            -19.037984
          ],
          [
            -26.564746,
            -20.744727
          ],
          [
            -26.748818,
            -20.844071
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "641",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107642",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.241511,
            -18.937983
          ],
          [
            -23.454328,
            -19.015589
          ],
          [
            -26.33671,
            -20.063052
          ],
          [
            -26.550343,
            -20.140416
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "642",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107643",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.274773,
            -18.928966
          ],
          [
            -23.649993,
            -18.892028
          ],
          [
            -26.220388,
            -18.638798
          ],
          [
            -26.596142,
            -18.601749
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "643",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107644",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.230573,
            -18.938085
          ],
          [
            -23.268306,
            -19.057238
          ],
          [
            -24.022868,
            -21.421183
          ],
          [
            -24.060426,
            -21.537889
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "644",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107646",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.235135,
            -18.938073
          ],
          [
            -23.372792,
            -19.043452
          ],
          [
            -25.823719,
            -20.908221
          ],
          [
            -25.960042,
            -21.011283
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "646",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Influence of AKT on progesterone action in endometrial diseases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "107647",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.229133,
            -18.937989
          ],
          [
            -23.229781,
            -19.047605
          ],
          [
            -23.242051,
            -21.097629
          ],
          [
            -23.242706,
            -21.206889
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "107",
        "dest": "647",
        "label": "CDC2 mediates progestin initiated endometrial stromal cell proliferation: a PR signaling to gene expression independently of its binding to chromatin. -- Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "111656",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.8995,
            -18.320228
          ],
          [
            -19.938924,
            -18.427275
          ],
          [
            -20.654024,
            -20.356791
          ],
          [
            -20.693105,
            -20.46156
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "111",
        "dest": "656",
        "label": "A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2. -- Novel role of signal transducer and activator of transcription 3 as a progesterone receptor coactivator in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "111658",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.90212,
            -18.320168
          ],
          [
            -19.993635,
            -18.416359
          ],
          [
            -21.511031,
            -20.003206
          ],
          [
            -21.602819,
            -20.098702
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "111",
        "dest": "658",
        "label": "A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2. -- Progesterone induces expression of the prolactin receptor gene through cooperative action of Sp1 and C/EBP.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114662",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.970385,
            -16.902194
          ],
          [
            -22.225704,
            -16.860942
          ],
          [
            -24.140873,
            -16.551195
          ],
          [
            -24.396885,
            -16.509752
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "662",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114663",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.956096,
            -16.91131
          ],
          [
            -22.142035,
            -16.972869
          ],
          [
            -24.145847,
            -17.635009
          ],
          [
            -24.331351,
            -17.696182
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "663",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- Expression of human MUC1 during early pregnancy in the human MUC1 transgenic mouse model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "114664",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.968207,
            -16.911286
          ],
          [
            -22.254434,
            -16.961561
          ],
          [
            -24.820815,
            -17.411744
          ],
          [
            -25.106882,
            -17.46186
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "114",
        "dest": "664",
        "label": "Cytokine and progesterone receptor interplay in the regulation of MUC1 gene expression. -- MUC1 protein expression in tumor cells regulates transcription of proinflammatory cytokines by forming a complex with nuclear factor-\u03baB p65 and binding to cytokine promoters: importance of extracellular domain.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "48123",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.337397,
            -7.229672
          ],
          [
            -19.798777,
            -7.186764
          ],
          [
            -23.267065,
            -6.864108
          ],
          [
            -23.729016,
            -6.821117
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "48",
        "dest": "123",
        "label": "Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. -- Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "48277",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -19.295642,
            -7.229615
          ],
          [
            -19.441791,
            -7.1514
          ],
          [
            -21.340615,
            -6.133943
          ],
          [
            -21.486893,
            -6.055484
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "48",
        "dest": "277",
        "label": "Strain-specific differences in the mechanisms of progesterone regulation of murine mammary gland development. -- Perfluorooctanoic acid effects on steroid hormone and growth factor levels mediate stimulation of peripubertal mammary gland development in C57BL/6 mice.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "35216",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.392315,
            3.823897
          ],
          [
            -47.660118,
            3.876895
          ],
          [
            -50.084561,
            4.356564
          ],
          [
            -50.352463,
            4.409545
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "216",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- In vivo expansion of the mammary stem/ progenitor cell population by xanthosine infusion.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "35217",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.38853,
            3.814328
          ],
          [
            -47.61783,
            3.759686
          ],
          [
            -49.725305,
            3.257315
          ],
          [
            -49.953082,
            3.203007
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "217",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Immortalized, pre-malignant epithelial cell populations contain long-lived, label-retaining cells that asymmetrically divide and retain their template DNA.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "35218",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.375025,
            3.814328
          ],
          [
            -47.485064,
            3.73526
          ],
          [
            -48.914029,
            2.707862
          ],
          [
            -49.0255,
            2.627678
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "218",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Putative rabbit conjunctival epithelial stem/progenitor cells preferentially reside in palpebral conjunctiva.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "35220",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.374964,
            3.824055
          ],
          [
            -47.494257,
            3.912274
          ],
          [
            -49.182228,
            5.159423
          ],
          [
            -49.300767,
            5.246918
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "220",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- Xanthosine administration does not affect the proportion of epithelial stem cells in bovine mammary tissue, but has a latent negative effect on cell proliferation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "35221",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.369587,
            3.81436
          ],
          [
            -47.394623,
            3.719589
          ],
          [
            -47.78312,
            2.247961
          ],
          [
            -47.808133,
            2.153144
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "35",
        "dest": "221",
        "label": "Progesterone stimulates proliferation of a long-lived epithelial cell population in rat mammary gland. -- In vitro expansion of the mammary stem/progenitor cell population by xanthosine treatment.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "40247",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.526483,
            1.649721
          ],
          [
            -43.646803,
            1.57759
          ],
          [
            -45.073919,
            0.721862
          ],
          [
            -45.193561,
            0.650112
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "40",
        "dest": "247",
        "label": "Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells. -- Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158910",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.828931,
            8.532667
          ],
          [
            -34.795418,
            8.450569
          ],
          [
            -34.34761,
            7.35206
          ],
          [
            -34.314416,
            7.270529
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "910",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158911",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.812753,
            8.532748
          ],
          [
            -34.615245,
            8.480884
          ],
          [
            -32.869615,
            8.022153
          ],
          [
            -32.672503,
            7.970321
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "911",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158912",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.833562,
            8.532711
          ],
          [
            -34.872445,
            8.462012
          ],
          [
            -35.327755,
            7.633176
          ],
          [
            -35.366814,
            7.562
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "912",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Growth hormone potentiates 17\u03b2-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "158913",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.825907,
            8.532711
          ],
          [
            -34.73862,
            8.44893
          ],
          [
            -33.538969,
            7.295651
          ],
          [
            -33.452391,
            7.212297
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "158",
        "dest": "913",
        "label": "Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. -- Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "159914",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -35.75237,
            9.522958
          ],
          [
            -35.450338,
            9.481356
          ],
          [
            -33.230128,
            9.175386
          ],
          [
            -32.92799,
            9.133731
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "159",
        "dest": "914",
        "label": "On the possible role of mammary-derived growth hormone in human breast cancer. -- Androgens and the breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "161919",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.197169,
            5.26989
          ],
          [
            -36.119586,
            5.20264
          ],
          [
            -35.273837,
            4.469071
          ],
          [
            -35.19636,
            4.401836
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "919",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Key signalling nodes in mammary gland development and cancer: Myc.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "161920",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.074061,
            5.270098
          ],
          [
            -35.772318,
            5.259037
          ],
          [
            -35.022433,
            5.23155
          ],
          [
            -34.720507,
            5.220483
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "920",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- The role of activin in mammary gland development and oncogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "161921",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.199332,
            5.279547
          ],
          [
            -36.149976,
            5.345543
          ],
          [
            -35.599237,
            6.081446
          ],
          [
            -35.549858,
            6.147381
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "921",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- TGF\u03b2 biology in breast: 15 years on.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "161922",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.20324,
            5.279679
          ],
          [
            -36.20928,
            5.357275
          ],
          [
            -36.28569,
            6.338293
          ],
          [
            -36.291646,
            6.414743
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "922",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- On mammary gland growth factors: roles in normal development and in cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "161923",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.196141,
            5.27978
          ],
          [
            -36.091709,
            5.356829
          ],
          [
            -34.804367,
            6.305737
          ],
          [
            -34.701451,
            6.381527
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "923",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "161924",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -36.170686,
            5.279566
          ],
          [
            -35.923174,
            5.316064
          ],
          [
            -34.324767,
            5.551691
          ],
          [
            -34.077301,
            5.588161
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "161",
        "dest": "924",
        "label": "Critical questions in mammary gland development, lactational biology and breast cancer. -- Lactation and neonatal nutrition: defining and refining the critical questions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "4780",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.596575,
            25.230723
          ],
          [
            15.311064,
            25.444844
          ],
          [
            4.624469,
            33.168016
          ],
          [
            4.337525,
            33.367096
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "80",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "47271",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.609775,
            25.230723
          ],
          [
            15.763441,
            25.321768
          ],
          [
            18.268485,
            26.796114
          ],
          [
            18.422456,
            26.886126
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "271",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47274",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.605091,
            25.230655
          ],
          [
            15.67604,
            25.343722
          ],
          [
            17.123469,
            27.627095
          ],
          [
            17.195515,
            27.739549
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "274",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ER\u03b1, Akt1, and Stat5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47275",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.603476,
            25.230763
          ],
          [
            15.629137,
            25.335506
          ],
          [
            16.103382,
            27.254611
          ],
          [
            16.128837,
            27.356705
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "275",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- ER\u03b1 phosphorylation at Y537 by Src triggers E6-AP-ER\u03b1 binding, ER\u03b1 ubiquitylation, promoter occupancy, and target gene expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "47276",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.629213,
            25.230666
          ],
          [
            15.926918,
            25.278587
          ],
          [
            18.609103,
            25.709469
          ],
          [
            18.906786,
            25.757193
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "47",
        "dest": "276",
        "label": "Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development. -- Canid progesterone receptors lack activation function 3 domain-dependent activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "50287",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.592267,
            12.275416
          ],
          [
            24.727646,
            12.392163
          ],
          [
            27.328119,
            14.62398
          ],
          [
            27.462629,
            14.738831
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "50",
        "dest": "287",
        "label": "Epimorphin is a novel regulator of the progesterone receptor isoform-a. -- MiR-126-3p regulates progesterone receptors and involves development and lactation of mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "50288",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            24.594217,
            12.275348
          ],
          [
            24.746383,
            12.370699
          ],
          [
            27.18577,
            13.894382
          ],
          [
            27.338089,
            13.989198
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "50",
        "dest": "288",
        "label": "Epimorphin is a novel regulator of the progesterone receptor isoform-a. -- Uterine progesterone receptor expression, conceptus development, and ovarian function in pigs treated with RU 486 during early pregnancy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "5156",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.433065,
            15.326488
          ],
          [
            25.588392,
            15.496554
          ],
          [
            29.92946,
            20.188129
          ],
          [
            30.086264,
            20.355184
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "51",
        "dest": "56",
        "label": "Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice. -- Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52289",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.888584,
            12.413033
          ],
          [
            15.837552,
            12.31409
          ],
          [
            15.019375,
            10.72301
          ],
          [
            14.96829,
            10.623371
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "289",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Estrogen-dependent and estrogen-independent mechanisms contribute to AIB1-mediated tumor formation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "52290",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.888888,
            12.42264
          ],
          [
            15.80429,
            12.606936
          ],
          [
            13.298538,
            17.998081
          ],
          [
            13.212919,
            18.179702
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "290",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "52291",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.872033,
            12.41323
          ],
          [
            15.646442,
            12.358373
          ],
          [
            13.489245,
            11.833216
          ],
          [
            13.262351,
            11.777918
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "291",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52292",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.869999,
            12.422566
          ],
          [
            15.64079,
            12.473663
          ],
          [
            13.61492,
            12.92483
          ],
          [
            13.38616,
            12.975728
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "292",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "52293",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.882764,
            12.413132
          ],
          [
            15.755353,
            12.340636
          ],
          [
            14.205533,
            11.457152
          ],
          [
            14.078608,
            11.38468
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "293",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52294",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.892278,
            12.413051
          ],
          [
            15.916803,
            12.314442
          ],
          [
            16.310038,
            10.728756
          ],
          [
            16.334594,
            10.629461
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "294",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "52295",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.886657,
            12.422609
          ],
          [
            15.774988,
            12.542197
          ],
          [
            13.587043,
            14.873585
          ],
          [
            13.476007,
            14.991266
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "52",
        "dest": "295",
        "label": "Altered AIB1 or AIB1\u03943 expression impacts ER\u03b1 effects on mammary gland stromal and epithelial content. -- Comparison of increased aromatase versus ER\u03b1 in the generation of mammary hyperplasia and cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53296",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.7855,
            11.889816
          ],
          [
            27.937933,
            12.006478
          ],
          [
            30.865931,
            14.236984
          ],
          [
            31.017381,
            14.351785
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "296",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53297",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.788494,
            11.880387
          ],
          [
            27.961133,
            11.791694
          ],
          [
            30.516554,
            10.475525
          ],
          [
            30.688546,
            10.386732
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "297",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 determines estrogen signaling in the mammary gland in vivo.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53298",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.785424,
            11.880251
          ],
          [
            27.906034,
            11.784354
          ],
          [
            29.777522,
            10.29226
          ],
          [
            29.898026,
            10.195936
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "298",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cooperative activation of cyclin D1 and progesterone receptor gene expression by the SRC-3 coactivator and SMRT corepressor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53299",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.816142,
            11.889741
          ],
          [
            28.206246,
            11.938993
          ],
          [
            31.573414,
            12.363727
          ],
          [
            31.963404,
            12.412878
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "299",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "53300",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.795075,
            11.889741
          ],
          [
            28.048146,
            11.964407
          ],
          [
            31.270476,
            12.913221
          ],
          [
            31.523403,
            12.987544
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "300",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Estrogen regulation of thrombospondin-1 in human breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53301",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.796423,
            11.880449
          ],
          [
            28.052892,
            11.810668
          ],
          [
            31.113336,
            10.976623
          ],
          [
            31.369912,
            10.906589
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "301",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "53303",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.946258,
            11.880449
          ],
          [
            28.548136,
            11.863689
          ],
          [
            30.602896,
            11.806466
          ],
          [
            31.204439,
            11.789707
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "303",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Differential expression of decorin, EGFR and cyclin D1 during mammary gland carcinogenesis in TA2 mice with spontaneous breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53304",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.783878,
            11.889846
          ],
          [
            27.898547,
            12.009613
          ],
          [
            30.145438,
            14.344968
          ],
          [
            30.259468,
            14.462873
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "304",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53305",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.781288,
            11.880418
          ],
          [
            27.825092,
            11.775634
          ],
          [
            28.590675,
            9.938227
          ],
          [
            28.634753,
            9.832118
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "305",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Cyclin D1 regulates hepatic estrogen and androgen metabolism.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "53306",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.790329,
            11.88976
          ],
          [
            28.019492,
            11.98685
          ],
          [
            31.755148,
            13.564429
          ],
          [
            31.984761,
            13.661069
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "306",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "53307",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            27.781745,
            11.889754
          ],
          [
            27.846693,
            12.014931
          ],
          [
            29.20001,
            14.609151
          ],
          [
            29.266054,
            14.735016
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "53",
        "dest": "307",
        "label": "Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression. -- Examining the role of cyclin D1 in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "44249",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.331725,
            -14.446626
          ],
          [
            33.464934,
            -14.527944
          ],
          [
            35.321576,
            -15.658088
          ],
          [
            35.455577,
            -15.739418
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "249",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "44251",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.336455,
            -14.437418
          ],
          [
            33.51691,
            -14.36959
          ],
          [
            35.629915,
            -13.573852
          ],
          [
            35.811169,
            -13.505461
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "251",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Cell adhesion signaling regulates RANK expression in osteoclast precursors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "44252",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.414999,
            -14.446626
          ],
          [
            33.868473,
            -14.469595
          ],
          [
            35.883962,
            -14.57166
          ],
          [
            36.33765,
            -14.594628
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "252",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "44253",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.33673,
            -14.4467
          ],
          [
            33.542662,
            -14.523415
          ],
          [
            36.218296,
            -15.5177
          ],
          [
            36.424411,
            -15.594099
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "44",
        "dest": "253",
        "label": "Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. -- Receptor activator of NF-\u03baB ligand promotes proliferation of a putative mammary stem cell unique to the lactating epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "45257",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.069277,
            -16.204261
          ],
          [
            33.2925,
            -16.278864
          ],
          [
            36.153752,
            -17.232592
          ],
          [
            36.376944,
            -17.306787
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "45",
        "dest": "257",
        "label": "RANKL inhibition: a promising novel strategy for breast cancer treatment. -- Central control of fever and female body temperature by RANKL/RANK.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "45258",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            33.062704,
            -16.20423
          ],
          [
            33.190291,
            -16.285199
          ],
          [
            34.968505,
            -17.410169
          ],
          [
            35.096846,
            -17.491094
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "45",
        "dest": "258",
        "label": "RANKL inhibition: a promising novel strategy for breast cancer treatment. -- RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "4661",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.791823,
            -23.28937
          ],
          [
            35.785333,
            -23.465788
          ],
          [
            35.587056,
            -28.732639
          ],
          [
            35.580475,
            -28.903298
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "61",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Role of the RANK/RANKL pathway in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46259",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.795014,
            -23.289474
          ],
          [
            35.908434,
            -23.459235
          ],
          [
            39.172054,
            -28.246088
          ],
          [
            39.283569,
            -28.406145
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "259",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications].",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "46260",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.796385,
            -23.289439
          ],
          [
            35.993147,
            -23.490717
          ],
          [
            42.727422,
            -30.182388
          ],
          [
            42.921389,
            -30.36909
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "260",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46261",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.773916,
            -23.289335
          ],
          [
            35.581321,
            -23.336165
          ],
          [
            33.910852,
            -23.741644
          ],
          [
            33.718996,
            -23.788135
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "261",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- RANK signalling in bone lesions with osteoclast-like giant cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46262",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.818283,
            -23.2893
          ],
          [
            36.129767,
            -23.340931
          ],
          [
            39.10901,
            -23.833764
          ],
          [
            39.420914,
            -23.885251
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "262",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46264",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.801877,
            -23.289376
          ],
          [
            35.99435,
            -23.375691
          ],
          [
            38.933583,
            -24.686784
          ],
          [
            39.125691,
            -24.772005
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "264",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "46265",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.795113,
            -23.280555
          ],
          [
            35.861447,
            -23.187559
          ],
          [
            36.961288,
            -21.636367
          ],
          [
            37.02782,
            -21.541982
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "265",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "46266",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.79982,
            -23.280537
          ],
          [
            35.949732,
            -23.196258
          ],
          [
            38.203448,
            -21.922965
          ],
          [
            38.35294,
            -21.838093
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "266",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- The RANKL/RANK system as a therapeutic target for bone invasion by oral             squamous cell carcinoma (Review).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46267",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.902364,
            -23.280578
          ],
          [
            36.456988,
            -23.258671
          ],
          [
            38.934901,
            -23.160737
          ],
          [
            39.489776,
            -23.138799
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "267",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Targeting RANKL in breast cancer: bone metastasis and beyond.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46268",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.79014,
            -23.289445
          ],
          [
            35.748735,
            -23.390459
          ],
          [
            35.024739,
            -25.143909
          ],
          [
            34.983769,
            -25.242413
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "268",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46269",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.78576,
            -23.289416
          ],
          [
            35.66454,
            -23.376549
          ],
          [
            33.814326,
            -24.699272
          ],
          [
            33.691591,
            -24.786527
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "269",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "46270",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.806028,
            -23.280578
          ],
          [
            36.036516,
            -23.209001
          ],
          [
            39.031175,
            -22.275561
          ],
          [
            39.261862,
            -22.203392
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "46",
        "dest": "270",
        "label": "Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis. -- Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "69336",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.590358,
            -13.077747
          ],
          [
            38.524468,
            -13.160423
          ],
          [
            51.641951,
            -14.31849
          ],
          [
            52.575901,
            -14.400724
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "336",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "69395",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.548634,
            -13.077851
          ],
          [
            37.749905,
            -13.167305
          ],
          [
            40.729254,
            -14.487488
          ],
          [
            40.929786,
            -14.576072
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "395",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69396",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.552236,
            -13.068435
          ],
          [
            37.783517,
            -12.992861
          ],
          [
            40.748189,
            -12.022161
          ],
          [
            40.979455,
            -11.946287
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "396",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69397",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.567592,
            -13.077728
          ],
          [
            37.886647,
            -13.127486
          ],
          [
            40.679441,
            -13.562605
          ],
          [
            40.998854,
            -13.612319
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "397",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69398",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.541383,
            -13.068343
          ],
          [
            37.624686,
            -12.952983
          ],
          [
            39.193837,
            -10.770439
          ],
          [
            39.276524,
            -10.654955
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "398",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "69399",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.547316,
            -13.068355
          ],
          [
            37.715607,
            -12.98303
          ],
          [
            40.096894,
            -11.772677
          ],
          [
            40.264118,
            -11.687472
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "399",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- RANKL Signaling and ErbB Receptors in Breast Carcinogenesis.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "69400",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            37.542533,
            -13.077771
          ],
          [
            37.653645,
            -13.190789
          ],
          [
            39.745712,
            -15.30855
          ],
          [
            39.857997,
            -15.421644
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "69",
        "dest": "400",
        "label": "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. -- Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4\u207a T cells to T-regulatory cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "7077",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.967436,
            -19.863277
          ],
          [
            25.697379,
            -19.784064
          ],
          [
            21.959652,
            -18.683738
          ],
          [
            21.689891,
            -18.604043
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "77",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70358",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.986135,
            -19.872344
          ],
          [
            26.057541,
            -19.970677
          ],
          [
            27.262044,
            -21.619929
          ],
          [
            27.33374,
            -21.717518
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "358",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- RAR\u03b11 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70401",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.995724,
            -19.872261
          ],
          [
            26.182996,
            -19.937132
          ],
          [
            28.349158,
            -20.685558
          ],
          [
            28.537077,
            -20.750313
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "401",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70402",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.982388,
            -19.872279
          ],
          [
            25.956613,
            -20.137282
          ],
          [
            24.796462,
            -31.534774
          ],
          [
            24.770413,
            -31.777442
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "402",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70403",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.975761,
            -19.872338
          ],
          [
            25.846948,
            -19.95524
          ],
          [
            23.997967,
            -21.140355
          ],
          [
            23.868118,
            -21.223232
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "403",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Transcriptomic profiling of progesterone in the male fathead minnow (Pimephales promelas) testis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70404",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.918118,
            -19.872267
          ],
          [
            25.556661,
            -19.897284
          ],
          [
            23.790634,
            -20.019453
          ],
          [
            23.429732,
            -20.044405
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "404",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70405",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            26.047922,
            -19.863331
          ],
          [
            26.413835,
            -19.838261
          ],
          [
            28.211151,
            -19.71506
          ],
          [
            28.577613,
            -19.689931
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "405",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "70406",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.9842,
            -19.872374
          ],
          [
            26.016762,
            -19.981141
          ],
          [
            26.618617,
            -21.977369
          ],
          [
            26.650919,
            -22.083747
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "406",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Regulation of the MIR155 host gene in physiological and pathological processes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70407",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.970978,
            -19.872249
          ],
          [
            25.784514,
            -19.942397
          ],
          [
            23.458044,
            -20.815012
          ],
          [
            23.269782,
            -20.885412
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "407",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Hypoxia-inducible factor 1\u03b1 promotes primary tumor growth and tumor-initiating cell activity in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "70408",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.989418,
            -19.872309
          ],
          [
            26.115565,
            -19.958781
          ],
          [
            28.012021,
            -21.252937
          ],
          [
            28.137818,
            -21.338388
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "408",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "70409",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.981253,
            -19.87235
          ],
          [
            25.945972,
            -19.974534
          ],
          [
            25.32915,
            -21.750228
          ],
          [
            25.294243,
            -21.850087
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "409",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70410",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.976157,
            -19.863307
          ],
          [
            25.872723,
            -19.793754
          ],
          [
            24.598779,
            -18.934641
          ],
          [
            24.494453,
            -18.864086
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "410",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70411",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.981397,
            -19.863087
          ],
          [
            25.956483,
            -19.781095
          ],
          [
            25.614098,
            -18.649969
          ],
          [
            25.58939,
            -18.568036
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "411",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "70412",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            25.979128,
            -19.872374
          ],
          [
            25.90076,
            -19.969608
          ],
          [
            24.601331,
            -21.572792
          ],
          [
            24.522726,
            -21.669214
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "70",
        "dest": "412",
        "label": "Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. -- Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "76446",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.672079,
            0.075687
          ],
          [
            15.635093,
            0.186758
          ],
          [
            14.976463,
            2.163789
          ],
          [
            14.939834,
            2.273697
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "76",
        "dest": "446",
        "label": "Hormone action in the mammary gland. -- Remodeling of the lymphatic vasculature during mouse mammary gland morphogenesis is mediated via epithelial-derived lymphangiogenic stimuli.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "27963",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.597765,
            3.018795
          ],
          [
            35.946693,
            3.178408
          ],
          [
            44.936154,
            7.278475
          ],
          [
            45.287176,
            7.437951
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "279",
        "dest": "63",
        "label": "Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution. -- Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125113",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.816888,
            -21.423684
          ],
          [
            -50.111776,
            -21.505142
          ],
          [
            -54.377385,
            -22.678292
          ],
          [
            -54.672791,
            -22.759169
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "113",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125126",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.808061,
            -21.414826
          ],
          [
            -50.114251,
            -21.226797
          ],
          [
            -60.07762,
            -14.987969
          ],
          [
            -60.384039,
            -14.792763
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "126",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- Protein kinases mediate ligand-independent derepression of sumoylated progesterone receptors in breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "125727",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -49.808,
            -21.414697
          ],
          [
            -49.962428,
            -21.316281
          ],
          [
            -52.568674,
            -19.645567
          ],
          [
            -52.721244,
            -19.547201
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "125",
        "dest": "727",
        "label": "ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells. -- Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "156898",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.094057,
            -29.601296
          ],
          [
            -22.256651,
            -29.670984
          ],
          [
            -24.428167,
            -30.597015
          ],
          [
            -24.591225,
            -30.666199
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "898",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156899",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.088665,
            -29.601318
          ],
          [
            -22.187141,
            -29.697743
          ],
          [
            -23.972209,
            -31.429533
          ],
          [
            -24.071493,
            -31.524939
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "899",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Distinct gene-expression profiles characterize mammary tumors developed in transgenic mice expressing constitutively active and C-terminally truncated variants of STAT5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156900",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.077651,
            -29.601362
          ],
          [
            -21.959387,
            -29.67439
          ],
          [
            -20.333925,
            -30.672637
          ],
          [
            -20.216621,
            -30.744289
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "900",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156901",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.056042,
            -29.601307
          ],
          [
            -21.814624,
            -29.636481
          ],
          [
            -20.109233,
            -29.884597
          ],
          [
            -19.867312,
            -29.919743
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "901",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Evaluation of molecular markers in canine mammary tumors: correlation with histological grading.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156902",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.086745,
            -29.601373
          ],
          [
            -22.142636,
            -29.703075
          ],
          [
            -23.195582,
            -31.599396
          ],
          [
            -23.251062,
            -31.698293
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "902",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Comparison of cellular and tissue transcriptional profiles in canine mammary tumor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156903",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.083341,
            -29.601384
          ],
          [
            -22.056903,
            -29.703405
          ],
          [
            -21.558787,
            -31.605594
          ],
          [
            -21.53254,
            -31.70479
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "903",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Transcriptomic \"portraits\" of canine mammary cancer cell lines with various phenotypes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156904",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.11172,
            -29.601324
          ],
          [
            -22.357533,
            -29.638696
          ],
          [
            -24.186863,
            -29.91639
          ],
          [
            -24.432272,
            -29.953584
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "904",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "156905",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.081474,
            -29.601428
          ],
          [
            -22.016291,
            -29.695008
          ],
          [
            -20.896737,
            -31.288512
          ],
          [
            -20.832285,
            -31.379448
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "905",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "156906",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.084658,
            -29.601456
          ],
          [
            -22.090454,
            -29.7118
          ],
          [
            -22.206297,
            -31.892291
          ],
          [
            -22.212062,
            -31.999523
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "156",
        "dest": "906",
        "label": "Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. -- Gene expression pattern in canine mammary osteosarcoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157907",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.177216,
            -26.126878
          ],
          [
            -22.322276,
            -26.208273
          ],
          [
            -24.469419,
            -27.406455
          ],
          [
            -24.613938,
            -27.48664
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "907",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157908",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.171862,
            -26.126901
          ],
          [
            -22.227425,
            -26.23004
          ],
          [
            -23.254337,
            -28.119436
          ],
          [
            -23.309451,
            -28.219932
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "908",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "157909",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.169942,
            -26.126844
          ],
          [
            -22.178915,
            -26.217858
          ],
          [
            -22.327668,
            -27.71641
          ],
          [
            -22.336664,
            -27.806418
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "157",
        "dest": "909",
        "label": "A potential role of progestin-induced laminin-5/\u03b16-integrin signaling in the formation of side branches in the mammary gland. -- Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106635",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.868277,
            -28.899523
          ],
          [
            -34.015835,
            -28.985326
          ],
          [
            -36.3428,
            -30.328936
          ],
          [
            -36.490358,
            -30.413529
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "635",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Bovine prolactin elevates hTF expression directed by a tissue-specific goat \u03b2-casein promoter through prolactin receptor-mediated STAT5a activation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106636",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.883571,
            -28.899446
          ],
          [
            -34.168862,
            -28.952272
          ],
          [
            -37.060947,
            -29.486236
          ],
          [
            -37.345514,
            -29.538623
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "636",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Regulatory roles of Oct proteins in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106637",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.980394,
            -28.891099
          ],
          [
            -34.449079,
            -28.874796
          ],
          [
            -36.159581,
            -28.815278
          ],
          [
            -36.628182,
            -28.798969
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "637",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Dynamic trafficking of STAT5 depends on an unconventional nuclear localization signal.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "106638",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -33.864308,
            -28.899457
          ],
          [
            -33.938297,
            -28.991741
          ],
          [
            -35.208409,
            -30.563063
          ],
          [
            -35.282763,
            -30.654284
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "106",
        "dest": "638",
        "label": "Interactions of the ubiquitous octamer-binding transcription factor-1 with both the signal transducer and activator of transcription 5 and the glucocorticoid receptor mediate prolactin and glucocorticoid-induced \u03b2-casein gene expression in mammary epithelial cells. -- Buffalo alpha S1-casein gene 5'-flanking region and its interspecies comparison.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "634108",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.045553,
            -37.995922
          ],
          [
            -37.163734,
            -38.188868
          ],
          [
            -41.672841,
            -45.164433
          ],
          [
            -41.789513,
            -45.334828
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "634",
        "dest": "108",
        "label": "Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells. -- Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "634109",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -37.094811,
            -37.988294
          ],
          [
            -37.454912,
            -37.962065
          ],
          [
            -39.587789,
            -37.806517
          ],
          [
            -39.947616,
            -37.780244
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "634",
        "dest": "109",
        "label": "Gap junctions mediate STAT5-independent \u03b2-casein expression in CID-9 mammary epithelial cells. -- Analysis of mammary specific gene locus regulation in differentiated cells derived by somatic cell fusion.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "123715",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.931026,
            -6.821098
          ],
          [
            -24.451154,
            -6.837293
          ],
          [
            -26.162966,
            -6.890601
          ],
          [
            -26.683223,
            -6.9068
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "123",
        "dest": "715",
        "label": "Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. -- Amphiregulin mediates progesterone-induced mammary ductal development during puberty.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "123716",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.789965,
            -6.811675
          ],
          [
            -23.964273,
            -6.730772
          ],
          [
            -26.325094,
            -5.633771
          ],
          [
            -26.500072,
            -5.552378
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "123",
        "dest": "716",
        "label": "Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. -- Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80199",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.332102,
            33.375142
          ],
          [
            4.342202,
            33.462299
          ],
          [
            4.515634,
            34.944839
          ],
          [
            4.525787,
            35.030823
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "199",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80272",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.337365,
            33.375174
          ],
          [
            4.463239,
            33.463117
          ],
          [
            6.624107,
            34.958788
          ],
          [
            6.750612,
            35.045524
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "272",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80273",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.334677,
            33.375216
          ],
          [
            4.402564,
            33.465696
          ],
          [
            5.589091,
            35.031641
          ],
          [
            5.657397,
            35.120901
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "273",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80472",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.319017,
            33.375132
          ],
          [
            4.158906,
            33.42533
          ],
          [
            2.527436,
            33.935161
          ],
          [
            2.366914,
            33.985159
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "472",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80473",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.38596,
            33.367202
          ],
          [
            4.752299,
            33.340386
          ],
          [
            6.858655,
            33.18606
          ],
          [
            7.225071,
            33.159183
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "473",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80474",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.334989,
            33.36718
          ],
          [
            4.395046,
            33.295523
          ],
          [
            5.243971,
            32.276287
          ],
          [
            5.30524,
            32.202275
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "474",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80475",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.330091,
            33.367043
          ],
          [
            4.304644,
            33.299191
          ],
          [
            3.973821,
            32.412412
          ],
          [
            3.948663,
            32.3446
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "475",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80476",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.328225,
            33.375206
          ],
          [
            4.260635,
            33.454989
          ],
          [
            3.211764,
            34.683433
          ],
          [
            3.144235,
            34.761917
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "476",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "80477",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.361015,
            33.375163
          ],
          [
            4.67384,
            33.417647
          ],
          [
            7.386575,
            33.785195
          ],
          [
            7.699453,
            33.827488
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "477",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "80478",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            4.342194,
            33.375195
          ],
          [
            4.534698,
            33.448501
          ],
          [
            7.299212,
            34.494371
          ],
          [
            7.490657,
            34.566323
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "80",
        "dest": "478",
        "label": "Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis. -- Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56315",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.091992,
            20.364311
          ],
          [
            30.126518,
            20.477568
          ],
          [
            30.802743,
            22.678378
          ],
          [
            30.837719,
            22.791292
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "315",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56316",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.111003,
            20.364276
          ],
          [
            30.367922,
            20.420482
          ],
          [
            32.971868,
            20.988948
          ],
          [
            33.229342,
            21.045035
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "316",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Analysis of PTEN, estrogen receptor \u03b1 and progesterone receptor expression in endometrial hyperplasia using tissue microarray.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "56317",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            30.096128,
            20.364288
          ],
          [
            30.221803,
            20.466256
          ],
          [
            32.458343,
            22.269277
          ],
          [
            32.584917,
            22.370647
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "56",
        "dest": "317",
        "label": "Overexpression of progesterone receptor A isoform in mice leads to endometrial hyperproliferation, hyperplasia and atypia. -- Endometrial progesterone resistance and PCOS.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "290146",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.238953,
            18.18897
          ],
          [
            13.621927,
            18.250036
          ],
          [
            17.771999,
            18.910317
          ],
          [
            18.156184,
            18.97131
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "290",
        "dest": "146",
        "label": "Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. -- Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "290150",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.211464,
            18.188976
          ],
          [
            13.235853,
            18.328593
          ],
          [
            13.818613,
            21.628979
          ],
          [
            13.84307,
            21.765963
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "290",
        "dest": "150",
        "label": "Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. -- Epithelial-stromal interaction and progesterone receptors in the mouse uterus.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "295117",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.468923,
            15.000548
          ],
          [
            13.389001,
            15.137518
          ],
          [
            11.568088,
            18.232725
          ],
          [
            11.488106,
            18.367495
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "295",
        "dest": "117",
        "label": "Comparison of increased aromatase versus ER\u03b1 in the generation of mammary hyperplasia and cancer. -- Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "6173",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.579965,
            -28.911998
          ],
          [
            35.56678,
            -29.080147
          ],
          [
            35.1759,
            -33.934842
          ],
          [
            35.162929,
            -34.091598
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "73",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "61340",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.585388,
            -28.911843
          ],
          [
            35.689417,
            -28.997934
          ],
          [
            37.357135,
            -30.368146
          ],
          [
            37.46127,
            -30.453076
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "340",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "61341",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.581282,
            -28.911848
          ],
          [
            35.604452,
            -29.011635
          ],
          [
            36.032327,
            -30.83738
          ],
          [
            36.05571,
            -30.936177
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "341",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Denosumab for the treatment of bone metastases in advanced breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "61342",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.578236,
            -28.911876
          ],
          [
            35.535803,
            -28.998625
          ],
          [
            34.855557,
            -30.379273
          ],
          [
            34.813087,
            -30.464847
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "342",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "61343",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.592936,
            -28.911865
          ],
          [
            35.744234,
            -28.962506
          ],
          [
            37.206591,
            -29.450651
          ],
          [
            37.357562,
            -29.500917
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "343",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Progestogens and risk of breast cancer: a link between bone and breast?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "61344",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.573148,
            -28.911876
          ],
          [
            35.465037,
            -28.975814
          ],
          [
            34.167116,
            -29.740311
          ],
          [
            34.058304,
            -29.804142
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "61",
        "dest": "344",
        "label": "Role of the RANK/RANKL pathway in breast cancer. -- Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "25957",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            39.28798,
            -28.414619
          ],
          [
            39.347047,
            -28.584758
          ],
          [
            41.150457,
            -33.642572
          ],
          [
            41.210316,
            -33.805765
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "259",
        "dest": "57",
        "label": "[The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. -- RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "26058",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            42.927627,
            -30.377348
          ],
          [
            43.022165,
            -30.576829
          ],
          [
            46.4957,
            -37.610776
          ],
          [
            46.590665,
            -37.794723
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "260",
        "dest": "58",
        "label": "Receptor activator of nuclear factor-kappa B ligand (RANKL) stimulates bone-associated tumors through functional RANK expressed on bone-associated cancer cells? -- Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "33671",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            52.632782,
            -14.410056
          ],
          [
            52.753499,
            -14.536916
          ],
          [
            55.270005,
            -17.16413
          ],
          [
            55.390357,
            -17.288896
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "71",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "33672",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            52.635098,
            -14.400724
          ],
          [
            52.796594,
            -14.291309
          ],
          [
            55.779737,
            -12.260955
          ],
          [
            55.942757,
            -12.149527
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "72",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "33674",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            52.66331,
            -14.409939
          ],
          [
            53.280261,
            -14.491069
          ],
          [
            61.849891,
            -15.614808
          ],
          [
            62.466286,
            -15.6954
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "336",
        "dest": "74",
        "label": "Activation of NF-\u03baB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. -- RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77308",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            20.98886,
            -18.59759
          ],
          [
            19.631772,
            -18.593791
          ],
          [
            16.650602,
            -18.58545
          ],
          [
            15.676657,
            -18.582724
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "308",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77447",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.663378,
            -18.594942
          ],
          [
            21.499048,
            -18.527788
          ],
          [
            19.573931,
            -17.73915
          ],
          [
            19.410667,
            -17.6721
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "447",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77448",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.676867,
            -18.594966
          ],
          [
            21.728957,
            -18.493167
          ],
          [
            22.639242,
            -16.704672
          ],
          [
            22.691645,
            -16.601184
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "448",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Altered proliferation and differentiation properties of primary mammary epithelial cells from BRCA1 mutation carriers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77449",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.668351,
            -18.594894
          ],
          [
            21.501813,
            -18.470796
          ],
          [
            18.029984,
            -15.86414
          ],
          [
            17.863948,
            -15.738584
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "449",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77450",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.68015,
            -18.594984
          ],
          [
            21.791125,
            -18.505458
          ],
          [
            23.513051,
            -17.110465
          ],
          [
            23.62392,
            -17.020275
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "450",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triple-negative breast cancer cells to EGF receptor blockade.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77451",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.675047,
            -18.594954
          ],
          [
            21.687492,
            -18.482369
          ],
          [
            21.926496,
            -16.305928
          ],
          [
            21.938858,
            -16.192665
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "451",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77452",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.62857,
            -18.604001
          ],
          [
            21.311495,
            -18.635012
          ],
          [
            19.452255,
            -18.816728
          ],
          [
            19.135043,
            -18.847711
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "452",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77453",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.67235,
            -18.594882
          ],
          [
            21.620374,
            -18.485007
          ],
          [
            20.65975,
            -16.442246
          ],
          [
            20.608185,
            -16.331975
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "453",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "77454",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.659448,
            -18.604043
          ],
          [
            21.44583,
            -18.668268
          ],
          [
            19.033794,
            -19.39172
          ],
          [
            18.819864,
            -19.45573
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "454",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77455",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.671231,
            -18.604073
          ],
          [
            21.600951,
            -18.700853
          ],
          [
            20.435675,
            -20.297283
          ],
          [
            20.365183,
            -20.393346
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "455",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77456",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.674376,
            -18.604085
          ],
          [
            21.670697,
            -18.704692
          ],
          [
            21.607578,
            -20.42232
          ],
          [
            21.603884,
            -20.522302
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "456",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "77457",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.689,
            -18.595002
          ],
          [
            21.851205,
            -18.544494
          ],
          [
            23.326854,
            -18.084283
          ],
          [
            23.489203,
            -18.033578
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "457",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "77458",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            21.669045,
            -18.604031
          ],
          [
            21.556401,
            -18.696626
          ],
          [
            19.750669,
            -20.17399
          ],
          [
            19.637926,
            -20.265788
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "77",
        "dest": "458",
        "label": "Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice. -- A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63355",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.301123,
            7.447555
          ],
          [
            45.383276,
            7.563937
          ],
          [
            46.930841,
            9.74997
          ],
          [
            47.012401,
            9.864801
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "355",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Mammary adipocytes bioactivate 25-hydroxyvitamin D\u2083 and signal via vitamin D\u2083 receptor, modulating mammary epithelial cell growth.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63356",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.294199,
            7.447612
          ],
          [
            45.224301,
            7.543844
          ],
          [
            44.139723,
            9.034121
          ],
          [
            44.069886,
            9.129879
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "356",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63357",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.299569,
            7.447574
          ],
          [
            45.344027,
            7.564438
          ],
          [
            46.181573,
            9.759503
          ],
          [
            46.225712,
            9.874804
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "357",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63359",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.308633,
            7.43797
          ],
          [
            45.492956,
            7.357245
          ],
          [
            47.954608,
            6.277793
          ],
          [
            48.139457,
            6.19664
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "359",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63360",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.406713,
            7.438045
          ],
          [
            45.856805,
            7.418618
          ],
          [
            47.568251,
            7.344762
          ],
          [
            48.01855,
            7.325324
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "360",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Adipocyte derived paracrine mediators of mammary ductal morphogenesis controlled by retinoic acid receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63361",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.309242,
            7.447461
          ],
          [
            45.50103,
            7.526064
          ],
          [
            48.027149,
            8.559913
          ],
          [
            48.219287,
            8.638437
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "361",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63362",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.338109,
            7.447455
          ],
          [
            45.696916,
            7.489284
          ],
          [
            48.334421,
            7.796643
          ],
          [
            48.693342,
            7.838457
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "362",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63364",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.299279,
            7.43792
          ],
          [
            45.333349,
            7.331795
          ],
          [
            45.918577,
            5.505315
          ],
          [
            45.952265,
            5.399975
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "364",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "63365",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.30439,
            7.43797
          ],
          [
            45.424079,
            7.352116
          ],
          [
            47.117572,
            6.135677
          ],
          [
            47.236499,
            6.050139
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "365",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63366",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.304162,
            7.447524
          ],
          [
            45.440516,
            7.548902
          ],
          [
            47.701353,
            9.226067
          ],
          [
            47.838118,
            9.327276
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "366",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "63367",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            45.296728,
            7.447561
          ],
          [
            45.273466,
            7.559619
          ],
          [
            44.851594,
            9.586504
          ],
          [
            44.828545,
            9.696942
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "63",
        "dest": "367",
        "label": "Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. -- Physiological functions of Vitamin D in adipose tissue.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "117677",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            11.480283,
            18.376728
          ],
          [
            11.385661,
            18.463084
          ],
          [
            10.006189,
            19.717017
          ],
          [
            9.912001,
            19.802283
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "117",
        "dest": "677",
        "label": "Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. -- 7,8-Dihydroxycoumarin exerts antitumor potential on DMBA-induced mammary carcinogenesis by inhibiting ER\u03b1, PR, EGFR, and IGF1R: involvement of MAPK1/2-JNK1/2-Akt pathway.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "117678",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            11.484579,
            18.376698
          ],
          [
            11.466101,
            18.482422
          ],
          [
            11.137137,
            20.353577
          ],
          [
            11.118841,
            20.45701
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "117",
        "dest": "678",
        "label": "Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis. -- Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73426",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.156972,
            -34.099634
          ],
          [
            35.033171,
            -34.188583
          ],
          [
            32.906951,
            -35.70161
          ],
          [
            32.784551,
            -35.787859
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "426",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Out-RANKing BRCA1 in Mutation Carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73427",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.16302,
            -34.099582
          ],
          [
            35.175763,
            -34.220153
          ],
          [
            35.472988,
            -36.98286
          ],
          [
            35.485754,
            -37.099368
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "427",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "73428",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.15995,
            -34.099645
          ],
          [
            35.090311,
            -34.206403
          ],
          [
            33.668893,
            -36.355731
          ],
          [
            33.599528,
            -36.459151
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "428",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-\u03baB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73429",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.161733,
            -34.099624
          ],
          [
            35.137405,
            -34.213127
          ],
          [
            34.607748,
            -36.646173
          ],
          [
            34.583444,
            -36.756014
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "429",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Can we prevent BRCA1-associated breast cancer by RANKL inhibition?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73430",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.1643,
            -34.099629
          ],
          [
            35.210129,
            -34.208312
          ],
          [
            36.165596,
            -36.441846
          ],
          [
            36.211289,
            -36.547107
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "430",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Persistent Activation of NF-\u03baB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73431",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.166866,
            -34.099529
          ],
          [
            35.266241,
            -34.191203
          ],
          [
            37.067747,
            -35.835707
          ],
          [
            37.167952,
            -35.926204
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "431",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "73432",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.172556,
            -34.099561
          ],
          [
            35.338485,
            -34.165701
          ],
          [
            37.524047,
            -35.032005
          ],
          [
            37.690289,
            -35.097526
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "432",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- RANKL/RANK control Brca1 mutation- .",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "73433",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            35.148678,
            -34.099571
          ],
          [
            34.963577,
            -34.15257
          ],
          [
            32.991229,
            -34.715218
          ],
          [
            32.80673,
            -34.767651
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "73",
        "dest": "433",
        "label": "RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. -- NF-\u03baB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of <i>BRCA1</i>-Mutated Breast Cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "57255",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            41.211329,
            -33.81397
          ],
          [
            41.198069,
            -33.918302
          ],
          [
            40.932955,
            -35.977346
          ],
          [
            40.919763,
            -36.078472
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "255",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANK as a therapeutic target in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57256",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            41.215526,
            -33.813938
          ],
          [
            41.299645,
            -33.905721
          ],
          [
            42.797351,
            -35.523197
          ],
          [
            42.880655,
            -35.61223
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "256",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANKL/RANK-beyond bones.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57263",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            41.213028,
            -33.813938
          ],
          [
            41.244957,
            -33.922022
          ],
          [
            41.910495,
            -36.143684
          ],
          [
            41.942318,
            -36.24841
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "263",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- RANKL/RANK - from bone physiology to breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57318",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            41.209364,
            -33.813865
          ],
          [
            41.144104,
            -33.917636
          ],
          [
            39.812731,
            -36.007054
          ],
          [
            39.746458,
            -36.109655
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "318",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- The effect of sex hormones on bone metabolism of the otic capsule--an overview.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "57319",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            41.224019,
            -33.813896
          ],
          [
            41.390017,
            -33.868086
          ],
          [
            43.199626,
            -34.456603
          ],
          [
            43.365396,
            -34.510305
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "319",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- Physiology and pathophysiology of the RANKL/RANK system.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57320",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            41.206706,
            -33.813954
          ],
          [
            41.10513,
            -33.893736
          ],
          [
            39.528941,
            -35.122107
          ],
          [
            39.427456,
            -35.200575
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "320",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "57321",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            41.194763,
            -33.813901
          ],
          [
            41.001147,
            -33.859089
          ],
          [
            39.222408,
            -34.273097
          ],
          [
            39.028433,
            -34.318118
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "57",
        "dest": "321",
        "label": "RANKL and RANK in sex hormone-induced breast cancer and breast cancer metastasis. -- The RANKL-RANK Story.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58322",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.592912,
            -37.802411
          ],
          [
            46.600415,
            -37.913162
          ],
          [
            46.767578,
            -40.335925
          ],
          [
            46.775088,
            -40.442742
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "322",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58323",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.582683,
            -37.802336
          ],
          [
            46.411734,
            -37.867096
          ],
          [
            44.096422,
            -38.738584
          ],
          [
            43.924818,
            -38.802755
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "323",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58324",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.612418,
            -37.794803
          ],
          [
            46.84654,
            -37.750288
          ],
          [
            49.085357,
            -37.323291
          ],
          [
            49.320827,
            -37.278242
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "324",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Expression of receptor activator of nuclear factor kappa-B as a poor prognostic marker in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58325",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.587558,
            -37.802421
          ],
          [
            46.475585,
            -37.887316
          ],
          [
            44.552448,
            -39.330079
          ],
          [
            44.441732,
            -39.412254
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "325",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58326",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.597497,
            -37.802431
          ],
          [
            46.714893,
            -37.896072
          ],
          [
            48.926329,
            -39.637732
          ],
          [
            49.042872,
            -39.72833
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "326",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58327",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.595083,
            -37.802346
          ],
          [
            46.663481,
            -37.908813
          ],
          [
            48.152824,
            -40.188509
          ],
          [
            48.221146,
            -40.29132
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "327",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "58328",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.599523,
            -37.794798
          ],
          [
            46.715663,
            -37.73124
          ],
          [
            48.266031,
            -36.877603
          ],
          [
            48.38396,
            -36.812277
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "328",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58329",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.590284,
            -37.802371
          ],
          [
            46.531925,
            -37.896491
          ],
          [
            45.410909,
            -39.680942
          ],
          [
            45.352931,
            -39.772022
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "329",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58330",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.593963,
            -37.802376
          ],
          [
            46.627218,
            -37.898577
          ],
          [
            47.278749,
            -39.758109
          ],
          [
            47.311813,
            -39.851175
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "330",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Effects of icariin on the regulation of the OPG-RANKL-RANK system are mediated through the MAPK pathways in IL-1\u03b2-stimulated human SW1353 chondrosarcoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58331",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.59129,
            -37.802411
          ],
          [
            46.55393,
            -37.908304
          ],
          [
            45.75823,
            -40.127431
          ],
          [
            45.720947,
            -40.229683
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "331",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58332",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.606584,
            -37.802386
          ],
          [
            46.817147,
            -37.860183
          ],
          [
            49.346206,
            -38.550852
          ],
          [
            49.555779,
            -38.607787
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "332",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58333",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.557289,
            -37.802331
          ],
          [
            46.288527,
            -37.830978
          ],
          [
            44.571201,
            -38.013785
          ],
          [
            44.302857,
            -38.04231
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "333",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Osteoprotegerin in bone metastases: mathematical solution to the puzzle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "58334",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.598975,
            -37.802326
          ],
          [
            46.730805,
            -37.88071
          ],
          [
            48.879837,
            -39.146699
          ],
          [
            49.011933,
            -39.223785
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "334",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "58335",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            46.657776,
            -37.802316
          ],
          [
            47.052251,
            -37.825071
          ],
          [
            49.11801,
            -37.944114
          ],
          [
            49.512768,
            -37.96684
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "58",
        "dest": "335",
        "label": "Expression profile of receptor activator of nuclear-\u03baB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. -- RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71250",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.403099,
            -17.298119
          ],
          [
            55.554252,
            -17.382074
          ],
          [
            57.724901,
            -18.583365
          ],
          [
            57.875223,
            -18.66625
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "250",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71254",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.399093,
            -17.298089
          ],
          [
            55.500707,
            -17.406562
          ],
          [
            57.377587,
            -19.398274
          ],
          [
            57.480154,
            -19.506439
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "254",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "71413",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.39418,
            -17.29818
          ],
          [
            55.379739,
            -17.40465
          ],
          [
            55.122585,
            -19.289625
          ],
          [
            55.108288,
            -19.393855
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "413",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-\u03baB ligand\u2013induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+\u2013nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "71414",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.438334,
            -17.298071
          ],
          [
            55.753802,
            -17.331055
          ],
          [
            57.686711,
            -17.53305
          ],
          [
            58.001706,
            -17.565944
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "414",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71415",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.397166,
            -17.298131
          ],
          [
            55.451945,
            -17.405536
          ],
          [
            56.445442,
            -19.342151
          ],
          [
            56.499734,
            -19.447343
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "415",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- RANK-Fc inhibits malignancy via inhibiting ERK activation and evoking caspase-3-mediated anoikis in human osteosarcoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71416",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.4108,
            -17.288962
          ],
          [
            55.586456,
            -17.238944
          ],
          [
            57.153847,
            -16.791975
          ],
          [
            57.329321,
            -16.741872
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "416",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Survival and differentiation of mammary epithelial cells in mammary gland development require nuclear retention of Id2 due to RANK signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "71417",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.391202,
            -17.298089
          ],
          [
            55.324213,
            -17.38281
          ],
          [
            54.347701,
            -18.613402
          ],
          [
            54.281025,
            -18.697111
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "71",
        "dest": "417",
        "label": "Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells. -- Impact of RANK signalling on survival and chemotherapy response in osteosarcoma.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72418",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.949018,
            -12.13999
          ],
          [
            55.934272,
            -12.034528
          ],
          [
            55.680887,
            -10.216986
          ],
          [
            55.666301,
            -10.11202
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "418",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-\u03baB in hormone-independent MDA-MB-231 cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72419",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.9516,
            -12.140114
          ],
          [
            55.99599,
            -12.031399
          ],
          [
            56.800738,
            -10.05343
          ],
          [
            56.845501,
            -9.943036
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "419",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Receptor activator of nuclear factor-\u03baB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72420",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            56.002471,
            -12.149434
          ],
          [
            56.33711,
            -12.178913
          ],
          [
            58.160377,
            -12.339464
          ],
          [
            58.494924,
            -12.368909
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "420",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72421",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.94626,
            -12.140009
          ],
          [
            55.882653,
            -12.051481
          ],
          [
            54.955353,
            -10.757701
          ],
          [
            54.892035,
            -10.669151
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "421",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-\u03baB-mediated epithelial-mesenchymal transition.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72422",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.966178,
            -12.140083
          ],
          [
            56.18812,
            -12.076779
          ],
          [
            58.580064,
            -11.393655
          ],
          [
            58.801496,
            -11.330329
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "422",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17\u03b2-estradiol.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72423",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.954006,
            -12.140126
          ],
          [
            56.048834,
            -12.037712
          ],
          [
            57.676794,
            -10.273693
          ],
          [
            57.772101,
            -10.170095
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "423",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Butein, a tetrahydroxychalcone, suppresses cancer-induced osteoclastogenesis through inhibition of receptor activator of nuclear factor-kappaB ligand signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72424",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.957335,
            -12.14004
          ],
          [
            56.106035,
            -12.047747
          ],
          [
            58.376881,
            -10.634513
          ],
          [
            58.5253,
            -10.541907
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "424",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Knockdown of receptor for advanced glycation end products attenuate 17\u03b1-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "72425",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            55.95748,
            -12.149521
          ],
          [
            56.069056,
            -12.217398
          ],
          [
            57.344181,
            -12.991827
          ],
          [
            57.456039,
            -13.059647
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "72",
        "dest": "425",
        "label": "Receptor activator for nuclear factor-\u03baB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis. -- Benzoquinone from Fusarium pigment inhibits the proliferation of estrogen receptor-positive MCF-7 cells through the NF-\u03baB pathway via estrogen receptor signaling.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "7481",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.539726,
            -15.704566
          ],
          [
            63.005867,
            -15.760191
          ],
          [
            67.558389,
            -16.302615
          ],
          [
            68.023974,
            -16.358006
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "81",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74434",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.506822,
            -15.704554
          ],
          [
            62.629565,
            -15.805326
          ],
          [
            64.736675,
            -17.527245
          ],
          [
            64.860034,
            -17.627562
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "434",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74435",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.503075,
            -15.695309
          ],
          [
            62.548409,
            -15.580057
          ],
          [
            63.419148,
            -13.354149
          ],
          [
            63.464186,
            -13.238432
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "435",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "74436",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.511118,
            -15.695346
          ],
          [
            62.688602,
            -15.612244
          ],
          [
            65.199815,
            -14.432863
          ],
          [
            65.376164,
            -14.349796
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "436",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74437",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.561677,
            -15.6954
          ],
          [
            62.940798,
            -15.666738
          ],
          [
            64.987172,
            -15.51195
          ],
          [
            65.366559,
            -15.483244
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "437",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74438",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.503097,
            -15.704676
          ],
          [
            62.549034,
            -15.820819
          ],
          [
            63.431411,
            -18.038405
          ],
          [
            63.47705,
            -18.152378
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "438",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "74439",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.511476,
            -15.70456
          ],
          [
            62.679568,
            -15.779873
          ],
          [
            64.863485,
            -16.755783
          ],
          [
            65.031722,
            -16.830755
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "439",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74440",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.499975,
            -15.704584
          ],
          [
            62.469942,
            -15.814043
          ],
          [
            61.915219,
            -17.824832
          ],
          [
            61.884905,
            -17.93409
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "440",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "74441",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.506289,
            -15.6954
          ],
          [
            62.623692,
            -15.589057
          ],
          [
            64.75206,
            -13.652058
          ],
          [
            64.870446,
            -13.543829
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "441",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "74442",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            62.500477,
            -15.695376
          ],
          [
            62.483271,
            -15.592406
          ],
          [
            62.182618,
            -13.78486
          ],
          [
            62.165305,
            -13.680353
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "74",
        "dest": "442",
        "label": "RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. -- TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30883",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.274123,
            -18.586343
          ],
          [
            14.520117,
            -18.624917
          ],
          [
            9.15114,
            -18.899319
          ],
          [
            8.397256,
            -18.937816
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "308",
        "dest": "83",
        "label": "c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. -- BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "44992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.85071,
            -15.729195
          ],
          [
            17.664375,
            -15.604676
          ],
          [
            13.860847,
            -13.047133
          ],
          [
            13.675236,
            -12.921603
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "449",
        "dest": "92",
        "label": "Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1687",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.849491,
            -41.552693
          ],
          [
            17.613321,
            -41.514687
          ],
          [
            15.555719,
            -41.182598
          ],
          [
            15.319396,
            -41.144346
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "16",
        "dest": "87",
        "label": "Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cells. -- Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "87100",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.294955,
            -41.137038
          ],
          [
            15.211567,
            -41.004882
          ],
          [
            12.944111,
            -37.309952
          ],
          [
            12.862209,
            -37.172875
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "100",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8786",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.303379,
            -41.144385
          ],
          [
            15.450282,
            -41.231792
          ],
          [
            18.21628,
            -42.855765
          ],
          [
            18.364737,
            -42.941749
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "86",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8788",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.297072,
            -41.144537
          ],
          [
            15.288557,
            -41.277619
          ],
          [
            15.056986,
            -44.792352
          ],
          [
            15.048623,
            -44.915532
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "88",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "87352",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.293187,
            -41.144461
          ],
          [
            15.214279,
            -41.215078
          ],
          [
            14.028072,
            -42.267475
          ],
          [
            13.949384,
            -42.336673
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "352",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "87514",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.31389,
            -41.137133
          ],
          [
            15.519418,
            -41.091994
          ],
          [
            17.570256,
            -40.639883
          ],
          [
            17.774025,
            -40.594793
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "87",
        "dest": "514",
        "label": "Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. -- Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100402",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.868835,
            -37.165173
          ],
          [
            13.229036,
            -37.007384
          ],
          [
            24.401134,
            -31.953591
          ],
          [
            24.761075,
            -31.785735
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "402",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100234",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.858103,
            -37.172865
          ],
          [
            12.79522,
            -37.303334
          ],
          [
            11.131668,
            -40.671888
          ],
          [
            11.068335,
            -40.796952
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "234",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Small molecule antagonists of the Wnt/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "10062",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.859017,
            -37.165208
          ],
          [
            12.829982,
            -37.042564
          ],
          [
            12.119018,
            -33.978492
          ],
          [
            12.089869,
            -33.850389
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "62",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100101",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.846968,
            -37.17287
          ],
          [
            12.596821,
            -37.246281
          ],
          [
            8.807604,
            -38.349521
          ],
          [
            8.556254,
            -38.42212
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "101",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "100219",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.856763,
            -37.165268
          ],
          [
            12.785745,
            -37.080194
          ],
          [
            11.544568,
            -35.578018
          ],
          [
            11.473108,
            -35.490656
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "219",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Differential gene expression in nuclear label-retaining cells in the developing mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100389",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.867068,
            -37.172906
          ],
          [
            13.013095,
            -37.251435
          ],
          [
            15.354098,
            -38.499142
          ],
          [
            15.50027,
            -38.576345
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "389",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100513",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.990085,
            -37.165284
          ],
          [
            13.473889,
            -37.151221
          ],
          [
            15.165532,
            -37.10203
          ],
          [
            15.649168,
            -37.087961
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "513",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100608",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.859825,
            -37.172891
          ],
          [
            12.857494,
            -37.25692
          ],
          [
            12.817499,
            -38.684818
          ],
          [
            12.815153,
            -38.76755
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "608",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100609",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.856603,
            -37.172855
          ],
          [
            12.779095,
            -37.261005
          ],
          [
            11.373985,
            -38.841012
          ],
          [
            11.29583,
            -38.92789
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "609",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100610",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.851225,
            -37.172941
          ],
          [
            12.69717,
            -37.241435
          ],
          [
            10.549007,
            -38.190036
          ],
          [
            10.396064,
            -38.25711
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "610",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Nitric oxide production upregulates Wnt/\u03b2-catenin signaling by inhibiting Dickkopf-1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100611",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.409374,
            -37.172845
          ],
          [
            11.836546,
            -37.177651
          ],
          [
            10.853347,
            -37.185891
          ],
          [
            10.280503,
            -37.190696
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "611",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "100612",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.876848,
            -37.172855
          ],
          [
            13.110208,
            -37.225126
          ],
          [
            15.683832,
            -37.799214
          ],
          [
            15.917093,
            -37.851029
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "612",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Tissue-dependent consequences of Apc inactivation on proliferation and differentiation of ciliated cell progenitors via Wnt and notch signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100613",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.850768,
            -37.165218
          ],
          [
            12.693499,
            -37.099095
          ],
          [
            10.562465,
            -36.197439
          ],
          [
            10.406598,
            -36.131078
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "613",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- How pregnancy at early age protects against breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "100614",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.861576,
            -37.172971
          ],
          [
            12.899782,
            -37.263843
          ],
          [
            13.592664,
            -38.892844
          ],
          [
            13.630526,
            -38.980814
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "100",
        "dest": "614",
        "label": "Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. -- Wnt signaling in triple negative breast cancer is associated with metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "86363",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.604442,
            -42.944123
          ],
          [
            19.069531,
            -42.941707
          ],
          [
            20.10783,
            -42.936306
          ],
          [
            20.585739,
            -42.933821
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "363",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Molecular aspects of adipoepithelial transdifferentiation in mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86507",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.380458,
            -42.941818
          ],
          [
            18.510147,
            -42.893826
          ],
          [
            19.923986,
            -42.368204
          ],
          [
            20.0535,
            -42.319833
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "507",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- The Pea3 Ets transcription factor regulates differentiation of multipotent progenitor cells during mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86509",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.370213,
            -42.948834
          ],
          [
            18.353853,
            -43.027091
          ],
          [
            18.067915,
            -44.378613
          ],
          [
            18.051455,
            -44.455491
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "509",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- DNA methylation restricts spontaneous multi-lineage differentiation of mesenchymal progenitor cells, but is stable during growth factor-induced terminal differentiation.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "86510",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.384837,
            -42.948825
          ],
          [
            18.581508,
            -42.998106
          ],
          [
            20.802175,
            -43.551857
          ],
          [
            20.999134,
            -43.600726
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "510",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Transcription factor regulatory networks in mammary epithelial development and tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86511",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.373885,
            -42.948922
          ],
          [
            18.435321,
            -43.023587
          ],
          [
            19.437181,
            -44.228431
          ],
          [
            19.497779,
            -44.300539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "511",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- Elf5 regulation in the trophectoderm.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "86512",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.375987,
            -42.94889
          ],
          [
            18.489102,
            -43.028426
          ],
          [
            20.466843,
            -44.402416
          ],
          [
            20.57877,
            -44.479236
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "86",
        "dest": "512",
        "label": "Lineage specific methylation of the Elf5 promoter in mammary epithelial cells. -- The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "8889",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.049766,
            -44.92231
          ],
          [
            15.092191,
            -45.026261
          ],
          [
            16.105766,
            -47.45367
          ],
          [
            16.148305,
            -47.55321
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "89",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "88516",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.052432,
            -44.922364
          ],
          [
            15.1323,
            -44.989877
          ],
          [
            16.371657,
            -46.027292
          ],
          [
            16.451449,
            -46.093433
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "516",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Insulin, a key regulator of hormone responsive milk protein synthesis during lactogenesis in murine mammary explants.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88517",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.028515,
            -44.922346
          ],
          [
            14.810061,
            -44.959662
          ],
          [
            12.860777,
            -45.291543
          ],
          [
            12.642551,
            -45.328579
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "517",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- The STAT5-regulated miR-193b locus restrains mammary stem and progenitor cell activity and alveolar differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88518",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.047336,
            -44.922315
          ],
          [
            15.022178,
            -45.002073
          ],
          [
            14.5575,
            -46.455475
          ],
          [
            14.532106,
            -46.533811
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "518",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Protein tyrosine phosphatase 1B restrains mammary alveologenesis and secretory differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88519",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.063186,
            -44.922373
          ],
          [
            15.250808,
            -44.965791
          ],
          [
            17.16354,
            -45.406547
          ],
          [
            17.349882,
            -45.449305
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "519",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Stat5 assumes distinct functions in mammary gland development and mammary tumor formation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "88521",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.042667,
            -44.92248
          ],
          [
            14.929331,
            -44.992301
          ],
          [
            13.170753,
            -46.064766
          ],
          [
            13.057523,
            -46.133114
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "88",
        "dest": "521",
        "label": "Elf5 conditional knockout mice reveal its role as a master regulator in mammary alveolar development: failure of Stat5 activation and functional differentiation in the absence of Elf5. -- Elf5, hormones and cell fate.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62228",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.075809,
            -33.842324
          ],
          [
            11.877379,
            -33.781639
          ],
          [
            9.494043,
            -33.049455
          ],
          [
            9.29655,
            -32.988504
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "228",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Deregulated ephrin-B2 signaling in mammary epithelial cells alters the             stem cell compartment and interferes with the epithelial differentiation pathway.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62345",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.135737,
            -33.842382
          ],
          [
            12.477574,
            -33.813497
          ],
          [
            14.586336,
            -33.635093
          ],
          [
            14.927975,
            -33.606154
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "345",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "62346",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.09172,
            -33.842293
          ],
          [
            12.179838,
            -33.713822
          ],
          [
            14.337355,
            -30.50921
          ],
          [
            14.425807,
            -30.37545
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "346",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "62347",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.083578,
            -33.842314
          ],
          [
            11.967713,
            -33.75543
          ],
          [
            10.013219,
            -32.276652
          ],
          [
            9.896889,
            -32.187858
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "347",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Preponderance of cells with stem cell characteristics in metastasising mouse mammary tumours induced by deregulated EphB4 and ephrin-B2 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "62351",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.092467,
            -33.842245
          ],
          [
            12.155746,
            -33.768748
          ],
          [
            13.051057,
            -32.722079
          ],
          [
            13.113932,
            -32.648107
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "351",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Genotoxic exposure during juvenile growth of mammary gland depletes stem cell activity and inhibits Wnt signaling.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "62353",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            11.981956,
            -33.842392
          ],
          [
            11.566824,
            -33.8271
          ],
          [
            10.065126,
            -33.771754
          ],
          [
            9.649575,
            -33.756434
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "353",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "62354",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            12.08664,
            -33.842261
          ],
          [
            12.032005,
            -33.7455
          ],
          [
            11.022269,
            -31.937755
          ],
          [
            10.968077,
            -31.839694
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "62",
        "dest": "354",
        "label": "Overexpression of EphB4 in the mammary epithelium shifts the differentiation pathway of progenitor cells and promotes branching activity and vascularization. -- Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101348",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.545164,
            -38.429767
          ],
          [
            8.586195,
            -38.508919
          ],
          [
            9.243957,
            -39.765943
          ],
          [
            9.285026,
            -39.843686
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "348",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101350",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.541135,
            -38.429672
          ],
          [
            8.49206,
            -38.521038
          ],
          [
            7.567616,
            -40.220376
          ],
          [
            7.5189,
            -40.308779
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "350",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- The proto-oncogene Myc is essential for mammary stem cell function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101444",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.511437,
            -38.429638
          ],
          [
            8.175275,
            -38.469242
          ],
          [
            5.273707,
            -38.81017
          ],
          [
            4.937651,
            -38.84955
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "444",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "101615",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.532231,
            -38.429707
          ],
          [
            8.332765,
            -38.499108
          ],
          [
            5.468298,
            -39.488408
          ],
          [
            5.269929,
            -39.556409
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "615",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Repression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101616",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.542132,
            -38.429638
          ],
          [
            8.518704,
            -38.514875
          ],
          [
            8.101736,
            -40.014906
          ],
          [
            8.078139,
            -40.098842
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "616",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Intraepithelial paracrine Hedgehog signaling induces the expansion of ciliated cells that express diverse progenitor cell markers in the basal epithelium of the mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101617",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.5384,
            -38.422055
          ],
          [
            8.452949,
            -38.352942
          ],
          [
            7.243777,
            -37.367977
          ],
          [
            7.158859,
            -37.298316
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "617",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Stem/progenitor cells in non-lactating versus lactating equine mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101618",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.53543,
            -38.429687
          ],
          [
            8.389761,
            -38.501037
          ],
          [
            6.233577,
            -39.548848
          ],
          [
            6.088456,
            -39.618815
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "618",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Irradiation of juvenile, but not adult, mammary gland increases stem cell self-renewal and estrogen receptor negative tumors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101619",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.439056,
            -38.422179
          ],
          [
            7.977279,
            -38.405688
          ],
          [
            6.116508,
            -38.339178
          ],
          [
            5.654564,
            -38.322659
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "619",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Notch3 marks clonogenic mammary luminal progenitor cells in vivo.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "101620",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.539154,
            -38.429677
          ],
          [
            8.44585,
            -38.51758
          ],
          [
            6.754535,
            -40.092362
          ],
          [
            6.660461,
            -40.178912
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "620",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Stem cell research: a novel boulevard towards improved bovine mastitis management.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "101621",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.529405,
            -38.422179
          ],
          [
            8.344304,
            -38.372121
          ],
          [
            6.35034,
            -37.830689
          ],
          [
            6.163808,
            -37.779834
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "101",
        "dest": "621",
        "label": "Somatic loss of p53 leads to stem/progenitor cell amplification in both mammary epithelial compartments, basal and luminal. -- Epithelial vimentin plays a functional role in mammary gland development.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "89508",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.145769,
            -47.559708
          ],
          [
            16.065588,
            -47.626756
          ],
          [
            14.780204,
            -48.689914
          ],
          [
            14.699947,
            -48.755568
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "508",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89515",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.152791,
            -47.559729
          ],
          [
            16.226642,
            -47.637969
          ],
          [
            17.591362,
            -49.062893
          ],
          [
            17.664611,
            -49.138243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "515",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "89522",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.14947,
            -47.559734
          ],
          [
            16.14439,
            -47.638037
          ],
          [
            16.050522,
            -49.064102
          ],
          [
            16.045487,
            -49.139513
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "522",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "89523",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.160065,
            -47.559636
          ],
          [
            16.323359,
            -47.610004
          ],
          [
            18.360852,
            -48.234403
          ],
          [
            18.525738,
            -48.284598
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "89",
        "dest": "523",
        "label": "Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland. -- ELF5 isoform expression is tissue-specific and significantly altered in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "1793",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.899316,
            27.198688
          ],
          [
            -3.573436,
            27.232516
          ],
          [
            -1.390853,
            27.458806
          ],
          [
            -1.064455,
            27.492611
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "93",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- RUNX2 in mammary gland development and breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1795",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.939685,
            27.190197
          ],
          [
            -3.928001,
            27.025416
          ],
          [
            -3.58199,
            22.039404
          ],
          [
            -3.570169,
            21.865629
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "95",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1796",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.961811,
            27.190214
          ],
          [
            -4.232325,
            27.137476
          ],
          [
            -6.931,
            26.610003
          ],
          [
            -7.200455,
            26.557203
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "96",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "1798",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.939913,
            27.198755
          ],
          [
            -3.93727,
            27.359243
          ],
          [
            -3.861278,
            31.872234
          ],
          [
            -3.858605,
            32.027107
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "98",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1799",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.943607,
            27.198738
          ],
          [
            -4.008578,
            27.27537
          ],
          [
            -4.927035,
            28.352968
          ],
          [
            -4.993323,
            28.430325
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "17",
        "dest": "99",
        "label": "Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease. -- ER and PR signaling nodes during mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "9355",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.023371,
            27.501079
          ],
          [
            -1.017605,
            27.588014
          ],
          [
            -0.925207,
            28.972112
          ],
          [
            -0.919434,
            29.057938
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "55",
        "label": "RUNX2 in mammary gland development and breast cancer. -- RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93223",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.026676,
            27.501259
          ],
          [
            -1.077868,
            27.576045
          ],
          [
            -1.761801,
            28.570394
          ],
          [
            -1.812497,
            28.643719
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "223",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93236",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.02021,
            27.49251
          ],
          [
            -0.952101,
            27.406909
          ],
          [
            0.104721,
            26.07021
          ],
          [
            0.172768,
            25.983611
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "236",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Mammary development and breast cancer: the role of stem cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93237",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.010529,
            27.492555
          ],
          [
            -0.831659,
            27.434187
          ],
          [
            1.118303,
            26.795956
          ],
          [
            1.29693,
            26.737308
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "237",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93314",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.020469,
            27.501236
          ],
          [
            -0.966588,
            27.575675
          ],
          [
            -0.246759,
            28.565397
          ],
          [
            -0.193411,
            28.638387
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "314",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Runx2 contributes to the regenerative potential of the mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "93540",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.02286,
            27.492409
          ],
          [
            -1.008236,
            27.410366
          ],
          [
            -0.794962,
            26.207489
          ],
          [
            -0.780399,
            26.12489
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "540",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure: implications for breast cancer progression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93541",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.002775,
            27.501062
          ],
          [
            -0.793294,
            27.543498
          ],
          [
            0.926432,
            27.891225
          ],
          [
            1.135578,
            27.933437
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "541",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBF\u03b2-dependent expression of the Wnt antagonist, sclerostin.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "93542",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.949664,
            27.501057
          ],
          [
            -0.557352,
            27.523435
          ],
          [
            1.276479,
            27.627974
          ],
          [
            1.668563,
            27.650315
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "542",
        "label": "RUNX2 in mammary gland development and breast cancer. -- Noncanonical TGF-\u03b2 signaling during mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "93543",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.018108,
            27.501118
          ],
          [
            -0.918558,
            27.578068
          ],
          [
            0.490041,
            28.660995
          ],
          [
            0.588967,
            28.736629
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "543",
        "label": "RUNX2 in mammary gland development and breast cancer. -- A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "93544",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.016661,
            27.492516
          ],
          [
            -0.908184,
            27.425484
          ],
          [
            0.427836,
            26.596606
          ],
          [
            0.53725,
            26.528455
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "93",
        "dest": "544",
        "label": "RUNX2 in mammary gland development and breast cancer. -- A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "9594",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.56924,
            21.8565
          ],
          [
            -3.55003,
            21.715073
          ],
          [
            -3.091262,
            18.296633
          ],
          [
            -3.072007,
            18.151572
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "94",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "95559",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.574678,
            21.856546
          ],
          [
            -3.673405,
            21.76399
          ],
          [
            -5.256114,
            20.272115
          ],
          [
            -5.354941,
            20.178469
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "559",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95560",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.580558,
            21.856593
          ],
          [
            -3.751408,
            21.785114
          ],
          [
            -5.912322,
            20.878009
          ],
          [
            -6.082989,
            20.806128
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "560",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95561",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.580794,
            21.865565
          ],
          [
            -3.737606,
            21.930054
          ],
          [
            -5.530482,
            22.665229
          ],
          [
            -5.686015,
            22.728821
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "561",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "95562",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.54185,
            21.856664
          ],
          [
            -3.284955,
            21.816289
          ],
          [
            -1.34168,
            21.510487
          ],
          [
            -1.084723,
            21.469998
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "562",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Clinicopathological significance of CADM4 expression in invasive ductal carcinoma of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95563",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.556626,
            21.865471
          ],
          [
            -3.374047,
            21.926248
          ],
          [
            -1.360432,
            22.594786
          ],
          [
            -1.177929,
            22.655218
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "563",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95564",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.592737,
            21.85664
          ],
          [
            -3.83395,
            21.80995
          ],
          [
            -5.905878,
            21.408263
          ],
          [
            -6.147853,
            21.361274
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "564",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95565",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.566589,
            21.856552
          ],
          [
            -3.507819,
            21.775363
          ],
          [
            -2.676237,
            20.621714
          ],
          [
            -2.61784,
            20.540364
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "565",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95566",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.487048,
            21.856658
          ],
          [
            -3.063766,
            21.834119
          ],
          [
            -1.145367,
            21.731923
          ],
          [
            -0.721644,
            21.709341
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "566",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95567",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.612799,
            21.865483
          ],
          [
            -3.947202,
            21.899878
          ],
          [
            -6.13057,
            22.124221
          ],
          [
            -6.464417,
            22.158489
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "567",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95568",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.564601,
            21.865565
          ],
          [
            -3.475653,
            21.941578
          ],
          [
            -2.287222,
            22.95329
          ],
          [
            -2.199143,
            23.027976
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "568",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "95569",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.562605,
            21.856582
          ],
          [
            -3.428224,
            21.773349
          ],
          [
            -1.469099,
            20.55456
          ],
          [
            -1.335335,
            20.470982
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "569",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "95570",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.571327,
            21.856458
          ],
          [
            -3.600361,
            21.765276
          ],
          [
            -4.050888,
            20.343109
          ],
          [
            -4.0799,
            20.251078
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "95",
        "dest": "570",
        "label": "Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. -- Testin is a tumor suppressor and prognostic marker in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96571",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.232377,
            26.548641
          ],
          [
            -7.369028,
            26.49119
          ],
          [
            -8.825124,
            25.877211
          ],
          [
            -8.961334,
            25.81961
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "571",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96572",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.217387,
            26.557344
          ],
          [
            -7.154633,
            26.615644
          ],
          [
            -6.48598,
            27.235029
          ],
          [
            -6.423432,
            27.292794
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "572",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96573",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.228363,
            26.548613
          ],
          [
            -7.340823,
            26.470428
          ],
          [
            -8.932055,
            25.358576
          ],
          [
            -9.043799,
            25.280108
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "573",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96574",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.223511,
            26.54863
          ],
          [
            -7.251266,
            26.462845
          ],
          [
            -7.682035,
            25.123653
          ],
          [
            -7.709775,
            25.036916
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "574",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96575",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.221135,
            26.557378
          ],
          [
            -7.204264,
            26.634305
          ],
          [
            -6.972313,
            27.686329
          ],
          [
            -6.955579,
            27.761872
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "575",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96576",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.231288,
            26.557271
          ],
          [
            -7.351951,
            26.613909
          ],
          [
            -8.622696,
            27.208679
          ],
          [
            -8.744037,
            27.265306
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "576",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "96577",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.220198,
            26.548624
          ],
          [
            -7.183622,
            26.465561
          ],
          [
            -6.633873,
            25.209727
          ],
          [
            -6.597404,
            25.125954
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "577",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96578",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.224372,
            26.557361
          ],
          [
            -7.265052,
            26.63643
          ],
          [
            -7.840729,
            27.749307
          ],
          [
            -7.881158,
            27.827038
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "578",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Role of deregulated microRNAs in breast cancer progression using FFPE tissue.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "96579",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.224242,
            26.548539
          ],
          [
            -7.268038,
            26.457966
          ],
          [
            -7.970098,
            24.996372
          ],
          [
            -8.01394,
            24.904522
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "579",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96580",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.289205,
            26.557214
          ],
          [
            -7.597155,
            26.576739
          ],
          [
            -8.873148,
            26.657592
          ],
          [
            -9.180686,
            26.677071
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "580",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96581",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.216092,
            26.548686
          ],
          [
            -7.127663,
            26.485843
          ],
          [
            -6.092144,
            25.747411
          ],
          [
            -6.003318,
            25.68385
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "581",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Morphogenesis of the papillary lesions of the breast: phenotypic observation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96582",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.226192,
            26.557373
          ],
          [
            -7.288017,
            26.624059
          ],
          [
            -8.03091,
            27.422381
          ],
          [
            -8.091744,
            27.487502
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "582",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- Aberrant activation of NF-\u03baB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "96583",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.253064,
            26.548703
          ],
          [
            -7.518642,
            26.512169
          ],
          [
            -9.409697,
            26.251683
          ],
          [
            -9.675222,
            26.215066
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "96",
        "dest": "583",
        "label": "Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer. -- TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "9880",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.833935,
            32.03534
          ],
          [
            -3.35921,
            32.113547
          ],
          [
            3.833552,
            33.290265
          ],
          [
            4.307165,
            33.367202
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "80",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98185",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.908928,
            32.035313
          ],
          [
            -4.606548,
            32.091065
          ],
          [
            -12.322782,
            32.70546
          ],
          [
            -13.020257,
            32.760784
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "185",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "98213",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.837438,
            32.027258
          ],
          [
            -3.529237,
            31.968345
          ],
          [
            0.057558,
            31.279996
          ],
          [
            0.366979,
            31.220382
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "213",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "9839",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.859527,
            32.035409
          ],
          [
            -3.884586,
            32.139385
          ],
          [
            -4.375656,
            34.152579
          ],
          [
            -4.400578,
            34.253508
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "39",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98597",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.852763,
            32.03542
          ],
          [
            -3.749169,
            32.109643
          ],
          [
            -2.28333,
            33.153383
          ],
          [
            -2.180391,
            33.226219
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "597",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Dysregulated STAT1-SOCS1 control of JAK2 promotes mammary luminal progenitor cell survival and drives ER\u03b1(+) tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98598",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.863015,
            32.035334
          ],
          [
            -3.9715,
            32.133352
          ],
          [
            -6.014203,
            33.959023
          ],
          [
            -6.123837,
            34.055935
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "598",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "98599",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.869093,
            32.027199
          ],
          [
            -4.169632,
            31.910876
          ],
          [
            -10.786634,
            29.312985
          ],
          [
            -11.086952,
            29.193436
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "599",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98600",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.871767,
            32.035329
          ],
          [
            -4.195354,
            32.134155
          ],
          [
            -10.349032,
            33.993012
          ],
          [
            -10.673313,
            34.089874
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "600",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "98601",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.865445,
            32.03542
          ],
          [
            -4.002248,
            32.117242
          ],
          [
            -6.124903,
            33.377365
          ],
          [
            -6.261577,
            33.45789
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "601",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98602",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.86284,
            32.027225
          ],
          [
            -3.945275,
            31.949481
          ],
          [
            -5.184571,
            30.772809
          ],
          [
            -5.266777,
            30.694243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "602",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98603",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.869802,
            32.035313
          ],
          [
            -4.044688,
            32.097755
          ],
          [
            -6.198618,
            32.863285
          ],
          [
            -6.375013,
            32.925685
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "603",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- AKT3 regulates ErbB2, ErbB3 and estrogen receptor \u03b1 expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98604",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.861446,
            32.035447
          ],
          [
            -3.928062,
            32.130434
          ],
          [
            -5.114109,
            33.805002
          ],
          [
            -5.180077,
            33.897204
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "604",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- ER\u03b136, a new variant of the ER\u03b1 is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "98605",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.856891,
            32.035399
          ],
          [
            -3.819463,
            32.129331
          ],
          [
            -3.153087,
            33.785395
          ],
          [
            -3.116024,
            33.876589
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "98",
        "dest": "605",
        "label": "STAT1-deficient mice spontaneously develop estrogen receptor \u03b1-positive luminal mammary carcinomas. -- Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "99606",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.003575,
            28.43897
          ],
          [
            -5.09413,
            28.498208
          ],
          [
            -6.104597,
            29.156965
          ],
          [
            -6.195205,
            29.215829
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "99",
        "dest": "606",
        "label": "ER and PR signaling nodes during mammary gland development. -- Diet and expression of estrogen alpha and progesterone receptors in the normal mammary gland.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "99607",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.076772,
            28.438908
          ],
          [
            -5.388568,
            28.455262
          ],
          [
            -6.524086,
            28.514802
          ],
          [
            -6.835692,
            28.531139
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "99",
        "dest": "607",
        "label": "ER and PR signaling nodes during mammary gland development. -- Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "55313",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.906043,
            29.066321
          ],
          [
            -0.775752,
            29.107933
          ],
          [
            0.284437,
            29.445943
          ],
          [
            0.4144,
            29.487297
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "55",
        "dest": "313",
        "label": "RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland. -- Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94545",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.057178,
            18.142308
          ],
          [
            -2.845373,
            18.074323
          ],
          [
            -0.333056,
            17.265937
          ],
          [
            -0.122431,
            17.198
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "545",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94546",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.056096,
            18.151404
          ],
          [
            -2.866738,
            18.207618
          ],
          [
            -0.978052,
            18.767303
          ],
          [
            -0.788548,
            18.823358
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "546",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in\u00a0situ ductal carcinoma (IDC\u00a0+\u00a0DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94547",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.070217,
            18.142236
          ],
          [
            -3.039507,
            18.020284
          ],
          [
            -2.412707,
            15.513222
          ],
          [
            -2.382119,
            15.39006
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "547",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94548",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.115438,
            18.15138
          ],
          [
            -3.412564,
            18.181823
          ],
          [
            -5.120948,
            18.35676
          ],
          [
            -5.418136,
            18.387173
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "548",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94549",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.066942,
            18.142272
          ],
          [
            -2.971002,
            18.042996
          ],
          [
            -1.352625,
            16.360128
          ],
          [
            -1.256304,
            16.259497
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "549",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94550",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.072137,
            18.142356
          ],
          [
            -3.093334,
            18.015379
          ],
          [
            -3.55457,
            15.230404
          ],
          [
            -3.576178,
            15.098964
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "550",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Expression of androgen receptors in primary breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "94551",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.068526,
            18.14226
          ],
          [
            -2.99335,
            18.021012
          ],
          [
            -1.458878,
            15.528505
          ],
          [
            -1.383998,
            15.406053
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "551",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "94552",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.073272,
            18.14226
          ],
          [
            -3.119086,
            18.030613
          ],
          [
            -3.982011,
            15.914637
          ],
          [
            -4.027482,
            15.802478
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "552",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94553",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.080645,
            18.142338
          ],
          [
            -3.234997,
            18.066883
          ],
          [
            -5.268034,
            17.070055
          ],
          [
            -5.422668,
            16.994012
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "553",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Angiogenesis in the progression of breast ductal proliferations.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94554",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.075747,
            18.14232
          ],
          [
            -3.179364,
            18.034346
          ],
          [
            -5.093277,
            16.028344
          ],
          [
            -5.197862,
            15.918115
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "554",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94555",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.934937,
            18.142356
          ],
          [
            -2.433158,
            18.125768
          ],
          [
            -0.693386,
            18.068229
          ],
          [
            -0.191606,
            18.051628
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "555",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94556",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.078504,
            18.142236
          ],
          [
            -3.217021,
            18.052133
          ],
          [
            -5.332433,
            16.67048
          ],
          [
            -5.470691,
            16.57982
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "556",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "94557",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.064398,
            18.142266
          ],
          [
            -2.921448,
            18.047979
          ],
          [
            -0.629741,
            16.529734
          ],
          [
            -0.486646,
            16.434526
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "557",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Which threshold for ER positivity? a retrospective study based on 9639 patients.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "94558",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.114516,
            18.14235
          ],
          [
            -3.435894,
            18.108674
          ],
          [
            -5.453341,
            17.897141
          ],
          [
            -5.774391,
            17.86346
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "94",
        "dest": "558",
        "label": "Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers. -- Significance of syndecan-1 expression in ductal carcinoma in situ of the breast.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39242",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.404165,
            34.261409
          ],
          [
            -4.462555,
            34.3493
          ],
          [
            -5.482924,
            35.870371
          ],
          [
            -5.541664,
            35.957072
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "242",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39243",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.39939,
            34.261523
          ],
          [
            -4.354185,
            34.345755
          ],
          [
            -3.616897,
            35.707451
          ],
          [
            -3.572302,
            35.789089
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "243",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39244",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.396434,
            34.261456
          ],
          [
            -4.304394,
            34.332836
          ],
          [
            -3.002071,
            35.336289
          ],
          [
            -2.910617,
            35.406295
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "244",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "39245",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.406465,
            34.261497
          ],
          [
            -4.512375,
            34.348224
          ],
          [
            -6.299836,
            35.798263
          ],
          [
            -6.404474,
            35.882348
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "245",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Atbf1 regulates pubertal mammary gland development likely by inhibiting the pro-proliferative function of estrogen-ER signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "39246",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.401697,
            34.261466
          ],
          [
            -4.404851,
            34.350714
          ],
          [
            -4.459904,
            35.894984
          ],
          [
            -4.463073,
            35.982993
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "39",
        "dest": "246",
        "label": "Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells. -- Cellular localization of ATBF1 protein and its functional implication in breast epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "599137",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -11.100449,
            29.184898
          ],
          [
            -11.225644,
            29.00015
          ],
          [
            -15.300532,
            22.815076
          ],
          [
            -15.423861,
            22.622969
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "599",
        "dest": "137",
        "label": "Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures. -- Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "600129",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.69534,
            34.097827
          ],
          [
            -10.952959,
            34.21528
          ],
          [
            -16.822299,
            36.846443
          ],
          [
            -17.080101,
            36.960028
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "600",
        "dest": "129",
        "label": "Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters. -- Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "18100",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.511485,
            -35.203375
          ],
          [
            5.863566,
            -35.298679
          ],
          [
            12.49609,
            -37.072906
          ],
          [
            12.845612,
            -37.165284
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "100",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "1837",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.465899,
            -35.203354
          ],
          [
            5.020902,
            -35.259456
          ],
          [
            -0.065611,
            -35.89794
          ],
          [
            -0.509336,
            -35.953399
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "37",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Progesterone induces adult mammary stem cell expansion.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "18102",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.478527,
            -35.195522
          ],
          [
            5.26967,
            -35.151101
          ],
          [
            3.35099,
            -34.741862
          ],
          [
            3.141759,
            -34.697111
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "102",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "18103",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.492831,
            -35.195398
          ],
          [
            5.374521,
            -35.078975
          ],
          [
            2.740071,
            -32.443982
          ],
          [
            2.621783,
            -32.323784
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "18",
        "dest": "103",
        "label": "Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk. -- Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "3754",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.551213,
            -35.961162
          ],
          [
            -0.749079,
            -36.031379
          ],
          [
            -3.548835,
            -37.018192
          ],
          [
            -3.745452,
            -37.087018
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "54",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "37229",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.554861,
            -35.953378
          ],
          [
            -0.818284,
            -35.883778
          ],
          [
            -4.544723,
            -34.892696
          ],
          [
            -4.80823,
            -34.822158
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "229",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Control of mammary stem cell function by steroid hormone signalling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "37230",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.541737,
            -35.961095
          ],
          [
            -0.575114,
            -36.044021
          ],
          [
            -1.137781,
            -37.428979
          ],
          [
            -1.17182,
            -37.511955
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "230",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "37231",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.547694,
            -35.953332
          ],
          [
            -0.667298,
            -35.890811
          ],
          [
            -2.179416,
            -35.096124
          ],
          [
            -2.300315,
            -35.032253
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "231",
        "label": "Progesterone induces adult mammary stem cell expansion. -- The WNT-controlled transcriptional regulator LBH is required for mammary stem cell expansion and maintenance of the basal lineage.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "37232",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -0.541996,
            -35.953189
          ],
          [
            -0.578975,
            -35.869952
          ],
          [
            -1.171797,
            -34.523702
          ],
          [
            -1.208814,
            -34.438904
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "37",
        "dest": "232",
        "label": "Progesterone induces adult mammary stem cell expansion. -- Ovarian steroid hormones: what's hot in the stem cell pool?",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "102622",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            3.109655,
            -34.689215
          ],
          [
            2.930777,
            -34.637439
          ],
          [
            1.045937,
            -34.089891
          ],
          [
            0.867798,
            -34.037958
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "102",
        "dest": "622",
        "label": "A mouse model to dissect progesterone signaling in the female reproductive tract and mammary gland. -- Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103623",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.589245,
            -32.315578
          ],
          [
            2.31723,
            -32.277005
          ],
          [
            0.179677,
            -31.973307
          ],
          [
            -0.09163,
            -31.934686
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "623",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Pubertal bisphenol A exposure alters murine mammary stem cell function leading to early neoplasia in regenerated glands.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103624",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.602925,
            -32.323634
          ],
          [
            2.406742,
            -32.377112
          ],
          [
            0.317272,
            -32.944735
          ],
          [
            0.119787,
            -32.998197
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "624",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "103625",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.616947,
            -32.315556
          ],
          [
            2.600541,
            -32.22465
          ],
          [
            2.313864,
            -30.621484
          ],
          [
            2.297358,
            -30.528359
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "625",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103626",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.615256,
            -32.315578
          ],
          [
            2.55545,
            -32.2159
          ],
          [
            1.407105,
            -30.281155
          ],
          [
            1.346591,
            -30.178103
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "626",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Bisphenol A alters the development of the rhesus monkey mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "103627",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.62726,
            -32.315519
          ],
          [
            2.757871,
            -32.259749
          ],
          [
            4.181657,
            -31.64953
          ],
          [
            4.312078,
            -31.59343
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "627",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Prenatal exposure to bisphenol A promotes angiogenesis and alters steroid-mediated responses in the mammary glands of cycling rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "103628",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.608835,
            -32.315583
          ],
          [
            2.444932,
            -32.240982
          ],
          [
            0.056622,
            -31.147021
          ],
          [
            -0.108775,
            -31.070781
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "628",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Low-dose BPA exposure alters the mesenchymal and epithelial transcriptomes of the mouse fetal mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "103629",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.620397,
            -32.315471
          ],
          [
            2.677027,
            -32.229132
          ],
          [
            3.600657,
            -30.809528
          ],
          [
            3.656525,
            -30.722971
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "629",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- Prenatal exposure to BPA alters the epigenome of the rat mammary gland and increases the propensity to neoplastic development.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "103630",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.612331,
            -32.315444
          ],
          [
            2.509978,
            -32.235726
          ],
          [
            0.971241,
            -31.028854
          ],
          [
            0.869169,
            -30.948247
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "103",
        "dest": "630",
        "label": "Perinatal exposure to bisphenol a increases adult mammary gland progesterone response and cell number. -- The male mammary gland: a target for the xenoestrogen bisphenol A.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "54309",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.762437,
            -37.094779
          ],
          [
            -3.875758,
            -37.168115
          ],
          [
            -5.527824,
            -38.229111
          ],
          [
            -5.640627,
            -38.301001
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "309",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "54310",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.789065,
            -37.094613
          ],
          [
            -4.066282,
            -37.126718
          ],
          [
            -6.017013,
            -37.352239
          ],
          [
            -6.294679,
            -37.384285
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "310",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- Effects of estrogen on the proportion of stem cells in the breast.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "54311",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.756366,
            -37.094734
          ],
          [
            -3.757197,
            -37.172085
          ],
          [
            -3.770175,
            -38.362153
          ],
          [
            -3.771013,
            -38.438121
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "54",
        "dest": "311",
        "label": "Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. -- Progesterone stimulates progenitor cells in normal human breast and breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "22966",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -4.828894,
            -34.814249
          ],
          [
            -4.970999,
            -34.719838
          ],
          [
            -7.597246,
            -32.955711
          ],
          [
            -7.738208,
            -32.860004
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "229",
        "dest": "66",
        "label": "Control of mammary stem cell function by steroid hormone signalling. -- Stem cells: Cues from steroid hormones.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "66390",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -7.747729,
            -32.852001
          ],
          [
            -7.827666,
            -32.763938
          ],
          [
            -9.199934,
            -31.238715
          ],
          [
            -9.280267,
            -31.148639
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "66",
        "dest": "390",
        "label": "Stem cells: Cues from steroid hormones. -- A novel role of microRNA146b in promoting mammary alveolar progenitor cell maintenance.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34565",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.029894,
            -33.606165
          ],
          [
            15.423753,
            -33.634483
          ],
          [
            17.804065,
            -33.805413
          ],
          [
            18.197673,
            -33.833649
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "345",
        "dest": "65",
        "label": "Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. -- Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "345116",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.966729,
            -33.606286
          ],
          [
            14.855221,
            -33.663396
          ],
          [
            13.610952,
            -34.298086
          ],
          [
            13.49939,
            -34.354765
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "345",
        "dest": "116",
        "label": "Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. -- Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34664",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.43235,
            -30.366979
          ],
          [
            14.540164,
            -30.244909
          ],
          [
            16.940752,
            -27.488115
          ],
          [
            17.048544,
            -27.362641
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "346",
        "dest": "64",
        "label": "FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. -- Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "346122",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            14.533614,
            -30.375308
          ],
          [
            15.002116,
            -30.393567
          ],
          [
            16.898998,
            -30.467462
          ],
          [
            17.367698,
            -30.48571
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "346",
        "dest": "122",
        "label": "FGF ligands of the postnatal mammary stroma regulate distinct aspects of epithelial morphogenesis. -- The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "113660",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.698253,
            -22.768001
          ],
          [
            -54.877573,
            -22.852647
          ],
          [
            -57.573338,
            -24.118737
          ],
          [
            -57.752155,
            -24.202284
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "113",
        "dest": "660",
        "label": "The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. -- ALU repeats in promoters are position-dependent co-response elements (coRE) that enhance or repress transcription by dimeric and monomeric progesterone receptors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "113661",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.878624,
            -22.767949
          ],
          [
            -55.558085,
            -22.783605
          ],
          [
            -57.865514,
            -22.836771
          ],
          [
            -58.545257,
            -22.852431
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "113",
        "dest": "661",
        "label": "The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention. -- Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108648",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.36094,
            -45.337032
          ],
          [
            -42.791259,
            -45.336157
          ],
          [
            -43.373852,
            -45.334975
          ],
          [
            -43.771093,
            -45.334166
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "648",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Prolactin and epidermal growth factor stimulate adipophilin synthesis in HC11 mouse mammary epithelial cells via the PI3-kinase/Akt/mTOR pathway.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108649",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.800603,
            -45.341534
          ],
          [
            -41.938892,
            -45.394184
          ],
          [
            -43.665114,
            -46.047296
          ],
          [
            -43.803128,
            -46.09918
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "649",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- The bovine mammary gland expresses multiple functional isoforms of serotonin receptors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "108650",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.775796,
            -45.33481
          ],
          [
            -41.596027,
            -45.296907
          ],
          [
            -39.960626,
            -44.950916
          ],
          [
            -39.780704,
            -44.912721
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "650",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Short communication: retinoic acid plus prolactin to synergistically increase specific casein gene expression in MAC-T cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108651",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.794441,
            -45.334708
          ],
          [
            -41.848139,
            -45.263388
          ],
          [
            -42.708976,
            -44.107779
          ],
          [
            -42.762727,
            -44.034858
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "651",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Increased STAT5 signaling in the ring dove brain in response to prolactin administration and spontaneous elevations in prolactin during the breeding cycle.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108652",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.79828,
            -45.334837
          ],
          [
            -41.922059,
            -45.2706
          ],
          [
            -43.78283,
            -44.29619
          ],
          [
            -43.906258,
            -44.230973
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "652",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Serotonin regulates \u03b2-casein expression via 5-HT7 receptors in human mammary epithelial MCF-12A cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108653",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.815722,
            -45.334846
          ],
          [
            -42.083929,
            -45.297347
          ],
          [
            -44.523842,
            -44.955055
          ],
          [
            -44.792269,
            -44.917269
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "653",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Inhibitory effect of fluvoxamine on \u03b2-casein expression via a serotonin-independent mechanism in human mammary epithelial cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "108654",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.775202,
            -45.341529
          ],
          [
            -41.564539,
            -45.383888
          ],
          [
            -39.417884,
            -45.813719
          ],
          [
            -39.206665,
            -45.855833
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "654",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- Serotonin suppresses \u03b2-casein expression via PTP1B activation in human mammary epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "108655",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.787921,
            -45.341569
          ],
          [
            -41.725815,
            -45.395507
          ],
          [
            -40.940619,
            -46.072964
          ],
          [
            -40.877842,
            -46.126774
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "108",
        "dest": "655",
        "label": "Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A. -- [Endogenous Serotonin and Milk Production Regulation in the Mammary Gland].",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "24131",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.981161,
            4.674476
          ],
          [
            -1.805642,
            4.768014
          ],
          [
            0.916553,
            6.216921
          ],
          [
            1.094478,
            6.311493
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "131",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24132",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.996768,
            4.674482
          ],
          [
            -2.234637,
            4.841709
          ],
          [
            -8.700188,
            9.366626
          ],
          [
            -8.940037,
            9.533532
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "132",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24134",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.986287,
            4.664892
          ],
          [
            -1.864039,
            4.506591
          ],
          [
            1.20521,
            0.524044
          ],
          [
            1.328052,
            0.364475
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "134",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24139",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.991284,
            4.664867
          ],
          [
            -2.033069,
            4.501568
          ],
          [
            -3.109535,
            0.285628
          ],
          [
            -3.151571,
            0.120826
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "139",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "24143",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.989128,
            4.674526
          ],
          [
            -1.967581,
            4.787872
          ],
          [
            -1.56954,
            6.877746
          ],
          [
            -1.547787,
            6.991714
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "24",
        "dest": "143",
        "label": "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a. -- Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "131750",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.146752,
            6.311613
          ],
          [
            1.499793,
            6.272941
          ],
          [
            3.909201,
            6.008952
          ],
          [
            4.262569,
            5.970221
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "750",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "131751",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.106863,
            6.321271
          ],
          [
            1.167256,
            6.412695
          ],
          [
            2.047661,
            7.743449
          ],
          [
            2.107779,
            7.834167
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "751",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131752",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.140994,
            6.321063
          ],
          [
            1.463103,
            6.361729
          ],
          [
            3.765672,
            6.652346
          ],
          [
            4.087873,
            6.692998
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "752",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kr\u00fcppel-like factor 4.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131754",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.112157,
            6.321089
          ],
          [
            1.258839,
            6.402511
          ],
          [
            3.245544,
            7.503951
          ],
          [
            3.39279,
            7.585482
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "754",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "131755",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.102864,
            6.321321
          ],
          [
            1.089116,
            6.413638
          ],
          [
            0.888752,
            7.757394
          ],
          [
            0.875065,
            7.848997
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "755",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "131756",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.105393,
            6.311456
          ],
          [
            1.136584,
            6.226355
          ],
          [
            1.565235,
            5.055328
          ],
          [
            1.596174,
            4.970729
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "131",
        "dest": "756",
        "label": "Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. -- Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "132133",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.94987,
            9.542996
          ],
          [
            -9.076597,
            9.742561
          ],
          [
            -13.19931,
            16.156616
          ],
          [
            -13.328115,
            16.354129
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "133",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "132135",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.948934,
            9.533401
          ],
          [
            -9.017453,
            9.369489
          ],
          [
            -10.783709,
            5.121731
          ],
          [
            -10.850949,
            4.959304
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "135",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "132757",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.967541,
            9.533613
          ],
          [
            -9.230949,
            9.473898
          ],
          [
            -11.929669,
            8.86147
          ],
          [
            -12.1939,
            8.801454
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "757",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "132758",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -8.939641,
            9.543065
          ],
          [
            -8.827227,
            9.617048
          ],
          [
            -7.442757,
            10.526907
          ],
          [
            -7.329375,
            10.601299
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "132",
        "dest": "758",
        "label": "Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. -- Progestins induce catalase activities in breast cancer cells through PRB isoform: correlation with cell growth inhibition.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "13443",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.331258,
            0.364481
          ],
          [
            1.320069,
            0.458943
          ],
          [
            1.15187,
            1.878698
          ],
          [
            1.140712,
            1.972843
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "43",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Signaling inputs to progesterone receptor gene regulation and promoter selectivity.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134136",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.468023,
            0.364291
          ],
          [
            1.854684,
            0.377751
          ],
          [
            2.956224,
            0.416106
          ],
          [
            3.343129,
            0.429578
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "136",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-221/222 control luminal breast cancer tumor progression by regulating different targets.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134142",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.334335,
            0.364336
          ],
          [
            1.397074,
            0.485026
          ],
          [
            2.625919,
            2.84756
          ],
          [
            2.689481,
            2.969658
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "142",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-129-2 mediates down-regulation of progesterone receptor in response to progesterone in breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134753",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.320542,
            0.364361
          ],
          [
            1.158603,
            0.433345
          ],
          [
            -0.691977,
            1.221615
          ],
          [
            -0.854311,
            1.290755
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "753",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134764",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.349005,
            0.354764
          ],
          [
            1.6191,
            0.279451
          ],
          [
            4.990732,
            -0.660702
          ],
          [
            5.260294,
            -0.735859
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "764",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134765",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.33774,
            0.35479
          ],
          [
            1.465122,
            0.251951
          ],
          [
            3.613841,
            -1.482592
          ],
          [
            3.741725,
            -1.5858
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "765",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134766",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.334236,
            0.354809
          ],
          [
            1.394553,
            0.235235
          ],
          [
            2.575832,
            -2.106053
          ],
          [
            2.636933,
            -2.22709
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "766",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134767",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.331837,
            0.354714
          ],
          [
            1.331738,
            0.232713
          ],
          [
            1.329697,
            -2.157334
          ],
          [
            1.32959,
            -2.278563
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "767",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134768",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.335303,
            0.354644
          ],
          [
            1.412841,
            0.244655
          ],
          [
            2.768481,
            -1.678254
          ],
          [
            2.845204,
            -1.787038
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "768",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134769",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.336613,
            0.364437
          ],
          [
            1.441578,
            0.47189
          ],
          [
            3.244364,
            2.316861
          ],
          [
            3.348148,
            2.423018
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "769",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134770",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.330748,
            0.36438
          ],
          [
            1.302437,
            0.488763
          ],
          [
            0.736403,
            2.974595
          ],
          [
            0.708229,
            3.098213
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "770",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "134771",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.334107,
            0.364418
          ],
          [
            1.384804,
            0.47347
          ],
          [
            2.271165,
            2.379643
          ],
          [
            2.321328,
            2.487463
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "771",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134772",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.324784,
            0.364424
          ],
          [
            1.215226,
            0.440065
          ],
          [
            -0.134115,
            1.37156
          ],
          [
            -0.244618,
            1.447831
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "772",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "134773",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.340299,
            0.354777
          ],
          [
            1.516488,
            0.255364
          ],
          [
            4.388549,
            -1.365146
          ],
          [
            4.565081,
            -1.464732
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "773",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134774",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.332355,
            0.364424
          ],
          [
            1.347002,
            0.504776
          ],
          [
            1.673285,
            3.627616
          ],
          [
            1.68794,
            3.767647
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "774",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134775",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.329027,
            0.364386
          ],
          [
            1.259448,
            0.483895
          ],
          [
            -0.077097,
            2.778525
          ],
          [
            -0.146226,
            2.897119
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "775",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134776",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.36414,
            0.354796
          ],
          [
            1.719024,
            0.302564
          ],
          [
            4.885645,
            -0.163507
          ],
          [
            5.240148,
            -0.215683
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "776",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "134777",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.343011,
            0.354695
          ],
          [
            1.523732,
            0.276088
          ],
          [
            3.840255,
            -0.731522
          ],
          [
            4.020961,
            -0.810117
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "134",
        "dest": "777",
        "label": "Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. -- Progestin drives breast cancer growth by inducing p21(CIP1) expression through the assembly of a transcriptional complex among Stat3, progesterone receptor and ErbB-2.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139804",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.089625,
            0.120617
          ],
          [
            -2.821472,
            0.140772
          ],
          [
            -1.779365,
            0.219089
          ],
          [
            -1.511219,
            0.239243
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "804",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "139805",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.159409,
            0.110919
          ],
          [
            -3.261472,
            0.03405
          ],
          [
            -4.519726,
            -0.913508
          ],
          [
            -4.620319,
            -0.989255
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "805",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139806",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.147451,
            0.1207
          ],
          [
            -3.06612,
            0.193687
          ],
          [
            -2.089706,
            1.069847
          ],
          [
            -2.00785,
            1.143295
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "806",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139807",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.189304,
            0.111103
          ],
          [
            -3.429047,
            0.07979
          ],
          [
            -4.776903,
            -0.096273
          ],
          [
            -5.016516,
            -0.127573
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "807",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139808",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.148753,
            0.111115
          ],
          [
            -3.070644,
            0.020261
          ],
          [
            -1.897522,
            -1.34422
          ],
          [
            -1.817418,
            -1.437373
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "808",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139809",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.152546,
            0.111071
          ],
          [
            -3.146361,
            0.007459
          ],
          [
            -3.041982,
            -1.739235
          ],
          [
            -3.035668,
            -1.844862
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "809",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "139810",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.141776,
            0.111033
          ],
          [
            -2.994683,
            0.046713
          ],
          [
            -1.427284,
            -0.638658
          ],
          [
            -1.280662,
            -0.702772
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "810",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "139811",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.151038,
            0.120782
          ],
          [
            -3.124593,
            0.192998
          ],
          [
            -2.814967,
            1.038627
          ],
          [
            -2.788408,
            1.111154
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "811",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139812",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.157032,
            0.120851
          ],
          [
            -3.225994,
            0.202696
          ],
          [
            -4.122432,
            1.266427
          ],
          [
            -4.190616,
            1.347322
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "812",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- The flavonoid apigenin reduces prostate cancer CD44(+) stem cell survival and migration through PI3K/Akt/NF-\u03baB signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "139813",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -3.165434,
            0.120662
          ],
          [
            -3.318026,
            0.178691
          ],
          [
            -4.808306,
            0.745403
          ],
          [
            -4.960716,
            0.803352
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "139",
        "dest": "813",
        "label": "Progesterone generates cancer stem cells through membrane progesterone receptor-triggered signaling in basal-like human mammary cells. -- Generation of breast cancer stem cells by steroid hormones in irradiated human mammary cell lines.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "43248",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.141451,
            1.982705
          ],
          [
            1.161909,
            2.059748
          ],
          [
            1.414166,
            3.009098
          ],
          [
            1.434335,
            3.084963
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "43",
        "dest": "248",
        "label": "Signaling inputs to progesterone receptor gene regulation and promoter selectivity. -- Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "25147",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.073443,
            -16.252931
          ],
          [
            -50.883498,
            -16.15219
          ],
          [
            -47.679426,
            -14.445273
          ],
          [
            -47.488727,
            -14.343248
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "147",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "25148",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.124673,
            -16.26218
          ],
          [
            -51.558885,
            -16.309065
          ],
          [
            -55.187785,
            -16.700445
          ],
          [
            -55.622111,
            -16.747236
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "148",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25151",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.085752,
            -16.262241
          ],
          [
            -51.160288,
            -16.360657
          ],
          [
            -52.39608,
            -17.984986
          ],
          [
            -52.470838,
            -18.082781
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "151",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- A comprehensive view of nuclear receptor cancer cistromes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25152",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.078287,
            -16.262187
          ],
          [
            -50.961744,
            -16.397444
          ],
          [
            -48.306629,
            -19.452273
          ],
          [
            -48.190003,
            -19.585212
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "152",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "25153",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -51.086193,
            -16.252986
          ],
          [
            -51.200139,
            -16.120131
          ],
          [
            -53.737393,
            -13.139947
          ],
          [
            -53.851316,
            -13.005218
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "25",
        "dest": "153",
        "label": "Research resource: Genome-wide profiling of progesterone receptor binding in the mouse uterus. -- Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "147842",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.432798,
            -14.343101
          ],
          [
            -47.123553,
            -14.373296
          ],
          [
            -45.385289,
            -14.542968
          ],
          [
            -45.075442,
            -14.573196
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "842",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Growth regulation by estrogen in breast cancer 1 (GREB1) is a novel progesterone-responsive gene required for human endometrial stromal decidualization.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "147843",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.473829,
            -14.333699
          ],
          [
            -47.358406,
            -14.241704
          ],
          [
            -45.623272,
            -12.854336
          ],
          [
            -45.508176,
            -12.762025
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "843",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Acceleration of the glycolytic flux by steroid receptor coactivator-2 is essential for endometrial decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147844",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.466783,
            -14.343193
          ],
          [
            -47.284052,
            -14.408782
          ],
          [
            -45.244022,
            -15.13963
          ],
          [
            -45.063095,
            -15.204327
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "844",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147845",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.473212,
            -14.343138
          ],
          [
            -47.357484,
            -14.423826
          ],
          [
            -45.76837,
            -15.528781
          ],
          [
            -45.650585,
            -15.610448
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "845",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The coregulator, repressor of estrogen receptor activity (REA), is a crucial regulator of the timing and magnitude of uterine decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147846",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.477051,
            -14.343334
          ],
          [
            -47.421586,
            -14.438937
          ],
          [
            -46.560962,
            -15.916937
          ],
          [
            -46.50555,
            -16.011738
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "846",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Evaluation of human first trimester decidual and telomerase-transformed endometrial stromal cells as model systems of in vitro decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147847",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.478696,
            -14.333816
          ],
          [
            -47.451695,
            -14.224656
          ],
          [
            -46.96198,
            -12.236144
          ],
          [
            -46.935215,
            -12.127023
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "847",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Evidence for a conserved function of heart and neural crest derivatives expressed transcript 2 in mouse and human decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147848",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.466075,
            -14.333822
          ],
          [
            -47.265916,
            -14.265815
          ],
          [
            -44.949622,
            -13.47733
          ],
          [
            -44.750941,
            -13.40957
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "848",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147849",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.480501,
            -14.333865
          ],
          [
            -47.495392,
            -14.225833
          ],
          [
            -47.765426,
            -12.258824
          ],
          [
            -47.780446,
            -12.148964
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "849",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Perturbing the cellular levels of steroid receptor coactivator-2 impairs murine endometrial function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147850",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.483525,
            -14.333675
          ],
          [
            -47.556043,
            -14.238095
          ],
          [
            -48.681309,
            -12.749959
          ],
          [
            -48.753759,
            -12.653835
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "850",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Endometrial stromal beta-catenin is required for steroid-dependent mesenchymal-epithelial cross talk and decidualization.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147851",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.47603,
            -14.333797
          ],
          [
            -47.390335,
            -14.228315
          ],
          [
            -45.891912,
            -12.376375
          ],
          [
            -45.807108,
            -12.271148
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "851",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Notch1 mediates uterine stromal differentiation and is critical for complete decidualization in the mouse.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "147852",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.484226,
            -14.343261
          ],
          [
            -47.548526,
            -14.41324
          ],
          [
            -48.30145,
            -15.230991
          ],
          [
            -48.36604,
            -15.300989
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "852",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "147853",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.449623,
            -14.333877
          ],
          [
            -47.174836,
            -14.291805
          ],
          [
            -45.113175,
            -13.975924
          ],
          [
            -44.838571,
            -13.933816
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "853",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Changes in global gene expression during in vitro decidualization of rat endometrial stromal cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147854",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.490509,
            -14.333883
          ],
          [
            -47.628729,
            -14.273872
          ],
          [
            -49.068412,
            -13.647911
          ],
          [
            -49.207279,
            -13.587445
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "854",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "147855",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.479755,
            -14.343285
          ],
          [
            -47.477995,
            -14.426575
          ],
          [
            -47.453774,
            -15.568145
          ],
          [
            -47.452022,
            -15.650296
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "147",
        "dest": "855",
        "label": "A murine uterine transcriptome, responsive to steroid receptor coactivator-2, reveals transcription factor 23 as essential for decidualization of human endometrial stromal cells. -- G-protein coupled receptor 64 is required for decidualization of endometrial stromal cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148727",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.659814,
            -16.756371
          ],
          [
            -55.531747,
            -16.878995
          ],
          [
            -52.863364,
            -19.41525
          ],
          [
            -52.733149,
            -19.538055
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "727",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148241",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.668657,
            -16.747236
          ],
          [
            -55.755258,
            -16.650209
          ],
          [
            -57.191156,
            -15.03456
          ],
          [
            -57.278016,
            -14.93642
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "241",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Transcription factor KLF11 integrates progesterone receptor signaling and proliferation in uterine leiomyoma cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "148465",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.665808,
            -16.747121
          ],
          [
            -55.69447,
            -16.637901
          ],
          [
            -56.21427,
            -14.646589
          ],
          [
            -56.24268,
            -14.537221
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "465",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "148856",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.686556,
            -16.74726
          ],
          [
            -55.90699,
            -16.701626
          ],
          [
            -57.715823,
            -16.326769
          ],
          [
            -57.93756,
            -16.280769
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "856",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone and mifepristone regulate L-type amino acid transporter 2 and 4F2 heavy chain expression in uterine leiomyoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148857",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.590167,
            -16.756353
          ],
          [
            -55.318046,
            -16.772957
          ],
          [
            -54.378634,
            -16.830283
          ],
          [
            -54.106178,
            -16.846905
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "857",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148858",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.672313,
            -16.747223
          ],
          [
            -55.801195,
            -16.67079
          ],
          [
            -57.498786,
            -15.661253
          ],
          [
            -57.627904,
            -15.584259
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "858",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- LAT1 regulates growth of uterine leiomyoma smooth muscle cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148859",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.656843,
            -16.756534
          ],
          [
            -55.554003,
            -16.819354
          ],
          [
            -54.458175,
            -17.487452
          ],
          [
            -54.35567,
            -17.54982
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "859",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148860",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.665549,
            -16.756365
          ],
          [
            -55.679488,
            -16.821629
          ],
          [
            -55.838798,
            -17.565829
          ],
          [
            -55.852775,
            -17.630966
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "860",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- GSTM1 gene expression correlates to leiomyoma volume regression in response to mifepristone treatment.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "148861",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.66232,
            -16.756377
          ],
          [
            -55.620504,
            -16.840915
          ],
          [
            -55.011504,
            -18.067852
          ],
          [
            -54.968729,
            -18.153706
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "861",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- The T47D cell line is an ideal experimental model to elucidate the progesterone-specific effects of a luminal A subtype of breast cancer.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "148862",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.660941,
            -16.747127
          ],
          [
            -55.591431,
            -16.657417
          ],
          [
            -54.546422,
            -15.303855
          ],
          [
            -54.47711,
            -15.213746
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "862",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Progesterone is essential for maintenance and growth of uterine leiomyoma.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148863",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.664391,
            -16.747121
          ],
          [
            -55.660332,
            -16.642014
          ],
          [
            -55.58939,
            -14.795263
          ],
          [
            -55.585376,
            -14.690251
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "863",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- The role of progesterone signaling in the pathogenesis of uterine leiomyoma.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "148864",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -55.679312,
            -16.756377
          ],
          [
            -55.798422,
            -16.793294
          ],
          [
            -56.602036,
            -17.042187
          ],
          [
            -56.721442,
            -17.079139
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "148",
        "dest": "864",
        "label": "Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells. -- Mifepristone inhibits extracellular matrix formation in uterine\u00a0leiomyoma.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "151876",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.463587,
            -18.092041
          ],
          [
            -52.353122,
            -18.139498
          ],
          [
            -51.429538,
            -18.535796
          ],
          [
            -51.319896,
            -18.582784
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "151",
        "dest": "876",
        "label": "A comprehensive view of nuclear receptor cancer cistromes. -- Genome-wide interplay of nuclear receptors with the epigenome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "151877",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -52.478942,
            -18.091951
          ],
          [
            -52.530781,
            -18.143499
          ],
          [
            -53.006991,
            -18.616344
          ],
          [
            -53.058922,
            -18.667831
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "151",
        "dest": "877",
        "label": "A comprehensive view of nuclear receptor cancer cistromes. -- Integrating multiple oestrogen receptor alpha ChIP studies: overlap with disease susceptibility regions, DNase I hypersensitivity peaks and gene expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "152878",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.244561,
            -19.585254
          ],
          [
            -48.517802,
            -19.564382
          ],
          [
            -49.666398,
            -19.476617
          ],
          [
            -49.940027,
            -19.455701
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "878",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor \u03b1 in luminal breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "152879",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.193514,
            -19.594194
          ],
          [
            -48.290398,
            -19.65217
          ],
          [
            -49.299053,
            -20.254496
          ],
          [
            -49.397323,
            -20.31306
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "879",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152880",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.180071,
            -19.585123
          ],
          [
            -48.061837,
            -19.494073
          ],
          [
            -46.227191,
            -18.074769
          ],
          [
            -46.109064,
            -17.982978
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "880",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "152881",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -47.897355,
            -19.594194
          ],
          [
            -47.466486,
            -19.600864
          ],
          [
            -46.659864,
            -19.613347
          ],
          [
            -46.229042,
            -19.620011
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "881",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Aryl hydrocarbon receptor modulation of estrogen receptor \u03b1-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152882",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.185852,
            -19.594337
          ],
          [
            -48.182188,
            -19.67974
          ],
          [
            -48.128833,
            -20.91959
          ],
          [
            -48.125185,
            -21.003882
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "882",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Novel DNA motif binding activity observed in vivo with an estrogen receptor \u03b1 mutant mouse.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152883",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.161699,
            -19.594212
          ],
          [
            -47.905009,
            -19.641525
          ],
          [
            -45.699652,
            -20.047404
          ],
          [
            -45.44316,
            -20.09454
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "883",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Nucleosome eviction and multiple co-factor binding predict estrogen-receptor-alpha-associated long-range interactions.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152884",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.184458,
            -19.585105
          ],
          [
            -48.149459,
            -19.483358
          ],
          [
            -47.548373,
            -17.726125
          ],
          [
            -47.513771,
            -17.624417
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "884",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Integrative model of genomic factors for determining binding site selection by estrogen receptor-\u03b1.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "152885",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.171746,
            -19.594289
          ],
          [
            -47.963978,
            -19.660535
          ],
          [
            -45.559634,
            -20.42517
          ],
          [
            -45.35339,
            -20.490581
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "885",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- A carrier-assisted ChIP-seq method for estrogen receptor-chromatin interactions from breast cancer core needle biopsy samples.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152886",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.174655,
            -19.585254
          ],
          [
            -48.011445,
            -19.52111
          ],
          [
            -46.146264,
            -18.78632
          ],
          [
            -45.98265,
            -18.721709
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "886",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Research resource: Aorta- and liver-specific ER\u03b1-binding patterns and gene regulation by estrogen.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "152887",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -48.187733,
            -19.585218
          ],
          [
            -48.218954,
            -19.501713
          ],
          [
            -48.673632,
            -18.280673
          ],
          [
            -48.705561,
            -18.194587
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "152",
        "dest": "887",
        "label": "Research resource: whole-genome estrogen receptor \u03b1 binding in mouse uterine tissue revealed by ChIP-seq. -- Genome-Wide Mapping of In Vivo ER\u03b1-Binding Sites in Male Mouse Efferent Ductules.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "153888",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.85875,
            -12.995812
          ],
          [
            -53.935275,
            -12.891715
          ],
          [
            -55.249686,
            -11.09737
          ],
          [
            -55.325358,
            -10.993716
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "888",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Integrated microarray and ChIP analysis identifies multiple Foxa2 dependent target genes in the notochord.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153889",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.866458,
            -12.995892
          ],
          [
            -54.020841,
            -12.931733
          ],
          [
            -55.723489,
            -12.223051
          ],
          [
            -55.877803,
            -12.158723
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "889",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153890",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.855467,
            -12.995738
          ],
          [
            -53.86054,
            -12.874539
          ],
          [
            -53.959938,
            -10.48855
          ],
          [
            -53.96498,
            -10.366939
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "890",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Foxa2 is essential for mouse endometrial gland development and fertility.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "153891",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.853875,
            -12.995849
          ],
          [
            -53.823751,
            -12.89455
          ],
          [
            -53.315894,
            -11.18065
          ],
          [
            -53.285168,
            -11.076629
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "891",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Cell-specific transcriptional profiling reveals candidate mechanisms regulating development and function of uterine epithelia in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "153892",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -53.848841,
            -12.995898
          ],
          [
            -53.736898,
            -12.915009
          ],
          [
            -52.199806,
            -11.801776
          ],
          [
            -52.085883,
            -11.719081
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "153",
        "dest": "892",
        "label": "Integrated chromatin immunoprecipitation sequencing and microarray analysis identifies FOXA2 target genes in the glands of the mouse uterus. -- Forkhead box a2 (FOXA2) is essential for uterine function and fertility.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "28163",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.921956,
            -53.576033
          ],
          [
            -40.039961,
            -53.462123
          ],
          [
            -43.642904,
            -49.835058
          ],
          [
            -43.762501,
            -49.709655
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "163",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "28164",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.909122,
            -53.581743
          ],
          [
            -39.66017,
            -53.653638
          ],
          [
            -34.782218,
            -55.037756
          ],
          [
            -34.534668,
            -55.106761
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "164",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "28165",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -39.921659,
            -53.581806
          ],
          [
            -40.015915,
            -53.684677
          ],
          [
            -42.577794,
            -56.38578
          ],
          [
            -42.672828,
            -56.482498
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "28",
        "dest": "165",
        "label": "Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. -- Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "163108",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.764024,
            -49.703232
          ],
          [
            -43.703441,
            -49.574548
          ],
          [
            -41.852907,
            -45.478871
          ],
          [
            -41.793291,
            -45.341583
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "108",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Serotonin suppresses \u03b2-casein expression via inhibition of the signal transducer and activator of transcription 5 (STAT5) protein phosphorylation in human mammary epithelial cells MCF-12A.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "16391",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.743665,
            -49.709561
          ],
          [
            -43.526186,
            -49.740372
          ],
          [
            -41.756586,
            -49.990362
          ],
          [
            -41.539663,
            -50.020918
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "91",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163162",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.770201,
            -49.70959
          ],
          [
            -43.876591,
            -49.781077
          ],
          [
            -45.770845,
            -51.036254
          ],
          [
            -45.876199,
            -51.105094
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "162",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "163532",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.874725,
            -49.709532
          ],
          [
            -44.737101,
            -49.733802
          ],
          [
            -50.4394,
            -49.893977
          ],
          [
            -51.30173,
            -49.91815
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "532",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "163685",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.750086,
            -49.703334
          ],
          [
            -43.566973,
            -49.666305
          ],
          [
            -41.81509,
            -49.310609
          ],
          [
            -41.632533,
            -49.273392
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "685",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Scribble is required for pregnancy-induced alveologenesis in the adult mammary gland.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "163935",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.765517,
            -49.709577
          ],
          [
            -43.764961,
            -49.775688
          ],
          [
            -43.755661,
            -50.858736
          ],
          [
            -43.755097,
            -50.92346
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "935",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary             carcinoma cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163936",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.769112,
            -49.703314
          ],
          [
            -43.842133,
            -49.638861
          ],
          [
            -45.012726,
            -48.593931
          ],
          [
            -45.085816,
            -48.527956
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "936",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- Pten regulates development and lactation in the mammary glands of dairy cows.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "163937",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -43.778344,
            -49.70333
          ],
          [
            -43.95272,
            -49.660707
          ],
          [
            -45.853745,
            -49.193616
          ],
          [
            -46.027885,
            -49.150605
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "163",
        "dest": "937",
        "label": "Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. -- miR-135a Targets and Regulates Prolactin Receptor Gene in Goat Mammary Epithelial Cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164124",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.523494,
            -55.112203
          ],
          [
            -34.482479,
            -55.190623
          ],
          [
            -33.569261,
            -56.897133
          ],
          [
            -33.52826,
            -56.971989
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "124",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Estradiol, progesterone and prolactin modulate mammary gland morphogenesis in adult female plains vizcacha (Lagostomus maximus).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164166",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.532284,
            -55.112189
          ],
          [
            -34.649771,
            -55.155449
          ],
          [
            -36.1352,
            -55.698294
          ],
          [
            -36.253959,
            -55.741376
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "166",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Cloning and expression of a unique short form of the porcine prolactin receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164167",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.505694,
            -55.112218
          ],
          [
            -34.260475,
            -55.147151
          ],
          [
            -31.747564,
            -55.503392
          ],
          [
            -31.502748,
            -55.537925
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "167",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164169",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.519579,
            -55.106671
          ],
          [
            -34.402244,
            -55.044867
          ],
          [
            -32.386946,
            -53.968405
          ],
          [
            -32.270929,
            -53.905569
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "169",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Reproductive experience alters prolactin receptor expression in mammary and hepatic tissues in female rats.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164939",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.523616,
            -55.106725
          ],
          [
            -34.494513,
            -55.045037
          ],
          [
            -33.985932,
            -53.951529
          ],
          [
            -33.956653,
            -53.887681
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "939",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Molecular characterization, mRNA expression of prolactin receptor (PRLR) gene during pregnancy, nonpregnancy in the yak (Bos grunniens).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164940",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.583369,
            -55.1122
          ],
          [
            -34.871782,
            -55.12562
          ],
          [
            -36.140737,
            -55.184614
          ],
          [
            -36.428754,
            -55.197992
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "940",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164941",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.47554,
            -55.106754
          ],
          [
            -34.162448,
            -55.089467
          ],
          [
            -32.456624,
            -54.995163
          ],
          [
            -32.143624,
            -54.977835
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "941",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Hormone interactions confer specific proliferative and histomorphogenic responses in the porcine mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164943",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.517942,
            -55.112218
          ],
          [
            -34.409678,
            -55.154745
          ],
          [
            -33.076378,
            -55.674783
          ],
          [
            -32.967185,
            -55.717068
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "943",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Short form 1b human prolactin receptor down-regulates expression of the long form.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "164944",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.537608,
            -55.106732
          ],
          [
            -34.680025,
            -55.075929
          ],
          [
            -35.975646,
            -54.794605
          ],
          [
            -36.118184,
            -54.763533
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "944",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- A novel first exon directs hormone-sensitive transcription of the pig prolactin receptor.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164945",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.526587,
            -55.112315
          ],
          [
            -34.555667,
            -55.161756
          ],
          [
            -34.955444,
            -55.835085
          ],
          [
            -34.984296,
            -55.883233
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "945",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Metoclopramide-induced hyperprolactinemia effects on the pituitary and uterine prolactin receptor expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164946",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.516693,
            -55.106761
          ],
          [
            -34.392541,
            -55.06571
          ],
          [
            -32.902001,
            -54.569599
          ],
          [
            -32.777035,
            -54.527727
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "946",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- The progesterone and estrogen modify the uterine prolactin and prolactin receptor expression of hyperprolactinemic mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "164947",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -34.526739,
            -55.106765
          ],
          [
            -34.565417,
            -55.049199
          ],
          [
            -35.206749,
            -54.082628
          ],
          [
            -35.245548,
            -54.023422
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "164",
        "dest": "947",
        "label": "Tissue-specific regulation of porcine prolactin receptor expression by estrogen, progesterone, and prolactin. -- Comparative genomics reveals tissue-specific regulation of prolactin receptor gene expression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "165191",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.693431,
            -56.487912
          ],
          [
            -42.915076,
            -56.520824
          ],
          [
            -45.125682,
            -56.847515
          ],
          [
            -45.347479,
            -56.880135
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "191",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165948",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.672523,
            -56.488
          ],
          [
            -42.61472,
            -56.540484
          ],
          [
            -41.745809,
            -57.320807
          ],
          [
            -41.688173,
            -57.371991
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "948",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165949",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.66464,
            -56.487916
          ],
          [
            -42.512283,
            -56.525103
          ],
          [
            -40.812232,
            -56.937563
          ],
          [
            -40.659799,
            -56.974325
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "949",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165950",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.675364,
            -56.487874
          ],
          [
            -42.669431,
            -56.575474
          ],
          [
            -42.516518,
            -58.763294
          ],
          [
            -42.510554,
            -58.846065
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "950",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin signaling through the short isoform of the mouse prolactin receptor regulates DNA binding of specific transcription factors, often with opposite effects in different reproductive issues.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "165951",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.681473,
            -56.488017
          ],
          [
            -42.791389,
            -56.539216
          ],
          [
            -44.393749,
            -57.277765
          ],
          [
            -44.503155,
            -57.327661
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "951",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "165952",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.882119,
            -56.482634
          ],
          [
            -43.328639,
            -56.476965
          ],
          [
            -44.379407,
            -56.463628
          ],
          [
            -44.825881,
            -56.457959
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "952",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165953",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.682714,
            -56.482599
          ],
          [
            -42.797071,
            -56.440237
          ],
          [
            -44.242916,
            -55.900594
          ],
          [
            -44.358514,
            -55.857119
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "953",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin (PRL) induction of cyclooxygenase 2 (COX2) expression and prostaglandin (PG) production in hamster Leydig cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "165954",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -42.676948,
            -56.487954
          ],
          [
            -42.707247,
            -56.546239
          ],
          [
            -43.218693,
            -57.516427
          ],
          [
            -43.248634,
            -57.572443
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "165",
        "dest": "954",
        "label": "Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. -- Prolactin activation of the long form of its cognate receptor causes increased visceral fat and obesity in males as shown in transgenic mice expressing only this receptor subtype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "91535",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.500864,
            -50.020893
          ],
          [
            -41.301292,
            -49.9847
          ],
          [
            -39.411333,
            -49.640576
          ],
          [
            -39.212561,
            -49.604241
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "91",
        "dest": "535",
        "label": "Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. -- Expression mechanism of tryptophan hydroxylase 1 in mouse islets during pregnancy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "91536",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -41.501991,
            -50.027067
          ],
          [
            -41.321674,
            -50.062032
          ],
          [
            -39.665159,
            -50.382073
          ],
          [
            -39.484514,
            -50.416846
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "91",
        "dest": "536",
        "label": "Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. -- Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29174",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.36285,
            44.473583
          ],
          [
            0.289997,
            44.601728
          ],
          [
            -1.74704,
            48.070745
          ],
          [
            -1.818636,
            48.188667
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "174",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "29175",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.365897,
            44.466513
          ],
          [
            0.408825,
            44.320605
          ],
          [
            1.761814,
            39.53642
          ],
          [
            1.804087,
            39.381186
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "175",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "29178",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.345286,
            44.473475
          ],
          [
            0.154549,
            44.506785
          ],
          [
            -1.370669,
            44.77245
          ],
          [
            -1.560575,
            44.805441
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "178",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29180",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.369469,
            44.473637
          ],
          [
            0.460854,
            44.544398
          ],
          [
            1.878799,
            45.631405
          ],
          [
            1.970092,
            45.700685
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "180",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29182",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.359796,
            44.473484
          ],
          [
            0.279189,
            44.528152
          ],
          [
            -0.739893,
            45.214855
          ],
          [
            -0.821376,
            45.269403
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "182",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "29184",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            0.386873,
            44.473452
          ],
          [
            0.642093,
            44.512795
          ],
          [
            3.034326,
            44.880256
          ],
          [
            3.289409,
            44.919301
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "29",
        "dest": "184",
        "label": "Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein. -- A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174176",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.822384,
            48.195144
          ],
          [
            -1.87599,
            48.292254
          ],
          [
            -3.097295,
            50.454963
          ],
          [
            -3.150939,
            50.54778
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "176",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174177",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.825552,
            48.195073
          ],
          [
            -1.939376,
            48.268739
          ],
          [
            -3.965955,
            49.562596
          ],
          [
            -4.078674,
            49.633578
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "177",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "174977",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.815194,
            48.195182
          ],
          [
            -1.705117,
            48.263471
          ],
          [
            0.059485,
            49.345782
          ],
          [
            0.169668,
            49.412588
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "977",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Constitutive ERK activity induces downregulation of tristetraprolin, a major protein controlling interleukin8/CXCL8 mRNA stability in melanoma cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174978",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.901856,
            48.188683
          ],
          [
            -2.33213,
            48.17194
          ],
          [
            -4.340543,
            48.093704
          ],
          [
            -4.770909,
            48.076925
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "978",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The mRNA decay factor tristetraprolin (TTP) induces senescence in human papillomavirus-transformed cervical cancer cells by targeting E6-AP ubiquitin ligase.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174979",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.824966,
            48.188633
          ],
          [
            -1.906533,
            48.129069
          ],
          [
            -3.095581,
            47.252834
          ],
          [
            -3.176775,
            47.192466
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "979",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174980",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.819969,
            48.195119
          ],
          [
            -1.806297,
            48.269775
          ],
          [
            -1.562899,
            49.580823
          ],
          [
            -1.549356,
            49.652737
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "980",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174981",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.797881,
            48.188646
          ],
          [
            -1.578795,
            48.157733
          ],
          [
            0.158099,
            47.912008
          ],
          [
            0.376035,
            47.881095
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "981",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "174982",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.818743,
            48.195094
          ],
          [
            -1.772776,
            48.276987
          ],
          [
            -0.872119,
            49.855168
          ],
          [
            -0.826411,
            49.933921
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "982",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- The role of tristetraprolin in cancer and inflammation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "174983",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.845295,
            48.195026
          ],
          [
            -2.11002,
            48.229083
          ],
          [
            -4.41642,
            48.524811
          ],
          [
            -4.681321,
            48.558669
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "983",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174984",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.830968,
            48.195035
          ],
          [
            -2.009419,
            48.249736
          ],
          [
            -4.426292,
            48.984809
          ],
          [
            -4.605421,
            49.038864
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "984",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tristetraprolin down-regulates IL-23 expression in colon cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174985",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.823709,
            48.195106
          ],
          [
            -1.890355,
            48.264199
          ],
          [
            -2.9953,
            49.396203
          ],
          [
            -3.062144,
            49.463861
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "985",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tristetraprolin is involved in the glucocorticoid-mediated interleukin 8 repression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174986",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.81041,
            48.195022
          ],
          [
            -1.65049,
            48.24497
          ],
          [
            0.345804,
            48.864375
          ],
          [
            0.505404,
            48.913567
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "986",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Dysregulation of TTP and HuR plays an important role in cancers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174987",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.833154,
            48.188629
          ],
          [
            -2.013562,
            48.142473
          ],
          [
            -4.076229,
            47.611819
          ],
          [
            -4.25516,
            47.565526
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "987",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Control of pro-angiogenic cytokine mRNA half-life in cancer: the role of AU-rich elements and associated proteins.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "174988",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -1.789899,
            48.195009
          ],
          [
            -1.511174,
            48.223759
          ],
          [
            0.579515,
            48.438899
          ],
          [
            0.858993,
            48.467588
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "174",
        "dest": "988",
        "label": "A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients. -- Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "17580",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.806707,
            39.373787
          ],
          [
            1.877489,
            39.211901
          ],
          [
            4.257923,
            33.552925
          ],
          [
            4.329977,
            33.375295
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "80",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "17536",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.798687,
            39.38124
          ],
          [
            1.609717,
            39.492369
          ],
          [
            -2.695697,
            41.975948
          ],
          [
            -2.884812,
            42.082909
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "36",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "175183",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.79497,
            39.373773
          ],
          [
            1.63981,
            39.317108
          ],
          [
            -0.247581,
            38.624156
          ],
          [
            -0.402146,
            38.567106
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "183",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "175989",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            2.207017,
            39.378347
          ],
          [
            2.76727,
            39.379568
          ],
          [
            3.784371,
            39.381792
          ],
          [
            4.409358,
            39.383155
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "989",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175990",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.803089,
            39.38123
          ],
          [
            1.758912,
            39.463964
          ],
          [
            1.00007,
            40.86951
          ],
          [
            0.956388,
            40.949539
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "990",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175991",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.818581,
            39.381176
          ],
          [
            2.033798,
            39.440303
          ],
          [
            4.755978,
            40.183867
          ],
          [
            4.970974,
            40.242249
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "991",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- The protein tyrosine phosphatase receptor type J is regulated by the pVHL-HIF axis in clear cell renal cell carcinoma.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "175992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.812579,
            39.38122
          ],
          [
            1.960564,
            39.455427
          ],
          [
            4.256765,
            40.596712
          ],
          [
            4.404605,
            40.669542
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "992",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175993",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.693203,
            39.373797
          ],
          [
            1.248663,
            39.359212
          ],
          [
            -0.389868,
            39.305423
          ],
          [
            -0.834218,
            39.290829
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "993",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175994",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.797392,
            39.381191
          ],
          [
            1.663178,
            39.445976
          ],
          [
            -0.1806,
            40.329886
          ],
          [
            -0.315461,
            40.394094
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "994",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Regulated expression of PTPRJ/CD148 and an antisense long noncoding RNA in macrophages by proinflammatory stimuli.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175995",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.788267,
            39.381157
          ],
          [
            1.564519,
            39.430166
          ],
          [
            -0.818581,
            39.950007
          ],
          [
            -1.043814,
            39.998939
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "995",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "175996",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.808923,
            39.381249
          ],
          [
            1.901649,
            39.472705
          ],
          [
            3.648246,
            41.173028
          ],
          [
            3.740293,
            41.261443
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "996",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- FoxM1 regulates mammary luminal cell fate.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "175997",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            1.806654,
            39.38123
          ],
          [
            1.84511,
            39.474149
          ],
          [
            2.583791,
            41.234825
          ],
          [
            2.621997,
            41.324637
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "175",
        "dest": "997",
        "label": "Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors. -- Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "36222",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.899314,
            42.090106
          ],
          [
            -3.156019,
            42.203329
          ],
          [
            -9.441086,
            44.912178
          ],
          [
            -9.698766,
            45.020634
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "222",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Role of epithelial stem/progenitor cells in mammary cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "36224",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.904044,
            42.090083
          ],
          [
            -3.100258,
            42.144402
          ],
          [
            -5.487128,
            42.801438
          ],
          [
            -5.682595,
            42.854939
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "224",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "36225",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.926529,
            42.083003
          ],
          [
            -3.238843,
            42.051718
          ],
          [
            -5.525417,
            41.82222
          ],
          [
            -5.837678,
            41.790816
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "225",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- Mammary stem cells and the differentiation hierarchy: current status and perspectives.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "36227",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -2.893518,
            42.090097
          ],
          [
            -2.944793,
            42.169775
          ],
          [
            -3.84082,
            43.54605
          ],
          [
            -3.8924,
            43.624348
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "36",
        "dest": "227",
        "label": "Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. -- The mammary cellular hierarchy and breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "222160",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -9.714684,
            45.027489
          ],
          [
            -9.94384,
            45.128488
          ],
          [
            -15.164795,
            47.381259
          ],
          [
            -15.394118,
            47.478086
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "222",
        "dest": "160",
        "label": "Role of epithelial stem/progenitor cells in mammary cancer. -- From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "30185",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.811191,
            32.130017
          ],
          [
            -22.022628,
            32.181575
          ],
          [
            -13.919558,
            32.709636
          ],
          [
            -13.132092,
            32.76079
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "185",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30186",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -23.213717,
            32.129546
          ],
          [
            -23.852178,
            32.136211
          ],
          [
            -25.22312,
            32.150519
          ],
          [
            -25.882854,
            32.157408
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "186",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30187",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.903284,
            32.121943
          ],
          [
            -23.234465,
            32.077942
          ],
          [
            -26.161617,
            31.68813
          ],
          [
            -26.492143,
            31.644013
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "187",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Form and function: how estrogen and progesterone regulate the mammary epithelial hierarchy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30188",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.876451,
            32.121793
          ],
          [
            -22.950744,
            32.035876
          ],
          [
            -24.141742,
            30.647566
          ],
          [
            -24.216103,
            30.560204
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "188",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30190",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.881851,
            32.121863
          ],
          [
            -23.049098,
            32.045345
          ],
          [
            -25.487305,
            30.922656
          ],
          [
            -25.653783,
            30.84551
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "190",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Prolactin activates ER\u03b1 in the absence of ligand in female mammary development and carcinogenesis in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30192",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.873815,
            32.130022
          ],
          [
            -22.895507,
            32.218686
          ],
          [
            -23.26791,
            33.727182
          ],
          [
            -23.289717,
            33.814694
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "192",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30193",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.883778,
            32.130108
          ],
          [
            -23.066281,
            32.198797
          ],
          [
            -25.471302,
            33.099056
          ],
          [
            -25.651894,
            33.166286
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "193",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "30194",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.877913,
            32.130006
          ],
          [
            -22.972086,
            32.204404
          ],
          [
            -24.343652,
            33.281033
          ],
          [
            -24.439973,
            33.35615
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "194",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "30195",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -22.875674,
            32.121857
          ],
          [
            -22.979123,
            31.971542
          ],
          [
            -25.870584,
            27.673211
          ],
          [
            -25.975024,
            27.514542
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "30",
        "dest": "195",
        "label": "Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action. -- Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "19568",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.977758,
            27.505834
          ],
          [
            -25.971216,
            27.334423
          ],
          [
            -25.771278,
            21.978857
          ],
          [
            -25.764636,
            21.797254
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "195",
        "dest": "68",
        "label": "Hormone signaling requirements for the conversion of non-mammary mouse cells to mammary cell fate(s) in vivo. -- <i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "68393",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.764164,
            21.788067
          ],
          [
            -25.755816,
            21.66252
          ],
          [
            -25.57789,
            18.963263
          ],
          [
            -25.569557,
            18.835672
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "68",
        "dest": "393",
        "label": "<i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. -- Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "68394",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -25.760729,
            21.788173
          ],
          [
            -25.672048,
            21.682402
          ],
          [
            -24.033912,
            19.715035
          ],
          [
            -23.944393,
            19.606801
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "68",
        "dest": "394",
        "label": "<i>In vivo</i> reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling. -- Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "32138",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.662337,
            1.083917
          ],
          [
            -10.88281,
            1.106552
          ],
          [
            -11.825907,
            1.203386
          ],
          [
            -12.046608,
            1.226045
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "138",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "32200",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.616873,
            1.083974
          ],
          [
            -10.631048,
            1.172971
          ],
          [
            -10.837635,
            2.469954
          ],
          [
            -10.851733,
            2.558472
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "200",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- Alpha-actinin 4 and tumorigenesis of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "32201",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -10.613682,
            1.083949
          ],
          [
            -10.572651,
            1.16464
          ],
          [
            -10.024973,
            2.241549
          ],
          [
            -9.983317,
            2.323437
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "32",
        "dest": "201",
        "label": "Role of KLF5 in hormonal signaling and breast cancer development. -- Impact of obesity on mammary gland inflammation and local estrogen production.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138135",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.091318,
            1.235665
          ],
          [
            -12.042488,
            1.382519
          ],
          [
            -10.903466,
            4.803067
          ],
          [
            -10.854544,
            4.94968
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "135",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138198",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.081988,
            1.226007
          ],
          [
            -11.930964,
            1.159792
          ],
          [
            -10.265348,
            0.429476
          ],
          [
            -10.114393,
            0.363286
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "198",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138799",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.133796,
            1.226052
          ],
          [
            -12.356059,
            1.200213
          ],
          [
            -13.417802,
            1.076768
          ],
          [
            -13.640308,
            1.050896
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "799",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kr\u00fcppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138800",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.091189,
            1.235583
          ],
          [
            -12.065452,
            1.30593
          ],
          [
            -11.76409,
            2.129434
          ],
          [
            -11.738247,
            2.200057
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "800",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kr\u00fcppel-like factor 5 in human breast carcinoma: a potent prognostic factor induced by androgens.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138801",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.088119,
            1.225938
          ],
          [
            -11.989521,
            1.126349
          ],
          [
            -10.408884,
            -0.470519
          ],
          [
            -10.310187,
            -0.570226
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "801",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "138802",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.091981,
            1.225957
          ],
          [
            -12.07105,
            1.119371
          ],
          [
            -11.711634,
            -0.710762
          ],
          [
            -11.690597,
            -0.817899
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "802",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "138803",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -12.099057,
            1.235709
          ],
          [
            -12.19409,
            1.31189
          ],
          [
            -13.365635,
            2.250785
          ],
          [
            -13.459297,
            2.325825
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "138",
        "dest": "803",
        "label": "The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation. -- Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34213",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.616488,
            30.251958
          ],
          [
            5.261063,
            30.317819
          ],
          [
            0.765514,
            31.14702
          ],
          [
            0.410462,
            31.212202
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "213",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34206",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.651731,
            30.251953
          ],
          [
            5.822146,
            30.306085
          ],
          [
            7.61698,
            30.874359
          ],
          [
            7.788363,
            30.928443
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "206",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34207",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.633801,
            30.243537
          ],
          [
            5.542081,
            30.163897
          ],
          [
            4.204919,
            28.995588
          ],
          [
            4.113618,
            28.915328
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "207",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34209",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.642758,
            30.243668
          ],
          [
            5.724752,
            30.158376
          ],
          [
            7.03917,
            28.781044
          ],
          [
            7.121248,
            28.694424
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "209",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Inhibiting breast cancer progression by exploiting TGFbeta signaling.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34210",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.637952,
            30.243679
          ],
          [
            5.619946,
            30.150641
          ],
          [
            5.305286,
            28.510619
          ],
          [
            5.287173,
            28.415407
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "210",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "34212",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.678488,
            30.243717
          ],
          [
            5.9632,
            30.214226
          ],
          [
            7.689666,
            30.035215
          ],
          [
            7.974324,
            30.005667
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "212",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A role of TGF\u00df1 dependent 14-3-3\u03c3 phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34214",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.640763,
            30.243575
          ],
          [
            5.680522,
            30.159322
          ],
          [
            6.297435,
            28.842803
          ],
          [
            6.337156,
            28.757453
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "214",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGF\u03b2 in claudin-low breast tumor cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34215",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            5.651357,
            30.243652
          ],
          [
            5.836885,
            30.182119
          ],
          [
            8.01032,
            29.458401
          ],
          [
            8.194644,
            29.396785
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "34",
        "dest": "215",
        "label": "TGF\u03b2 induces the formation of tumour-initiating cells in claudinlow breast cancer. -- A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "38234",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.375439,
            -44.364142
          ],
          [
            7.50506,
            -44.242455
          ],
          [
            10.935591,
            -40.930466
          ],
          [
            11.062851,
            -40.804222
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "234",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Small molecule antagonists of the Wnt/\u03b2-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38233",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.370268,
            -44.371166
          ],
          [
            7.333365,
            -44.462959
          ],
          [
            6.580121,
            -46.305121
          ],
          [
            6.543362,
            -46.39348
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "233",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38238",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.366193,
            -44.371125
          ],
          [
            7.238804,
            -44.451344
          ],
          [
            4.929448,
            -45.886461
          ],
          [
            4.800993,
            -45.965225
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "238",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Key signaling nodes in mammary gland development and cancer: \u03b2-catenin.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38239",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.352208,
            -44.371098
          ],
          [
            7.096486,
            -44.416033
          ],
          [
            4.401993,
            -44.887406
          ],
          [
            4.147321,
            -44.931759
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "239",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "38240",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            7.373314,
            -44.371175
          ],
          [
            7.413188,
            -44.455843
          ],
          [
            8.164337,
            -46.027933
          ],
          [
            8.203921,
            -46.109569
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "38",
        "dest": "240",
        "label": "Wnt and mammary stem cells: hormones cannot fly wingless. -- Wnt signaling in stem and cancer stem cells.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "65380",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.258865,
            -33.833518
          ],
          [
            18.364981,
            -33.762389
          ],
          [
            19.823461,
            -32.778817
          ],
          [
            19.928724,
            -32.707403
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "380",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Lineage enforcement by inductive mesenchyme on adult epithelial stem cells across developmental germ layers.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65381",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.243098,
            -33.841573
          ],
          [
            18.102685,
            -33.899236
          ],
          [
            16.478496,
            -34.563419
          ],
          [
            16.337595,
            -34.620787
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "381",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "65382",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.257106,
            -33.841626
          ],
          [
            18.310803,
            -33.891532
          ],
          [
            18.846599,
            -34.387901
          ],
          [
            18.899839,
            -34.437063
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "382",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Peroxisomal membrane channel Pxmp2 in the mammary fat pad is essential for stromal lipid homeostasis and for development of mammary gland epithelium in mice.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65383",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.356107,
            -33.841547
          ],
          [
            18.651406,
            -33.852831
          ],
          [
            19.496645,
            -33.885124
          ],
          [
            19.791646,
            -33.896391
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "383",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Human amniotic fluid stem cells have a potential to recover ovarian function in mice with chemotherapy-induced sterility.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65384",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.254379,
            -33.83357
          ],
          [
            18.284114,
            -33.758867
          ],
          [
            18.717572,
            -32.662489
          ],
          [
            18.747171,
            -32.587131
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "384",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Amniotic fluid stem cell-based models to study the effects of gene mutations and toxicants on male germ cell formation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "65385",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.251545,
            -33.841704
          ],
          [
            18.231963,
            -33.907274
          ],
          [
            17.984101,
            -34.732625
          ],
          [
            17.964762,
            -34.796662
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "385",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Bovine mammary epithelial cells retain stem-like phenotype in long-term cultures.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "65386",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.275119,
            -33.833644
          ],
          [
            18.513064,
            -33.791496
          ],
          [
            20.575967,
            -33.425247
          ],
          [
            20.814894,
            -33.38273
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "386",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- The potential of amniotic fluid stem cells for cellular therapy and tissue engineering.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "65387",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.250449,
            -33.83357
          ],
          [
            18.205868,
            -33.756376
          ],
          [
            17.535676,
            -32.587584
          ],
          [
            17.491218,
            -32.509502
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "387",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- Reconstitution of mammary epithelial morphogenesis by murine embryonic stem cells undergoing hematopoietic stem cell differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "65388",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            18.24466,
            -33.833576
          ],
          [
            18.120401,
            -33.771985
          ],
          [
            16.60887,
            -33.019176
          ],
          [
            16.485092,
            -32.957234
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "65",
        "dest": "388",
        "label": "Murine amniotic fluid stem cells contribute mesenchymal but not epithelial components to reconstituted mammary ducts. -- The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "116674",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.505247,
            -34.362776
          ],
          [
            13.640215,
            -34.401339
          ],
          [
            14.719461,
            -34.70906
          ],
          [
            14.853842,
            -34.747296
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "116",
        "dest": "674",
        "label": "Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. -- The miR-17/92 cluster is targeted by STAT5 but dispensable for mammary development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "116676",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.492946,
            -34.362896
          ],
          [
            13.513039,
            -34.415771
          ],
          [
            13.722376,
            -34.964774
          ],
          [
            13.74237,
            -35.017007
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "116",
        "dest": "676",
        "label": "Development of mammary luminal progenitor cells is controlled by the transcription factor STAT5A. -- Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64368",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.048597,
            -27.353994
          ],
          [
            16.975614,
            -27.269128
          ],
          [
            15.843249,
            -25.944029
          ],
          [
            15.770342,
            -25.858184
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "368",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Extracellular matrix composition reveals complex and dynamic stromal-epithelial interactions in the mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64369",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.060639,
            -27.354067
          ],
          [
            17.199895,
            -27.283794
          ],
          [
            19.034045,
            -26.35405
          ],
          [
            19.173553,
            -26.283024
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "369",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- P190A RhoGAP is required for mammary gland development.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64370",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.0514,
            -27.354017
          ],
          [
            17.031627,
            -27.258406
          ],
          [
            16.686073,
            -25.574382
          ],
          [
            16.666178,
            -25.476691
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "370",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90\u03b2.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64371",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.00784,
            -27.362495
          ],
          [
            16.704757,
            -27.391205
          ],
          [
            14.945219,
            -27.557748
          ],
          [
            14.641656,
            -27.586457
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "371",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "64372",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.054545,
            -27.353944
          ],
          [
            17.104305,
            -27.258428
          ],
          [
            17.958912,
            -25.605252
          ],
          [
            18.008116,
            -25.509366
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "372",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The role of the microenvironment in mammary gland development and cancer.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "64373",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.063823,
            -27.362535
          ],
          [
            17.23583,
            -27.425873
          ],
          [
            19.275129,
            -28.173998
          ],
          [
            19.448073,
            -28.237211
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "373",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "64374",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.056373,
            -27.354062
          ],
          [
            17.129775,
            -27.27831
          ],
          [
            18.167366,
            -26.201937
          ],
          [
            18.242253,
            -26.123864
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "374",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64375",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.055056,
            -27.362703
          ],
          [
            17.099286,
            -27.433212
          ],
          [
            17.659021,
            -28.321564
          ],
          [
            17.702687,
            -28.390551
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "375",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Transplantation of a mammary stromal cell line into a mammary fat pad: development of the site-specific in vivo analysis system for mammary stromal cells.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "64376",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.050958,
            -27.362535
          ],
          [
            17.028611,
            -27.434374
          ],
          [
            16.730273,
            -28.388777
          ],
          [
            16.707583,
            -28.461027
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "376",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64377",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.040805,
            -27.354022
          ],
          [
            16.876346,
            -27.292963
          ],
          [
            14.996937,
            -26.59278
          ],
          [
            14.832073,
            -26.531154
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "377",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64378",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.094998,
            -27.354056
          ],
          [
            17.407061,
            -27.323185
          ],
          [
            19.332124,
            -27.132543
          ],
          [
            19.643997,
            -27.101628
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "378",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- Mammary ductal elongation and myoepithelial migration are regulated by the composition of the extracellular matrix.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "64379",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            17.2474,
            -27.362501
          ],
          [
            17.687926,
            -27.372017
          ],
          [
            18.755389,
            -27.395078
          ],
          [
            19.195869,
            -27.404592
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "64",
        "dest": "379",
        "label": "Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. -- SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "38167",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            16.325301,
            -34.628674
          ],
          [
            16.274879,
            -34.706191
          ],
          [
            15.492455,
            -35.899691
          ],
          [
            15.442078,
            -35.975934
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "381",
        "dest": "67",
        "label": "Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. -- Reprogramming human cancer cells in the mouse mammary gland.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "67391",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.448278,
            -35.975928
          ],
          [
            15.568949,
            -35.92283
          ],
          [
            16.899112,
            -35.335104
          ],
          [
            17.020964,
            -35.281052
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "67",
        "dest": "391",
        "label": "Reprogramming human cancer cells in the mouse mammary gland. -- The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "67392",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            15.447425,
            -35.975821
          ],
          [
            15.538993,
            -35.9299
          ],
          [
            16.397866,
            -35.497903
          ],
          [
            16.488199,
            -35.452329
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "67",
        "dest": "392",
        "label": "Reprogramming human cancer cells in the mouse mammary gland. -- Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in-vivo.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81211",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.067389,
            -16.357915
          ],
          [
            68.180139,
            -16.253508
          ],
          [
            70.151428,
            -14.419271
          ],
          [
            70.262997,
            -14.314992
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "211",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "81479",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.069217,
            -16.36722
          ],
          [
            68.207178,
            -16.46077
          ],
          [
            70.382869,
            -17.929831
          ],
          [
            70.520837,
            -18.022594
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "479",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81480",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.087459,
            -16.358012
          ],
          [
            68.38809,
            -16.303403
          ],
          [
            71.293177,
            -15.77489
          ],
          [
            71.5945,
            -15.719994
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "480",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "81481",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.07886,
            -16.36716
          ],
          [
            68.326463,
            -16.436001
          ],
          [
            71.281043,
            -17.255524
          ],
          [
            71.528745,
            -17.324067
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "481",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "81482",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.075097,
            -16.357927
          ],
          [
            68.27013,
            -16.286728
          ],
          [
            70.64262,
            -15.41864
          ],
          [
            70.836914,
            -15.347389
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "482",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Cell fate takes a slug in BRCA1-associated breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81484",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.06547,
            -16.367226
          ],
          [
            68.135086,
            -16.471513
          ],
          [
            69.352415,
            -18.285535
          ],
          [
            69.421308,
            -18.387649
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "484",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "81485",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.062187,
            -16.367148
          ],
          [
            68.058143,
            -16.473598
          ],
          [
            67.984779,
            -18.392856
          ],
          [
            67.980696,
            -18.499001
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "485",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81486",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.106501,
            -16.367142
          ],
          [
            68.458864,
            -16.403624
          ],
          [
            70.810713,
            -16.646939
          ],
          [
            71.162413,
            -16.683296
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "486",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "81487",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            68.064327,
            -16.35797
          ],
          [
            68.104551,
            -16.263643
          ],
          [
            68.749463,
            -14.745527
          ],
          [
            68.789733,
            -14.650375
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "81",
        "dest": "487",
        "label": "BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development. -- BRCA1 mutations and luminal-basal transformation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "83495",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.30226,
            -18.946947
          ],
          [
            8.177971,
            -19.027878
          ],
          [
            6.469656,
            -20.136214
          ],
          [
            6.346365,
            -20.215909
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "495",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "83496",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.309907,
            -18.937654
          ],
          [
            8.319672,
            -18.848753
          ],
          [
            8.466491,
            -17.506656
          ],
          [
            8.476233,
            -17.417269
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "496",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "83497",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.300105,
            -18.937786
          ],
          [
            8.157962,
            -18.868711
          ],
          [
            6.429622,
            -18.026592
          ],
          [
            6.286398,
            -17.95662
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "497",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83498",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.280233,
            -18.937816
          ],
          [
            8.002643,
            -18.895109
          ],
          [
            5.83102,
            -18.56064
          ],
          [
            5.553285,
            -18.517813
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "498",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83499",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.285999,
            -18.946809
          ],
          [
            8.024914,
            -18.997125
          ],
          [
            5.661251,
            -19.451951
          ],
          [
            5.400068,
            -19.502136
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "499",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Correlations between BRCA1 defect and environmental factors in the risk of breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "83500",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.307158,
            -18.947025
          ],
          [
            8.262882,
            -19.040512
          ],
          [
            7.575941,
            -20.484179
          ],
          [
            7.531711,
            -20.576675
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "500",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "83501",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            8.30616,
            -18.937726
          ],
          [
            8.248045,
            -18.855573
          ],
          [
            7.425748,
            -17.688894
          ],
          [
            7.367998,
            -17.606671
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "83",
        "dest": "501",
        "label": "BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact? -- Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "92189",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.661328,
            -12.921677
          ],
          [
            13.541465,
            -13.005785
          ],
          [
            11.893945,
            -14.158793
          ],
          [
            11.775041,
            -14.241784
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "189",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "92443",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.666378,
            -12.921578
          ],
          [
            13.625256,
            -13.027572
          ],
          [
            12.906256,
            -14.873164
          ],
          [
            12.865568,
            -14.977166
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "443",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "92524",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.748714,
            -12.912218
          ],
          [
            14.065431,
            -12.894002
          ],
          [
            15.223769,
            -12.82735
          ],
          [
            15.54057,
            -12.809116
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "524",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "92525",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.661724,
            -12.91215
          ],
          [
            13.56372,
            -12.841176
          ],
          [
            12.387156,
            -11.987569
          ],
          [
            12.288512,
            -11.915879
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "525",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- FOXA1 represses the molecular phenotype of basal breast cancer cells.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "92538",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.67481,
            -12.912107
          ],
          [
            13.780103,
            -12.836381
          ],
          [
            15.11124,
            -11.877079
          ],
          [
            15.217668,
            -11.800235
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "538",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "92539",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.670263,
            -12.921566
          ],
          [
            13.710783,
            -13.014834
          ],
          [
            14.339579,
            -14.457438
          ],
          [
            14.380061,
            -14.550011
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "92",
        "dest": "539",
        "label": "Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression. -- Loss of ER\u03b1 and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "75349",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            11.637179,
            -9.53142
          ],
          [
            11.737263,
            -9.618976
          ],
          [
            13.153387,
            -10.855321
          ],
          [
            13.25283,
            -10.941954
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "75",
        "dest": "349",
        "label": "Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. -- Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "75445",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            11.613118,
            -9.521837
          ],
          [
            11.442756,
            -9.478439
          ],
          [
            10.148422,
            -9.148587
          ],
          [
            9.978525,
            -9.105268
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "75",
        "dest": "445",
        "label": "Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. -- Lgr6 labels a rare population of mammary gland progenitor cells that are able to originate luminal mammary tumours.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "34992",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            13.259297,
            -10.951413
          ],
          [
            13.280578,
            -11.054026
          ],
          [
            13.645851,
            -12.809745
          ],
          [
            13.667231,
            -12.912169
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "349",
        "dest": "92",
        "label": "Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "9092",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.436569,
            -12.685927
          ],
          [
            10.855951,
            -12.715907
          ],
          [
            13.184044,
            -12.882268
          ],
          [
            13.603464,
            -12.912224
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "92",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "90526",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.362177,
            -12.685964
          ],
          [
            10.203537,
            -12.762593
          ],
          [
            8.142424,
            -13.756025
          ],
          [
            7.983647,
            -13.832384
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "526",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "90527",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.359427,
            -12.676614
          ],
          [
            10.198236,
            -12.61576
          ],
          [
            8.518627,
            -11.980847
          ],
          [
            8.358251,
            -11.920141
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "527",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "90528",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.367387,
            -12.686112
          ],
          [
            10.292134,
            -12.767544
          ],
          [
            9.286633,
            -13.853009
          ],
          [
            9.212111,
            -13.933258
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "528",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Foxa1 is essential for mammary duct formation.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "90529",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.369131,
            -12.676663
          ],
          [
            10.318998,
            -12.590872
          ],
          [
            9.588909,
            -11.338195
          ],
          [
            9.537633,
            -11.250012
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "529",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "90530",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.371637,
            -12.686199
          ],
          [
            10.36792,
            -12.77702
          ],
          [
            10.313765,
            -14.097283
          ],
          [
            10.310064,
            -14.187161
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "530",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "90531",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            10.165514,
            -12.676669
          ],
          [
            9.6471,
            -12.665043
          ],
          [
            8.294453,
            -12.634699
          ],
          [
            7.776085,
            -12.623071
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "90",
        "dest": "531",
        "label": "RUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells. -- RUNX1 prevents oestrogen-mediated AXIN1 suppression and \u03b2-catenin activation in ER-positive breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97312",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.298898,
            30.138318
          ],
          [
            -21.214582,
            30.217017
          ],
          [
            -19.985462,
            31.357104
          ],
          [
            -19.901534,
            31.434457
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "312",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97584",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.29573,
            30.129898
          ],
          [
            -21.167229,
            30.060355
          ],
          [
            -19.474626,
            29.13986
          ],
          [
            -19.345889,
            29.069504
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "584",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97585",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.301892,
            30.129887
          ],
          [
            -21.261097,
            30.019703
          ],
          [
            -20.428289,
            27.744271
          ],
          [
            -20.387646,
            27.631968
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "585",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "97586",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.305129,
            30.129936
          ],
          [
            -21.342169,
            30.038981
          ],
          [
            -21.97804,
            28.464616
          ],
          [
            -22.015263,
            28.3717
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "586",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97587",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.311039,
            30.138231
          ],
          [
            -21.403026,
            30.188562
          ],
          [
            -22.300964,
            30.678558
          ],
          [
            -22.393667,
            30.729002
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "587",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- The diverse distribution of risk factors between breast cancer subtypes of ER, PR and HER2: a 10-year retrospective multi-center study in China.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97588",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.316059,
            30.129931
          ],
          [
            -21.475986,
            30.077437
          ],
          [
            -23.105675,
            29.540921
          ],
          [
            -23.266021,
            29.487979
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "588",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "97589",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.293666,
            30.138253
          ],
          [
            -21.169575,
            30.191278
          ],
          [
            -19.904527,
            30.730208
          ],
          [
            -19.781282,
            30.782548
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "589",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97590",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.305388,
            30.138231
          ],
          [
            -21.337294,
            30.206473
          ],
          [
            -21.751588,
            31.08841
          ],
          [
            -21.783906,
            31.156872
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "590",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97591",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.30263,
            30.138187
          ],
          [
            -21.286514,
            30.219629
          ],
          [
            -21.036435,
            31.474597
          ],
          [
            -21.020333,
            31.554832
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "591",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Expression of AIB1 protein as a prognostic factor in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97592",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.497488,
            30.138171
          ],
          [
            -21.807868,
            30.144731
          ],
          [
            -22.410546,
            30.157469
          ],
          [
            -22.700924,
            30.163607
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "592",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Estrogen and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97593",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.284891,
            30.138242
          ],
          [
            -21.087223,
            30.182676
          ],
          [
            -19.372715,
            30.567215
          ],
          [
            -19.175801,
            30.611281
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "593",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97594",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.308153,
            30.1298
          ],
          [
            -21.398243,
            30.048038
          ],
          [
            -22.752634,
            28.810773
          ],
          [
            -22.842472,
            28.728175
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "594",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "97595",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.300033,
            30.129964
          ],
          [
            -21.240699,
            30.058468
          ],
          [
            -20.425935,
            29.071487
          ],
          [
            -20.36555,
            28.997955
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "595",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Histological and immunohistochemical study of estrogen and progesterone receptors in normal human breast tissue in adult age groups vulnerable to malignancy.",
        "weight": "",
        "level": 4
      }
    },
    {
      "type": "Feature",
      "id": "97596",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -21.278455,
            30.129942
          ],
          [
            -21.05128,
            30.09242
          ],
          [
            -19.346895,
            29.810444
          ],
          [
            -19.119879,
            29.772828
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "97",
        "dest": "596",
        "label": "Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. -- Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "585141",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -20.38399,
            27.623331
          ],
          [
            -20.325555,
            27.502716
          ],
          [
            -19.081034,
            24.902762
          ],
          [
            -19.022729,
            24.779547
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "585",
        "dest": "141",
        "label": "Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers. -- Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "112645",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.41249,
            -3.776424
          ],
          [
            -54.203557,
            -3.836281
          ],
          [
            -52.097377,
            -4.439417
          ],
          [
            -51.888101,
            -4.499319
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "645",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "112657",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.444793,
            -3.776436
          ],
          [
            -54.734592,
            -3.865158
          ],
          [
            -58.959376,
            -5.15739
          ],
          [
            -59.247843,
            -5.245534
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "657",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "112659",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -54.408629,
            -3.766892
          ],
          [
            -54.175871,
            -3.712903
          ],
          [
            -52.037555,
            -3.216813
          ],
          [
            -51.804378,
            -3.162698
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "112",
        "dest": "659",
        "label": "Multimodal regulation of E2F1 gene expression by progestins. -- The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "657127",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -59.266268,
            -5.255066
          ],
          [
            -59.354979,
            -5.400033
          ],
          [
            -61.423975,
            -8.769391
          ],
          [
            -61.512839,
            -8.913507
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "657",
        "dest": "127",
        "label": "Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1). -- Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "115181",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.534436,
            -56.914192
          ],
          [
            -67.397618,
            -56.951026
          ],
          [
            -65.870892,
            -57.359543
          ],
          [
            -65.734005,
            -57.395953
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "181",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115520",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.543881,
            -56.914237
          ],
          [
            -67.536775,
            -56.96905
          ],
          [
            -67.422837,
            -57.836823
          ],
          [
            -67.415723,
            -57.890327
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "520",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Coregulation of genetic programs by the transcription factors NFIB and STAT5.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115537",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.550272,
            -56.908856
          ],
          [
            -67.652525,
            -56.863163
          ],
          [
            -69.018684,
            -56.24727
          ],
          [
            -69.11994,
            -56.201221
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "537",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115666",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.568354,
            -56.908957
          ],
          [
            -67.801188,
            -56.883844
          ],
          [
            -69.646192,
            -56.684268
          ],
          [
            -69.879484,
            -56.658957
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "666",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Genome-wide chromatin occupancy analysis reveals a role for ASH2 in transcriptional pausing.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115667",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.54938,
            -56.914282
          ],
          [
            -67.647986,
            -56.96642
          ],
          [
            -69.13036,
            -57.741465
          ],
          [
            -69.228684,
            -57.792298
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "667",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Chromatin signature of embryonic pluripotency is established during genome activation.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "115668",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.574698,
            -56.914148
          ],
          [
            -67.828349,
            -56.935721
          ],
          [
            -69.586074,
            -57.084868
          ],
          [
            -69.839649,
            -57.106336
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "668",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Three distinct patterns of histone H3Y41 phosphorylation mark active genes.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115669",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.541505,
            -56.908881
          ],
          [
            -67.475521,
            -56.84404
          ],
          [
            -66.232593,
            -55.601408
          ],
          [
            -66.167097,
            -55.534806
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "669",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "115670",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.553646,
            -56.914154
          ],
          [
            -67.683571,
            -56.949988
          ],
          [
            -69.116429,
            -57.342886
          ],
          [
            -69.246294,
            -57.37829
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "670",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Epigenetic modifications unlock the milk protein gene loci during mouse mammary gland development and differentiation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115671",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.5412,
            -56.91422
          ],
          [
            -67.481257,
            -56.966872
          ],
          [
            -66.55113,
            -57.774353
          ],
          [
            -66.491248,
            -57.825739
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "671",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "115673",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -67.546753,
            -56.914234
          ],
          [
            -67.593588,
            -56.963811
          ],
          [
            -68.276263,
            -57.679115
          ],
          [
            -68.322877,
            -57.727449
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "115",
        "dest": "673",
        "label": "Mammary-specific gene activation is defined by progressive recruitment of STAT5 during pregnancy and the establishment of H3K4me3 marks. -- Differential cytokine sensitivities of STAT5-dependent enhancers rely on Stat5 autoregulation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "669118",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -66.161765,
            -55.529389
          ],
          [
            -66.092134,
            -55.458732
          ],
          [
            -64.671447,
            -53.989281
          ],
          [
            -64.600734,
            -53.914742
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "669",
        "dest": "118",
        "label": "Sequential activation of genetic programs in mouse mammary epithelium during pregnancy depends on STAT5A/B concentration. -- PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "118179",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.609721,
            -53.914697
          ],
          [
            -64.756662,
            -53.950235
          ],
          [
            -66.23794,
            -54.306777
          ],
          [
            -66.385125,
            -54.342036
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "179",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Forced activation of Stat5 subjects mammary epithelial cells to DNA damage and preferential induction of the cellular response mechanism during proliferation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118665",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.597535,
            -53.909066
          ],
          [
            -64.584853,
            -53.832122
          ],
          [
            -64.314849,
            -52.160208
          ],
          [
            -64.301939,
            -52.078624
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "665",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "118672",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.577343,
            -53.914674
          ],
          [
            -64.390498,
            -53.94011
          ],
          [
            -62.994672,
            -54.129634
          ],
          [
            -62.807408,
            -54.154994
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "672",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- MiR-21 is under control of STAT5 but is dispensable for mammary development and lactation.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118679",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.603613,
            -53.908992
          ],
          [
            -64.690725,
            -53.864428
          ],
          [
            -65.763588,
            -53.311661
          ],
          [
            -65.851446,
            -53.266069
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "679",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Prolactin promotes mammary pathogenesis independently from cyclin D1.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118680",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.580298,
            -53.909051
          ],
          [
            -64.404391,
            -53.881122
          ],
          [
            -62.97301,
            -53.653166
          ],
          [
            -62.797545,
            -53.625138
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "680",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "118681",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.596034,
            -53.914678
          ],
          [
            -64.551263,
            -53.978943
          ],
          [
            -63.754452,
            -55.10615
          ],
          [
            -63.709353,
            -55.169018
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "681",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Dystroglycan controls signaling of multiple hormones through modulation of STAT5 activity.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118682",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.598395,
            -53.914689
          ],
          [
            -64.606553,
            -53.972577
          ],
          [
            -64.737354,
            -54.889657
          ],
          [
            -64.745519,
            -54.946239
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "682",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118683",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.638048,
            -53.909066
          ],
          [
            -64.898447,
            -53.890878
          ],
          [
            -66.348481,
            -53.789463
          ],
          [
            -66.609017,
            -53.771215
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "683",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Function of phosphoenolpyruvate carboxykinase in mammary gland epithelial cells.",
        "weight": "",
        "level": 3
      }
    },
    {
      "type": "Feature",
      "id": "118684",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.591259,
            -53.914745
          ],
          [
            -64.473748,
            -53.964954
          ],
          [
            -62.858699,
            -54.648923
          ],
          [
            -62.742141,
            -54.697847
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "118",
        "dest": "684",
        "label": "PIKE-A is required for prolactin-mediated STAT5a activation in mammary gland development. -- Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "665120",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.345026,
            -52.078523
          ],
          [
            -64.7908,
            -52.108469
          ],
          [
            -68.516326,
            -52.35794
          ],
          [
            -68.962222,
            -52.387706
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "665",
        "dest": "120",
        "label": "Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. -- Signal transducer and activator of transcription 5a inhibited by pimozide may regulate survival of goat mammary gland epithelial cells by regulating parathyroid hormone-related protein.",
        "weight": "",
        "level": 2
      }
    },
    {
      "type": "Feature",
      "id": "665168",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -64.285167,
            -52.072659
          ],
          [
            -63.962852,
            -52.014504
          ],
          [
            -58.961623,
            -51.102371
          ],
          [
            -58.639613,
            -51.043016
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "665",
        "dest": "168",
        "label": "Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. -- Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways.",
        "weight": "",
        "level": 1
      }
    },
    {
      "type": "Feature",
      "id": "119140",
      "geometry": {
        "type": "LineString",
        "coordinates": [
          [
            -5.537391,
            4.351237
          ],
          [
            -5.712871,
            4.271294
          ],
          [
            -8.056426,
            3.202925
          ],
          [
            -8.232402,
            3.122656
          ]
        ]
      },
      "properties": {
        "fill": "none",
        "stroke": "grey",
        "src": "119",
        "dest": "140",
        "label": "Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a. -- Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.",
        "weight": "",
        "level": 2
      }
    }
  ]
}